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Abstract 
 
During the course of the studies outlined in this thesis, an ether-directed Pd(II)-catalysed 
aza-Claisen rearrangement reaction that had previously been developed by the Sutherland 
group  was  expanded  to  include  more  functionalised  rearrangement  substrates.  This 
methodology  has  been  applied  for  the  synthesis  of  several  natural  products  including 
dihydroxylated-α-amino acids. 
 
Further  investigation  of  substrates  for  the  rearrangement  led  to  the  synthesis  of  δ,ε-
substituted  trichloroacetimidates.  Rearrangement  of  these  compounds  demonstrated  the 
role of 1,3-allylic strain on the stereocontrol of the rearrangement and also highlighted the 
role that solvent can have upon the diastereoselectivity of ether-directed rearrangements. 
 
In addition to this, a novel tandem aza-Claisen rearrangement and ring closing metathesis 
reaction  has  been  developed.  This  reaction  allows  the  synthesis  of  cyclic  allylic 
trichloroacetamides  in  excellent  yields  from  simple  allylic  alcohols.  The  use  of 
commercially available chiral rearrangement catalysts allowed a highly enantioselective 
tandem process to be developed. 
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Further development of this process has provided an ether-directed tandem aza-Claisen 
rearrangement and RCM reaction which occurs with high yield and diastereoselectivity to 
provide functionalised cyclic products. The use of these compounds for the total synthesis 
of the amaryllidaceae alkaloid (+)-γ-lycorane was also investigated. 
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1.0  Introduction 
1.1  Aza-Claisen Rearrangements 
Synthetic organic chemists in the 21
st century have a hugely diverse range of reaction 
methodologies and synthetic approaches at their disposal. In recent years, chemists have 
turned  their  attention  to  reactions  that  have  greater  atom  efficiency,  enhanced 
stereoselectivity and those that require less purification, whilst using less toxic reagents. 
All of these approaches are designed to reduce the environmental impact of the chemistry 
that is undertaken and increase the efficiency of synthetic applications.
1  
[3,3]-Sigmatropic  rearrangements  are  a  class  of  organic  reaction  that  is  highly  atom 
efficient. The reaction involves the migration of a σ-bond to form a new bond with a [3,3] 
relationship to the original bond, as such every atom from the starting reagent is retained in 
the product. The Claisen rearrangement is one of the most well known types of [3,3]-
sigmatropic  rearrangement  and  was  originally  discovered  by  Ludwig  Claisen  in  1912 
(Scheme 1).
2 There are several different variants of the Claisen rearrangement, many of 
which have found widespread use in synthetic chemistry.
3 
EtO O
O
EtO O
O
∆
NH4Cl
 
Scheme 1 - The first aliphatic Claisen rearrangement 
One such variant,  widely  used in synthetic  chemistry is the  aza-Claisen rearrangement 
reaction (Scheme 2). This is the [3,3]-sigmatropic rearrangement of an allylic imidate 1 to 
the amide 2, containing both an oxygen and nitrogen atom. 
O NH
X
O NH
X
X= H, Ar, CCl3, CF3
1 2
 
Scheme 2 - Aza-Claisen rearrangement 
The  aza-Claisen  rearrangement  was  first  reported  by  Mumm  and  Möller  in  1937  who 
reported the rearrangement of an allylic benzimidate to the corresponding benzamide.
4 10 
However,  this  reaction  did  not  see  widespread  application  until  1974  when  Overman 
developed the rearrangement of allylic trichloroacetimidates 3 to the corresponding allylic 
trichloroacetamides  4  (Scheme  3).
5  This  reaction  (often  referred  to  as  the  Overman 
rearrangement) has been widely used in synthetic chemistry over the last 30 years due to 
the relative ease with which a wide variety of allylic trichloro- and trifluoroacetimidates 
can be prepared from the corresponding allylic alcohol.
6  
1.1.1  Thermal Overman Rearrangement 
Overman  reported  both  the  thermal  and  metal  catalysed  aza-Claisen  rearrangement  of 
allylic  trichloroacetimidates.
5,7  The  thermal  reaction  typically  occurs  at  elevated 
temperatures  of  approximately  140 
oC,  usually  in  aromatic  solvents  such  as  p-xylene, 
whilst the metal catalysed process is normally conducted at room temperature. 
The thermal process proceeds via a highly ordered chair-like transition state and obeys 
Woodward  Hoffmann  rules  which  state  that  in  a  thermal  pericyclic  reaction,  the  total 
number  of  (4q+2)s  and  (4r)a  components  must  be  odd.
8  The  thermal  aza-Claisen 
rearrangement has 3 components (one σ-bond and two π-bonds), although only the alkene 
π2s component is counted. As such the rearrangement has one (4q+2)s component and no 
(4r)a components (an odd number) so this suprafacial process is thermally allowed. The 
mechanism for this thermal reaction has been shown to occur via a concerted pathway, 
although a competing non-concerted ionisation pathway leading to the [1,3]-rearranged 
product has been observed.
9 A concerted mechanism means that the reaction proceeds with 
excellent  transfer  of  chirality  from  the  starting  material  to  the  amide  product.  This  is 
because the new C-N bond forms on the same face as to where the C-O σ-bond breaks, 
thus making the reaction extremely useful in organic synthesis (Scheme 3). 
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3 4  
Scheme 3 - Thermal rearrangement of allylic trichloroacetimidates 
The thermal process has been shown to obey first order kinetics,
7 whilst the rate of reaction 
is also affected by both steric and electronic effects of the substrate, thus leading to large 11 
variations in reactivity between different substrates.
6 In particular, E-imidates usually react 
more rapidly than Z-imidates due to the fact that they are less stable. 
The reaction is driven to completion by a negative change in enthalpy associated with the 
conversion of the imidate to the corresponding amide, with a negative enthalpy change of 
approximately 15 kcal mol
-1.
10,11 As such, this process is effectively irreversible.  
1.1.2  Metal catalysed aza-Claisen rearrangement 
Initially  Overman  reported  the  metal  catalysed  aza-Claisen  rearrangement,  using 
mercury(II) salts,
5,7 however it has subsequently been shown that a variety of transition 
metals (including Pd, Au and Pt) can catalyse the rearrangement process.
3,12-14 The metal 
catalysed  aza-Claisen rearrangement has been shown to increase the reaction rate very 
significantly (by approximately the order of 10
12).
5 This rate enhancement often allows the 
reaction to proceed at room temperature and under much milder conditions than for the 
thermal process, often giving the rearrangement products in improved yields. 
Palladium(II) has emerged as the most effective catalyst for the aza-Claisen rearrangement, 
this is because it equilibrates with the substrate more quickly than other transition metal 
catalysts and as such in most cases, the reaction proceeds more rapidly and in higher yield. 
As a result it is also usually possible to use lower catalyst loadings if palladium(II) is used 
as catalyst.
15,16 Extensive studies by Overman and others have shown that the palladium 
(II)-catalysed process is likely to proceed by a cyclisation induced mechanism (Scheme 
4).
9,16-18 This mechanism proceeds via a stepwise pathway where the alkene of the imidate 
substrate 6 is subjected to carbo-palladation 7, thus activating the olefin to antarafacial 
nucleophilic attack from the imidate nitrogen. This leads to the formation of the cyclic 
carbocation intermediate 8, which then rapidly undergoes Grob-like fragmentation to give 
the amide product 5,
6,16,19 thus regenerating the catalyst to react with a second imidate 
molecule. In a similar way to the thermal process, amide formation is irreversible and is 
the driving force for the reaction.  12 
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Scheme 4 - Mechanism of Pd(II)-catalysed Overman rearrangement 
The  above  mechanism  is  similar  to  that  previously  proposed  by  Henry  for  the 
rearrangement of allylic esters.
20 Schenck and Bosnich have also suggested that the cyclic 
carbocation intermediate 9 formed during the reaction adopts a chair-like conformation, 
with the bulky metal complex at C2, in the equatorial position (Scheme 5).
18 This chair-
like transition state would be the most stable and as such explains why the process occurs 
with complete suprafacial transfer of chirality, as the new C-N bond forms on the same 
face as the breaking C-O bond.  
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9  
Scheme 5 - Proposed chair-like transition state  
The metal catalysed aza-Claisen rearrangement has broad scope and can be applied to a 
wide variety of primary and secondary imidates. Early work by Overman demonstrated 
that the imidates must have a substituent at C-3 that favours nucleophilic attack from the 
imidate nitrogen (Scheme 6).
21 Imidates that favour C-2 attack such as 10 do not rearrange, 
whereas  imidate  11  (which  favours  C-3  attack)  rearranges  successfully.  In  addition, 
substitution at the C-2 position is not favoured as this is where the metal catalyst is thought 
to  coordinate  (see  Scheme  5  above).  Only  C-2  substituted  imidate  substrates  with  an 13 
electron  donating  group  (which  stabilises  the  transition  state)  at  C-3  will  undergo 
rearrangement.
22 
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Scheme 6 - Scope of metal catalysed rearrangement 
1.2  Enantioselective aza-Claisen Rearrangement 
Following the development of a metal catalysed rearrangement process, recent efforts have 
turned to developing an enantioselective variant of the aza-Claisen rearrangement for use 
in  asymmetric  synthesis.  Early  applications  of  the  aza-Claisen  rearrangement  as  a  key 
synthetic step were either non-enantioselective,
23 or made use of a chiral secondary imidate 
to introduce stereoselectivity via chirality transfer.
24,25 This clearly placed limits on the 
application of this reaction in modern organic synthesis where stereoselective synthetic 
methods are of great importance. Different approaches to develop a stereoselective aza-
Claisen rearrangement to address this problem have been developed. 
A variety of chiral metal catalysts have been developed to introduce enantioselectivity to 
the rearrangement process. 
1.2.1  Diamine catalysts 
Overman developed the first chiral catalyst for the aza-Claisen rearrangement in 1997.
26 
Initially  bis(oxazoline)  palladium(II)  catalysts  were  synthesised,  however  these  were 
largely  unsuccessful.  Cationic  diamine  palladium  complexes  14,  proved  to  be  more 
successful. The catalysts were constructed from two diamine ligands, synthesised from (S)-14 
proline and could catalyse the rearrangement of various benzimidate substrates including 
12, to the amides such as 13, in good yield and modest enantioselectivity (Scheme 7).  
F3C
N O
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F3C
N O
Ph Pd
Cl Cl
Pd
N N
N N
(BF4
-)2
2+
12 13 14
14 (5 mol%)
DCM, 40
 oC
69% yield, 60% ee  
Scheme 7 - Overman's first chiral catalyst for the aza-Claisen rearrangement 
Unfortunately these cationic catalysts were incompatible with other imidate substrates (e.g. 
X= CCl3, CF3) and caused the formation of significant quantities of an undesired 1,3-
rearranged product, similar to 15, which is formed via a competing ionisation pathway 
(Scheme 8). Various elimination products were also formed using these catalysts.
9  
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Scheme 8 - [3,3]- and [1,3]- rearrangement pathways 
1.2.2  Ferrocenyl palladacycles 
Leung and co-workers reported similar cationic complexes to that reported by Overman 
and these suffered from the same problems of ionisation and elimination.
27 As such, new 
catalysts  that  were  less  prone  to  providing  products  associated  with  a  non-concerted 
ionisation pathway were required. Overman and co-workers were the first to develop such 
catalysts.
28  The  first  neutral  chiral  complexes  for  the  rearrangement  of  benzimidate 
substrates 16, were ferrocenyl palladacycles 18, consisting of a dimeric complex that gave 15 
much greater yields for the aza-Claisen rearrangement, whilst also eliminating formation of 
the undesired by-products (Scheme 9). Although the yield of the rearranged products 17 
was  greatly  enhanced  with  these  catalysts  (up  to  98%),  enantioselectivity  remained 
moderate at 61% ee. 
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Scheme 9 - Neutral chiral ferrocenyl palladacycle catalysts 
1.2.3  Ferrocenyl oxazoline (FOP) catalysts 
Significant enhancements of the enantioselectivity of the aza-Claisen rearrangement were 
reported  by  Donde  and  Overman,
29  who  synthesised  several  ferrocenyl  oxazoline 
complexes with structures similar to 19. These complexes catalysed the rearrangement of 
various benzimidate substrates 16 to the corresponding benzamides 17, in poor to excellent 
yields and in up to 92% ee (Scheme 10). Unfortunately, whilst these FOP catalysts gave 
much  improved  enantioselectivities,  initially  they  were  rather  limited  in  scope  being 
successful for benzimidate substrates only, which are not easily converted to synthetically 
useful products (e.g. the corresponding chiral allylic amines). Higher enantioselectivities 
were  achieved  using  Z-  rather  than  E-imidates,  although  enantioselectivities  with  E-
imidates were still very reasonable for some substrates. 
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Scheme 10 - Rearrangement using ferrocenyl oxazoline catalysts 16 
Later  Kang  and  co-workers  expanded  upon  this  work  to  synthesise  a  variety  of 
palladacycles  based  upon  complex  22  which  gave  improved  yields  of  the  rearranged 
products 21 whilst also providing excellent enantioselectivity (Scheme 11).
30 Once again 
the catalyst was limited in scope to benzimidate substrates 20. 
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Scheme 11 - Neutral ferrocenyl catalysts for the rearrangement developed by Kang 
In  2005,  Overman  and  co-workers  reported  a  comprehensive  evaluation  of  the  FOP 
catalyst  scaffold.
31  In  this  study  they  synthesised  a  variety  of  FOP  catalysts  25  and 
substrates 23 giving differing functionality of rearranged products 24 (Scheme 12). Results 
from this study led to an increase in the reported enantioselectivity achievable with these 
catalysts,  due  to  an  optimisation  of  both  the  catalyst  structure  and  its  substrate,  thus 
providing a greater understanding of the scope and activity of these FOP complexes.  
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Scheme 12 - Evaluation of FOP catalyst for the aza-Claisen rearrangement reaction 
Perhaps more importantly, this paper also showed that the FOP catalyst 25 could rearrange 
substrates containing removable protecting groups on the nitrogen atom. Best results were 
attained  with  E-trifluoroacetimidates  26  (CF3  at  position  R
2),  with  a  variety  of  aryl 
protecting groups at R
3. These substrates could readily undergo rearrangement to the amide 
27,  in  good  yield  and  ee  (although  somewhat  lower  than  with  the  corresponding 
benzimidates) but could then be readily cleaved to the synthetically useful allylic amines 
28 using sodium ethoxide to hydrolyse the trifluoroacetyl group, followed by treatment 
with CAN to remove the aryl group (Scheme 13).  17 
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Scheme 13 - Conversion of amide to allylic amine 
Although  FOP  complexes  25  catalyse  the  rearrangement  of  several  allylic  imidates  in 
excellent yield and enantioselectivity, they suffer from a number of drawbacks. Firstly, the 
air stable pre-catalysts must be activated with stoichiometric quantities of AgOCOCF3 to 
generate the active catalyst which is unstable to air and moisture. Secondly, although the 
substrate scope is broader for these catalysts than for previous examples it remains limited 
by the requirement for an aromatic substituent on the imidate and only limited tolerance of 
cleavable protecting groups (e.g. CF3). As such, attention turned to the development of a 
catalyst  that  would  not  require  pre-activation,  successfully  tolerate  a  wider  variety  of 
imidates  (particularly  the  readily  cleavable  CF3  and  CCl3  amides),  whilst  retaining 
excellent enantioselectivity. 
1.2.4  Cobalt Oxazoline Palladcycle (COP) Catalysts  
Cobalt  oxazoline  palladacycles  (COP)  29  (Figure  1),  have  recently  emerged  as  highly 
successful chiral catalysts for the aza-Claisen rearrangement. The COP scaffold was first 
reported by Richards,
32 but the first use of this complex as a catalyst for the aza-Claisen 
rearrangement was reported by Kang and co-workers,
33 who reported the rearrangement of 
allylic benzimidates using a AgOCOCF3 activated COP complex (Scheme 14). Excellent 
yields  and  enantioselectivities  of  rearranged  products  31  were  achieved  using  Z-
benzimidates 30, although results for the corresponding E-imidates were disappointing. 18 
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Figure 1 - COP-Cl catalyst complexes 
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Scheme 14 - Rearrangement of Z-benzimidates with an activated COP catalyst  
At  the  same  time,  the  groups  of  Overman  and  Richards  reported  the  use  of    COP 
complexes 29 for the aza-Claisen rearrangement of allylic trifluoroacetimidates (Scheme 
15).
34  Optimal  results  of  the  rearranged  products  33,  were  achieved  using  E-
trifluoroacetimidates 32  (80-85%  yield, 92-96% ee) in direct contrast to the results by 
Kang,
33  who  saw  very  poor  yields  and  enantioselectivities  with  E-benzimidates.  An 
additional advantage to this work by Overman was that COP-Cl complexes 29 did not 
require any pre-activation to achieve excellent yields and stereoselectivities, thus making 
this a more practical catalytic method.  
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Scheme 15 - Rearrangement of E-imidates with COP catalyst 
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Further improvements to this approach were reported by Anderson and Overman,
35 who 
demonstrated  that  COP-Cl  could  also  catalyse  the  rearrangement  of  E-allylic 
trichloroacetimidates  34,  to  the  trichloroacetamides  35,  in  excellent  yield  and 
enantioselectivity  (Scheme  16).  These  allylic  trichloroacetimidates  34  are  the  preferred 
substrates for the aza-Claisen rearrangement because they are readily synthesised from the 
corresponding allylic alcohols in high yields. 
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Scheme 16 - Highly enantioselective rearrangement of allylic trichloroacetimidates 
This paper also demonstrated the synthetic potential for these chiral trichloroacetamide 
products by their straightforward conversion to the oxazolidinones 36, bioactive natural 
products ((S)-vigabatrin 37) and α-amino esters 38 (precursors for unnatural amino acids) 
(Scheme 17).  
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Scheme 17 - Synthetic utility of chiral allylic trichloroacetamides 
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It has subsequently been demonstrated by Overman and co-workers that the loading of 
COP  catalysts  29  can  be  lowered  to  2  mol%  for  some  substrates  whilst  maintaining 
excellent  yield  and  enantioselectivity.
36  (S)-COP-Cl  29a  and  (R)-COP-Cl  29b  are  now 
commercially available aza-Claisen rearrangement catalysts.
36,37 
Recently,  Overman  and  co-workers  have  reported  a  comprehensive  kinetic  and 
computational study of COP-Cl catalysed aza-Claisen rearrangements.
19 The purpose of 
this study was to probe in more detail the reaction mechanism and provide insights into the 
further development of these chiral catalysts. Data from this study further supported the 
cyclisation-induced reaction mechanism that had previously been proposed (discussed in 
section 1.1). In addition to this, the study identified a previously undiscovered palladium-
imidate complex 39 (Figure 2), which appears to be the resting state of the catalyst. It is 
unclear what role (if any) this complex plays in the rearrangement reaction mechanism as 
both kinetic and computational calculations conducted during this study, supported the 
formation  of  a  palladium-olefin  intermediate,  which  activates  the  C=C  double  bond  to 
nucleophilic attack from the imidate nitrogen. Further data also supported the hypothesis 
that C-N bond formation is indeed both the rate- and enantio-determining step, leading to 
formation of a six-membered cyclic alkyl palladium intermediate, which rapidly fragments 
to give the trichloroamide product. 
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Figure 2 - COP-Cl-imidate complex as observed by Overman 
In  addition,  these  results  also  supported  previous  work  by  the  Overman  and  Richards 
groups  that  suggested  enantioselectivity  of  COP-Cl  catalysed  rearrangements  was  the 
result of planar chirality of the tetraarylcyclobutadiene ligand and not the chirality on the 
oxazoline  substituent.
38  It  was  proposed  that  increasing  the  steric  bulk  of  the 
tetraarylcyclobutadiene ligand should further enhance enantioselectivity. This is because 
the  transition  state  leading  to  formation  of  the  undesired  enantiomer  would  be  further 
disfavoured due to steric hindrance. The synthesis of COP-Cl is achieved by a modular 21 
synthesis  so  the  authors  suggested  that  bulkier  ligands  should  be  easily  introduced  to 
provide more selective COP catalysts. 
At a similar time, Richards and Nomura reported a study showing that COP with a Cl 
ligand is the favoured catalyst of this type, due to the fact that chlorine is a better leaving 
group than other similar ligands (e.g. Br, I, OAc).
39 They also showed that if the reaction 
was performed at elevated temperatures then the catalyst loading could be lowered to only 
0.25  mol%,  whilst  still  maintaining  good  yields  and  excellent  enantioselectivities. 
Problems  with  purification  of  a  large  scale  reaction  led  to  the  synthesis  of  a  polymer 
supported  rearrangement  catalyst  40  (Figure  3)  which  retained  excellent  yields  and 
enantioselectivities whilst reducing problems with purification. Recycling of the catalyst 
led  to  disappointing  yields  in  further  reactions  but  excellent  enantioselectivities  were 
retained. This could be a promising area for future study if a truly recyclable polymer 
supported chiral catalyst could be developed.  
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Figure 3 - Polymer supported COP-Cl catalyst 
1.2.5  Ferrocenylimidazoline Palladacycle (FIP) Catalysts 
Peters and co-workers have recently reported an alternative rearrangement catalyst to the 
COP  complexes.  These  ferrocenylimidazoline  palladacycles  (FIP)  41  (Figure  4)  are 
excellent  chiral  catalysts  for  the  aza-Claisen  rearrangement  of  N-para-methoxyphenyl 
trifluoroacetimidates such as 42.
40  22 
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Figure 4 - Peters' FIP catalyst 
The  catalyst  is  most  effective  with  Z-imidates  as  these  (in  direct  contrast  to  the  COP 
catalysts) react more quickly and in much higher yield than with E-imidates (Scheme 18). 
Interestingly, FIP catalysts also give the opposite enantiomer to that reported for the COP 
catalysts by Overman.
34 It is also possible to use much lower catalyst loadings using this 
FIP catalyst (as low as 0.1 mol%) than has been reported typically for the COP complexes. 
Yields and enantioselectivities of the rearranged products 43, are generally superior than 
those achieved using other chiral complexes but the FIP complex must be pre-activated by 
stoichiometric quantities of a silver salt prior to use and a proton sponge is also added to 
the reaction as an acid scavenger to suppress formation of by-products via an ionisation 
pathway. The COP-Cl catalysts prepared by Overman do not require this. 
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MeO 41 (0.1-5.0 mol%) 
6 mol% AgOTf
42 43
PS, DCM, RT
up to 98% ee  
Scheme 18 - Rearrangement using activated FIP catalyst 
In a later paper, Peters and co-workers reported that the FIP catalysts can tolerate a wide 
variety  of  different  alkyl  groups  attached  to  the  (Z)-N-para-methoxyphenyl 
trifluoroacetimidate rearrangement substrates 44.
41 As a result, the catalyst could be used 
to prepare several highly enantiopure allylic amines 45, which are useful building blocks 
for organic synthesis (Table 1). 23 
Catalyst Loading (mol%) yield ee
(CH2)2CO2Me
(CH2)2C(=O)Me
(CH2)3OBn
(CH2)3N(Bn)Boc
CH2OTBS
CH2OTHP
CH2OBn
0.5
0.5
0.2
0.2
0.05
0.2
0.2
98%
97%
100%
99%
94%
94%
99%
98%
97%
97%
98%
97%
98%
96%
O R CF3
R
N
MeO
R
N CF3
O
MeO 41 (X mol%)
6 mol% AgOTs, PS
CHCl3, 55 
oC, 72 h
44 45
 
Table 1 - Asymmetric synthesis of functionalised allylic amines 
The  above  results  clearly  demonstrate  that  these  FIP  catalysts  could  find  significant 
applications  in  the  asymmetric  synthesis  of  a  variety  of  nitrogen  containing  natural 
products. The FIP catalysts are readily synthesised in only 4 steps from ferrocene and 
although  they  require  pre-activation,  the  high  yields  and  enantioselectivities  achieved 
coupled with excellent functional group tolerance makes them good alternatives (especially 
for Z-imidates) to the COP-Cl catalysts. 
1.2.6  Conclusions to chiral catalysts 
Significant  attention  has  turned  to  the  development  of  chiral  catalysts  for  use  in  a 
stereoselective aza-Claisen rearrangement. Efforts in this area have led to several highly 
effective  catalysts  for  use  in  this  reaction  and  have  been  the  subject  of  several 
comprehensive  reviews.
6,13,14  One  drawback  of  this  approach  is  that  the  most 
enantioselective catalysts often suffer from substrate specificity issues due to their highly 
complex  and  bulky  nature.  As  has  already  been  highlighted  in  this  short  overview, 
extensive  efforts  to  tailor  the  activity  of  catalysts  to  suit  different  substrates  can  take 
considerable  time  and  require  the  synthesis  and  screening  of  many  different  catalyst 
complexes.  
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1.3  Substrate directed aza-Claisen rearrangement 
Another approach to introduce stereoselectivity in the aza-Claisen rearrangement reactions 
involves  the  use  of  a  chiral  substrate  to  direct  the  stereochemical  outcome  of  the 
rearrangement. This is achieved by coordination of the directing group to the achiral metal 
catalyst  and  as  such  this  type  of  approach  is  more  flexible  than  for  the  use  of  chiral 
catalysts and in theory can be applied to a much broader number of substrates. It does 
however, require an asymmetric centre on the molecule close enough to coordinate to the 
catalyst to exert a directing effect upon the rearrangement process. Diastereoselectivities 
can also be somewhat variable as this is controlled by the effectiveness of the directing 
group. 
The  first  example  of  a  substrate  directed  aza-Claisen  rearrangement  was  reported  by 
Bellûs, for the synthesis of diamines.
42 Bellûs synthesised allylic alcohol 46 containing a 
chiral Boc protected nitrogen. This nitrogen directing group was then used successfully for 
the  palladium(II)-catalysed  rearrangement  of  47  to  give  the  anti-diastereomer  48  with 
excellent diastereoselectivity, although yields were fairly modest (Scheme 19). 
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Scheme 19 - The first substrate directed rearrangement 
It was postulated that the significant anti-diastereoselectivity of this process was the result 
of rearrangement via a chair-like transition state 49, with coordination of the palladium 
catalyst  to  both  the  amine  nitrogen  atom  and  double  bond  forcing  the  nitrogen  of  the 
trichloroacetimidate to attack from the opposite face when forming the new stereocentre. 
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Scheme 20 - Coordination of nitrogen to Pd(II) directs the rearrangement 25 
Work by Jamieson and Sutherland has demonstrated that ether directing groups can be 
employed  in  the  substrate  directed  aza-Claisen  rearrangement  of  allylic 
trichloroacetimidates.
43 The directing effect is believed to occur in a similar fashion to that 
described by Bellûs, in that the oxygen atom coordinates to the metal catalyst, once again 
giving  the  anti-diastereomer  as  the  major  product  of  the  rearrangement.  A  number  of 
different ether groups were tested and it was discovered that the methoxymethyl (MOM) 
ether 50 was the most selective, giving the rearranged products 51 in 64% yield and in a 10 
:  1  ratio  of  diastereomers  (Scheme  21).  The  importance  of  the  oxygen  atoms  of  this 
directing  group  was  subsequently  demonstrated  by  the  comprehensive  synthesis  and 
rearrangement of several analogues of the MOM group.
43,44 
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Scheme 21 - MOM ether-directed rearrangement 
These results clearly demonstrated that an oxygen atom adjacent to the alkene is crucial for 
diastereoselectivity, whilst the presence of a second oxygen atom on the MOM ether leads 
to  an  enhancement  in  this  diastereoselectivity  due  to  the  coordination  of  both  oxygen 
atoms to the palladium catalyst (Scheme 22).  26 
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Scheme 22 - Coordination of oxygen atoms to palladium 
Sutherland and co-workers then expanded upon this work with the synthesis of several 
MOM  protected  trichloroacetimidates  52,  with  a  variety  of  side-chains.
45  These  all 
underwent diastereoselective rearrangement to the corresponding trichloroacetamides 53 
and demonstrated the flexibility of a substrate directed rearrangement approach to a variety 
of different substrates. In some cases however, formation of the [1,3]-rearranged product 
was  observed.  This  was  most  apparent  with  bulkier  substrates  which  rearrange  fairly 
slowly.  These  slower  rearrangements  allowed  Pd(0)  to  eliminate  from  the  cyclisation 
induced pathway and this then catalysed formation of the [1,3]-product via the ionisation 
pathway that had previously been reported by Ikariya.
9 This problem was overcome by 
addition  of  the  in  situ  oxidant  p-benzoquinone,  to  re-oxidise  the  Pd(0)  to  Pd(II),  thus 
inhibiting formation of the [1,3]-products and increasing the yield of the desired [3,3]-
products (Table 2).  
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Table 2 - Suppression of 1,3-products using an in situ oxidant 
The trichloroacetamides 53a, formed as major products from these rearrangements, were 
converted to the corresponding ￿-hydroxy-￿-amino acids 54 using an oxidation procedure 27 
first reported by Sharpless;
46 hydrolysis of the protecting groups under acidic conditions 
then gave the target amino acid products (Scheme 23). 
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Scheme 23 - β β β β-Hydroxy-α α α α-amino acids 
Further work by the Sutherland group using a catalyst screen to study the rearrangement, 
showed that a variety of transition metal complexes including: Pd(II), Pt(II) and Au(III) 
could be successfully employed with high diastereoselectivity as catalysts for the ether-
directed  aza-Claisen  rearrangement.  Although  no  catalyst  was  seen  to  exceed  the 
capabilities  that  had  previously  been  observed  with  PdCl2(MeCN)2,  which  is  the  most 
commonly employed metal catalyst for this reaction. A solvent screen was also employed 
and this showed that switching from THF, a known coordinating solvent, to toluene which 
is a non-coordinating solvent, leads to a great enhancement in diastereoselectivity (from 10 
: 1 to 15 : 1) (Table 3).
47 This enhancement of selectivity was explained by the fact that 
coordinating  solvents  (such  as  THF)  compete  with  the  chiral  ether  directing  group  to 
coordinate  to  the  palladium  catalyst,  reducing  its  effectiveness  in  controlling  the 
diastereomeric outcome of the rearrangement. Non-coordinating solvents (such as toluene) 
do  not  compete  with  the  directing  group  to  coordinate  with  the  catalyst,  thus  giving 
enhanced  diastereoselectivities  from  the  rearrangement  reaction.  Further  evidence  to 
confirm this was provided when the rearrangement was performed in a highly coordinating 
ionic liquid solvent. As expected, the diastereoselectivity was significantly reduced at 5 : 1. 28 
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47%
32%
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56%
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Table 3 - The effect of solvent upon MOM ether directing effect 
More  recently,  Jaunzeme  and  Jirgensons  have  reported  a  comparative  study  of  metal 
catalysts for the ether-directed aza-Claisen rearrangement (Table 3).
48 Their results showed 
that for δ-methoxy and δ-TBDMSO ethers, diastereoselectivity for the trichloroacetamide 
products 55a and 55b was enhanced if PtCl2 was used as catalyst. They also reported the 
formation of oxazoline 55c as a significant by-product in the δ-methoxy rearrangement 
reaction. 
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Catalyst yield (a+b) Ratio (a : b)
PtCl2
PtCl4
AuCl
AuCl3
PdCl2
PtCl2
PtCl4
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AuCl3
PdCl2
65%
35%
48%
41%
50%
11 : 1
10 : 1
  5 : 1
  5 : 1
  8 : 1
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RT, 24 h CCl3
O N
55a 55b 55c
R Ratio (a+b : c )
3 : 1
2 : 1
1 : 1
1 : 1
2 : 1
Me
TBDMS 85%
50%
70%
40%
62%
  6 : 1
  6 : 1
  2 : 1
  2 : 1
  2 : 1
  8 : 1
10 : 1
  5 : 1
  5 : 1
   n.d.
 
Table 4 - Ether-directed rearrangement by Jaunzeme and Jirgensons 29 
1.3.1  Conclusions to substrate directed rearrangement 
Substrate directed aza-Claisen rearrangements have emerged as an excellent alternative to 
chiral  catalysts  for  a  stereoselective  rearrangement.  Typically  a  chiral  directing  group 
capable of coordination to the achiral metal catalyst is required. MOM ether groups have 
been extensively studied as directing groups for the rearrangement and have been shown to 
have  broad  scope  for  a  variety  of  substrates.  The  rearrangement  is  often  more 
stereoselective  if  a  non-coordinating  solvent  is  employed  for  the  reaction.  Substrate-
directed rearrangement is a flexible methodology that has broad scope; as such it has seen 
a variety of applications in natural product synthesis making it an excellent alternative to 
chiral catalysis.  
1.4  Applications in Natural Product Synthesis 
Aza-Claisen rearrangements have found widespread application in the synthesis of natural 
products since Overman first reported the rearrangement of allylic trichloroacetimidates to 
the corresponding amides in 1974.
5 As highlighted previously, the reason why this reaction 
is so widely employed in organic synthesis is the relative ease in which the rearrangement 
substrates can be prepared from the corresponding allylic alcohols. In addition to this, both 
the thermal and metal-catalysed processes are well understood and generally proceed in 
high yield via a highly concerted reaction mechanism that occurs with excellent transfer of 
chirality. 
An early application of this reaction was reported by Overman in 1975 for the synthesis of 
1-azaspiro[5.5]undec-7-en-2-one 59 (Scheme 24), which is a precursor for a number of 
spirocyclic  natural  products.
49  In  this  paper,  a  thermal  aza-Claisen  rearrangement  was 
employed  as  a  key  step  in  the  synthesis.  Enone  56  was  converted  to  the 
trichloroacetimidate rearrangement substrate 57 via reduction of the ketone to the alcohol, 
followed  by  treatment  with  trichloroacetonitrile  and  base.  Overman  rearrangement  was 
carried out in refluxing p-xylene to give the trichloroacetamide product 58 in a modest 
yield. After successful synthesis of 58, the acetal protecting group was hydrolysed to the 
aldehyde and the aldehyde was oxidised to give the carboxylic acid. After hydrolysis of the 
trichloroacetyl  group  with  base,  spontaneous  cyclisation  gave  the  desired  spirocyclic 
product 59. This synthesis by Overman highlighted at an early stage, the great synthetic 
potential of this reaction in the synthesis of complex organic compounds.  30 
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Scheme 24 - Overman synthesis of 1-azaspiro[5.5]undec-7-en-2-one 
Danishefsky and co-workers reported the use of a thermal Overman rearrangement as a 
key step in their 1989 synthesis of (±)-pancratistatin 64.
50 Pancratistatin 64 is an alkaloid 
natural product that has potent biological activity against many cancers and also possesses 
antiviral  activity.
51  As  such,  there  has  been  much  interest  in  the  development  of  total 
syntheses towards this potential drug target. This first total synthesis of (±)-pancratistatin 
64 was achieved from the simple aromatic starting material pyrogallol 60 (Scheme 25), 
which  was  converted  in  several  steps  to  allylic  alcohol  61.  Compound  61  was  readily 
converted under standard conditions to the corresponding allylic trichloroacetimidate 62, 
which  upon  heating  under  vacuum  in  the  absence  of  any  solvent  underwent  Overman 
rearrangement to the trichloroacetamide 63 in 56% yield. The rearranged product 63 was 
then subjected to dihydroxylation and following treatment with base to unmask the amine 
and carboxylic acid, cyclisation with DCC gave, after cleavage of the benzyl protecting 
groups, the target compound (±)-pancratistatin 64, in only four steps from 63. This very 
elegant synthetic approach by Danishesky made use of the concerted nature of aza-Claisen 
rearrangements to transfer chirality from the allylic alcohol to the new C-N bond. 31 
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Scheme 25 - Danishefsky's synthesis of (±)-pancratistatin 
Another example of the utilization of the suprafacial nature of the Overman rearrangement 
to give the desired chirality on the trichloroacetamide product was reported by Kim and co-
workers  who  used  the  Overman  rearrangement  in  their  synthesis  of  the 
phenanthroindolizidine  and  phenanthroquinolizidine  alkaloids  (-)-antofine  70  and  (-)-
cryptopleurine 71 (Scheme 26).
52 These alkaloids are known for their potent cytoxicity 
hence the interest in their asymmetric synthesis. The synthesis was achieved by a Stille 
coupling of aromatic compound 65 using the chiral stannyl alcohol 66, to give the allylic 
alcohol 67 in excellent  yield. Synthesis of the  allylic trichloroacetimidate 68 was then 
achieved under standard conditions. Overman rearrangement of 68 gave 69 as a single 
enantiomer,  in  an  excellent  93%  yield.  Rearranged  product  68  was  then  further 
functionalised  to  complete  the  asymmetric  syntheses  of  (-)-antofine  70  and  (-)-
cryptopleurine 71. 32 
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Scheme 26 - Synthesis of (-)-antofine and (-)-cryptopleurine via Overman rearrangement 
The  above  examples  make  use  of  chirality  transfer  to  introduce  the  correct  relative 
stereochemistry  in  the  new  C-N  σ-bond  formed  during  the  aza-Claisen  rearrangement. 
However, recent developments of an asymmetric aza-Claisen rearrangement reaction using 
either  chiral  catalysis  or  a  substrate  directed  rearrangement  have  opened  many  new 
opportunities for the reaction to be employed in asymmetric synthesis. 
As mentioned previously Overman and co-workers have demonstrated the application of 
their COP-Cl chiral catalyst 29 to the synthesis of the natural product (S)-vigabatrin 37 and 
precursors of unnatural amino acids (Scheme 17).
31 Despite this there are still relatively 
few examples of these COP complexes being applied to natural product synthesis. This is 
perhaps due to the relatively recent advances in the development of these chiral catalysts, 33 
such as COP-Cl, which have only been commercially available for a short time. It is also 
possible  that  further  development  of  these  catalysts  is  required  to  make  them  more 
practical catalysts for the complex substrates that are often required for the synthesis of 
natural products. 
One example of the application of chiral catalysts to natural products has been recently 
reported by Han and co-workers in their synthesis of (+)-iso-6-cassine 73.
53 The target 
compound has three stereocentres and the first was introduced via enzymatic resolution. 
An  (S)-COP-Cl  catalysed  asymmetric  aza-Claisen  rearrangement  was  then  used  to 
establish the second stereocentre. The trichloroacetamide product 72 of this rearrangement 
was  then  used  to  direct  the  introduction  of  the  third  stereogenic  centre  through  a 
diastereoselective intramolecular amido mercuration. Cross metathesis was then employed 
to introduce the side-chain of the target compound 73 (Scheme 27). 
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Scheme 27 - Synthesis of (+)-iso-6-cassine by Han and co-workers 
Peters and co-workers have demonstrated the application of their highly enantioselective 
FIP  catalysts  76  to  the  synthesis  of  several  interesting  organic  compounds  (Scheme 
28).
54,55  In  particular,  the  catalyst  can  be  used  for  the  enantioselective  synthesis  of 
quaternary centres, which is something that still remains a significant challenge in organic 
synthesis.  This  process  is  even  more  remarkable  in  that  excellent  yields  and 
enantioselectivities  could  be  achieved  with  very  low  catalyst  loadings  (0.5-4.0  mol%) 
making this process highly efficient. The rearranged products such as 75 synthesised from 
imidate 74, were converted to a number of secondary allylic amines 78, which could then 34 
undergo further manipulation to synthesise α,α-disubstituted α-amino acids 77 and β,β-
disubstituted β-amino acids 79.  
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Scheme 28 - Stereoselective synthesis of amino acids with quaternary centres 
A common application of aza-Claisen rearrangements in natural product synthesis is the 
synthesis of chiral secondary amines which themselves are precursors for the synthesis of 
various unusual amino acids. As mentioned previously, the Bellûs and Sutherland groups 
have both made use of a substrate-directed rearrangement to synthesise several of these 
compounds.
42,45,56 
Jamieson  and  Sutherland  have  recently  employed  a  substrate  directed  aza-Claisen 
rearrangement for the synthesis of the alkaloid natural product (+)-α-conhydrine 82.
57 In 
this  approach,  the  trichloroacetamide  product  80  of  the  highly  diastereoselective 
rearrangement was converted to the N-heterocycle 83 of the target compound using ring 
closing  metathesis  of  the  diene  81  (Scheme  29).  This  approach  demonstrated  that  the 
trichloroacetyl  protecting  group  could  be  removed  and  the  amine  undergo  further 
functionalisation to give (+)-α-conhydrine 82 and a pyrrolidine analogue 84 that is also 
known to have biological activity.  35 
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Scheme 29 - Synthesis of (+)-α α α α-conhydrine using a substrate directed rearrangement 
Aza-Claisen  rearrangements  have  also  found  application  for  the  synthesis  of  complex 
carbohydrates. A recent example of this has been reported by Nguyen and co-workers for 
the stereoselective synthesis of glycosyl ureas (Scheme 30).
58 In this paper, the authors 
synthesised a number of N-glycosyl trichloroacetamides 86 and 87 from the corresponding 
N-glycosyl imidates 85. Interestingly, it was possible to exert control over the α- and β- 
stereoselectivity of the rearranged compound at the anomeric position. This was achieved 
through the choice of the palladium(II) catalyst that was employed for the aza-Claisen 
rearrangement.  Cationic  palladium(II)  complexes  gave  predominantly  the  α-N-glycosyl 
trichloroacetamide 86, whilst neutral palladium(II) catalysts were shown to favour the β-N-
glycosyl trichloroacetamide 87. Hydrolysis of the trichloroacetyl group then allowed the 
easy introduction of a variety of amine substituents, giving rise to several different α-
glycosyl 88 or β-glycosyl ureas 89 for biological evaluation of their anti-bacterial activity. 
The  selectivity  of  this  process  was  explained  by  the  fact  that  cationic  palladium(II) 
catalysts have been shown to coordinate to the imidate nitrogen,
26 thus promoting a non-
concerted  ionization  pathway,  which  leads  to  formation  of  α-N-glycosyl 
trichloroacetamide 86. Neutral palladium(II) complexes coordinate instead to the olefin, 
promoting  a  concerted  cyclisation  mechanism,
19,35  thus  leading  to  formation  of  β-N-
glycosyl trichloroacetamide 87.  36 
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Scheme 30 - Stereoselective synthesis of glycosyl ureas 
1.4.1  Conclusions 
Aza-Claisen rearrangement has been employed as a key step in the synthesis of many 
natural products. Recent advances in highly  enantioselective chiral catalysts potentially 
broaden its synthetic applicability and examples of the use of commercially available COP-
Cl catalysts in natural product synthesis have recently been reported. In addition to this, the 
development of highly diastereoselective substrate-directed rearrangement methodologies 
has also provided an excellent approach for the synthesis of a variety of natural products. 
Both of these approaches provide significant scope for further development, to enable even 
more elaborate methodologies and applications in asymmetric organic synthesis. 37 
2.0  Results and Discussion 
2.1  Studies  on  the  aza-Claisen  rearrangement  of  dihydroxylated 
allylic  trichloroacetimidates:  synthesis of  2-amino-3,4-dihydroxybutyric 
acids. 
2.1.1  Hydroxylated amino acids 
Hydroxylated natural products are widely prevalent in nature, many of which also possess 
biological  activity.
59  As  such  there  is  great  interest  in  new  methodologies  for  their 
stereoselective synthesis to enable full evaluation of these compounds for the treatment of 
disease.  
(2R,3S)-2-Amino-3,4-dihydroxybutyric acid 90 is one such hydroxylated natural product 
(Figure 5). It was first isolated by Sasaoka and co-workers from the edible mushroom 
Lyophyllum ulmarium.
60 Although this compound does not possess any known biological 
activity, it represents an interesting initial target to investigate the effect of more complex 
and functionalised substrates upon the ether-directed aza-Claisen rearrangement reaction, 
whilst also demonstrating the use of this methodology for the stereoselective synthesis of 
functionalised natural products. 
As  such,  it  was  proposed  to  undertake  the  synthesis  of  both  (2R,3S)-2-amino-3,4-
dihydroxybutyric acid 90 and its unnatural (2S,3S)-diastereomer 91 (Figure 5), with the 
key C-N stereocentre at C2, introduced via a diastereoselective aza-Claisen rearrangement. 
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Figure 5 - (2R,3S)-2-Amino-3,4-dihydroxybutyric acid and its (2S,3S)-diastereomer 
2.1.2  Synthesis of (2S,3S)-2-amino-3,4-dihydroxybutyric acid 
The  strategy  to  prepare  the  above  amino  acids  was  to  synthesise  a  4,5-dihydroxylated 
allylic alcohol which upon conversion to the corresponding allylic trichloroacetimidate and 
subsequent  aza-Claisen  rearrangement  should  provide  the  two  diastereomers  that  were 38 
required. Conversion of these compounds to the desired amino acids should then be easily 
achieved. Previously the Sutherland group have shown that chiral ether groups can direct 
the aza-Claisen rearrangement of allylic trichloroacetimidates in a highly diastereoselective 
fashion.
43  It  has  also  been  shown  that  the  oxygen  adjacent  to  the  olefin  is  critical  for 
diastereoselectivity.
44  It  was  proposed  that  the  acetonide  protected  allylic 
trichloroacetimidate  97  might  undergo  a  diastereoselective  rearrangement  in  a  similar 
manner.  
The synthesis of an acetonide protected allylic alcohol 96 was achieved in 3 steps from 
commercially available chiral pool starting material, D-mannitol 92 (Scheme 31). Firstly 
92  was  protected  as  the  acetonide  at  the  1,2-  and  5,6-  positions,  using  2,2-
dimethoxypropane 93. A one-pot oxidation with sodium periodate (oxidative cleavage of 
94,  gave  two  equivalents  of  the  aldehyde)  followed  by  Horner-Wadsworth-Emmons 
(HWE)  reaction  under  conditions  reported  by  Masamune  and  Roush,  which  uses 
triethylphosphonoacetate, LiCl and DBU,
61 gave exclusively the E-α,β-unsaturated ester 
95. The geometry of the resulting alkene could be easily determined from the 
1H NMR 
spectrum of the product (Figure 6). In this example, the alkene protons show a 15.7 Hz 
coupling constant proving that the geometry is trans. All unsaturated esters synthesised by 
this method, showed this coupling pattern and a coupling constant greater than 15.0 Hz, 
thus demonstrating that in all reactions the synthesised product was the E-alkene.  
 
Figure 6 - Alkene signals in 
1H NMR spectrum of compound 95 39 
Following this, reduction of the ester 95 using DIBAL-H then gave the desired allylic 
alcohol  96  in  excellent  yield.  Compound  96  could  then  be  readily  converted  to  the 
corresponding allylic trichloroacetimidate 97, which was used without further purification. 
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Scheme 31 - Synthesis of allylic trichloroacetimidate 97 
Allylic  trichloroacetimidate  97  was  then  subjected  to  a  Pd(II)-catalysed  aza-Claisen 
rearrangement using standard conditions (Table 5, entry 1). Surprisingly, no [3,3]-product 
was formed, with only the deprotected [1,3]-product 98c isolated. This compound likely 
forms  via  Pd(II)-catalysed  hydrolysis  of  the  acetonide  followed  by  1,3-rearrangement 
through a known competing ionisation pathway.
9,45 Previously Schmeck and Hegedus have 
reported  the  hydrolysis  of  acetonides  by  palladium  in  aqueous  acetonitrile,
62  but  it  is 
surprising to observe the hydrolysis also occurring in anhydrous solvents.  
In an effort to overcome this problem, a variety of metal catalysts were screened in DCM 
in an attempt to find reaction conditions that would provide the desired [3,3]-products 98a 
and  98b,  whilst  eliminating  formation  of  the  undesired  [1,3]-product  98c  (Table  5). 
Switching solvent (whilst also performing the reaction at 38 
oC) meant that the Pd(II)-
catalysed rearrangement (Table 5, entry 2) gave the two [3,3]-products 98a and 98b in a 
modest 32% yield (7 : 1 ratio, 98a : 98b). Unfortunately, significant quantities of the [1,3]-
product 98c were still formed. Other metal catalysts [Pt(II), Au(III) and Au(I)] were then 
employed for the rearrangement (Table 5, entries 3 - 5) without any improvement over that 
achieved  using  PdCl2(MeCN)2.  With  all  of  these  catalysts,  the  1,3-ionisation  pathway 40 
remained  a  problem,  preventing  the  formation  of  the  desired  products  in  synthetically 
useful yields. 
The rearrangement was also performed using the commercially available chiral COP-Cl 
catalysts (Table 5, entries 6 and 7).
36,63 These catalysts are very sterically hindered (see 
Chapter  1.2.4,  Figure  1)  and  it  was  hoped  that  this  would  prevent  hydrolysis  of  the 
acetonide group, whilst also giving an enhancement in diastereoselectivity. Rearrangement 
using  (S)-COP-Cl  catalyst  proceeded  in  an  excellent  81%  yield  (over  2  steps)  and  an 
outstanding 52 : 1 ratio of the expected (3R,4S) diastereomer 98b, with no [1,3]-product 
98c isolated. This is an example of a matched pairing as the chirality of both the substrate 
and chiral catalyst complement one another; the bulky catalyst coordinates to the opposite 
face to the existing (4S) stereocentre (so blocking the back side from attack) thus ensuring 
that the new C-N bond forms on the same side as the stereocentre and giving a significant 
enhancement in diastereoselectivity.  
Rearrangement using the mismatched (R)-COP-Cl proceeded much more slowly (14 days). 
This  is  because  the  bulky  catalyst  was  required  to  coordinate  to  the  same  side  of  the 
compound  as  the  existing  stereocentre.  As  expected,  this  resulted  in  lower 
diastereoselectivity of the [3,3]-products 98a and 98b, lower yields and some formation of 
the [1,3]-product 98c. 
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Table 5 - Rearrangement of acetonide protected trichloroacetimidate 97 41 
The highly successful rearrangement using (S)-COP-Cl provided significant quantities of 
the  (3R,4S)-diastereomer  98b  and  allowed  the  synthesis  of  (2S,3S)-2-amino-3,4-
dihydroxybutyric  acid  91  to  be  completed.  This  was  achieved  by  a  ruthenium(III)-
catalysed oxidation of allylic trichloroacetamide 98b, to the carboxylic acid 99, using a 
procedure reported by Sharpless (Scheme 32).
46 Deprotection of the amine and hydroxyl 
groups was then achieved using 6M hydrochloric acid, to give the target amino acid 91 in 
47% yield over 2 steps. 
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Scheme 32 - Synthesis of (2S,3S)-2-amino-3,4-dihydroxybutyric acid 
The  synthesis  of  (2S,3S)-2-amino-3,4-dihydroxybutyric  acid  91  was  successfully 
completed in just 7 steps from D-mannitol 92. The use of the commercially available (S)-
COP-Cl gave excellent stereoselectivity for the S-stereocentre. Unfortunately the acetonide 
protecting group was readily cleaved under standard rearrangement conditions, meaning 
that it was impossible to synthesise the opposite 2R-stereocentre selectively, which was 
required to synthesise the natural butyric acid isomer, in practical yields. Consequently, a 
second synthetic route was employed, making use of more stable protecting groups. 
2.1.3  Synthesis of (2R,3S)-2-amino-3,4-dihydroxybutyric acid 
A second synthetic approach was designed to begin from acetonide protected compound 
95. This was hydrolysed under acidic conditions to give the diol 100 in excellent yield 
(Scheme  33).  Protecting  groups  known  to  be  stable  to  metal  catalysed  aza-Claisen 
rearrangements  yet  easily  removed  in  subsequent  steps  were  required.  As  such  it  was 
decided to introduce a MOM ether at the secondary alcohol as this group has previously 
proved  to  both  withstand  rearrangement  conditions  and  also  to  provide  an  enhanced 
directing effect for the desired anti-diastereomer.
43,44 A silyl ether was chosen to protect 
the primary alcohol as these are also known to survive the rearrangement yet are readily 
cleaved under very mild conditions.
43,56  42 
Protection of the primary alcohol using the TBDPS ether proceeded smoothly to give 101 
in  quantitative  yield.  Initially,  the  less  bulky  TBDMS  ether  was  employed,  but  when 
introducing the MOM ether protecting group, the TBDMS was lost. This problem was 
successfully overcome by the use of the less labile TBDPS group. The MOM ether was 
then successfully introduced in excellent yield to give orthogonally protected diol 102. 
Reduction of the ester was once again successfully achieved in high yield using DIBAL-H, 
to give allylic alcohol 103 (Scheme 33). 
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Scheme 33 - Synthesis of the second trichloroacetimidate 
Allylic  alcohol  103  was  then  converted  to  the  allylic  trichloroacetimidate  104  and 
subjected to Pd(II)-catalysed aza-Claisen rearrangement in THF (Table 6, entry 1). This 
substrate  successfully  gave  the  [3,3]-products  105,  with  no  [1,3]-product  isolated. 
Unfortunately, the yield of the reaction was disappointing at 32% (over 2 steps) and in a 
rather modest 3 : 1 ratio for the desired anti-diastereomer 105a. In an attempt to improve 
both the yield and stereoselectivity, a catalyst screen was employed, whilst the solvent was 
also changed to toluene (which is a non-coordinating solvent and has recently been shown 
to improve the stereoselectivity of ether-directed aza-Claisen rearrangements) (Table 6).
47 
 43 
Rearrangement using PdCl2(MeCN)2 as catalyst in toluene gave a much improved 68% 
yield  of  the  [3,3]-products  105  and  the  reaction  was  complete  in  12  hours. 
Diastereoselectivity of the reaction was only slightly improved (4 : 1 in favour of anti 
diastereomer 105a) and this was somewhat surprising as previous results within the group 
had  shown  that  switching  to  toluene  as  a  solvent,  gave  a  significant  enhancement  of 
diastereoselectivity for MOM ether-directed rearrangements.
47 A likely explanation for this 
is that the bulky TBDPS group attached at the primary alcohol interferes with the directed 
rearrangement, meaning that the MOM ether coordinates less effectively to the catalyst, 
leading to a reduction in diastereoselectivity. It is likely that if a less bulky group could be 
introduced at the primary position then diastereoselectivity of the rearrangement would be 
improved. 
Once again Pt(II), Au(I) and Au(III) complexes were also tested with this substrate (Table 
6,  entries  3  -  6)  in  an  attempt  to  find  a  more  selective  catalyst.  All  of  these  metal 
complexes could successfully catalyse the rearrangement; however, yields were poor to 
modest (25-49%, over 2 steps). The diastereoselectivity was also quite variable (2 : 1 - 4 : 
1, 105a : 105b) and no catalyst was seen to give an improved diastereoselectivity when 
compared to PdCl2(MeCN)2. These results, coupled with the results from table 5, clearly 
demonstrate that for these dihydroxylated substrates Pd(II) is the most efficient catalyst for 
the rearrangement. As was discussed previously, palladium is an excellent metal catalyst 
for the Overman rearrangement and often provides the rearranged products in high yields 
and short reaction times. PdCl2(MeCN)2 is often used to catalyse the rearrangement as it 
possesses organic acetonitrile ligands which help to make the catalyst soluble in a wide 
variety of organic solvents. The excellent catalytic activity and solubility makes this the 
optimal  catalyst  for  ether-directed  aza-Claisen  rearrangements,  which  rely  on  a  rapid 
rearrangement process to allow the desired anti-diastereomer to be synthesised selectively 
in high yields and in preference to other competing reaction pathways.  
In  an  attempt  to  improve  the  diastereoselectivity  of  the  rearrangement  process,  allylic 
trichloroacetimidate 104 was subjected to rearrangement using (R)-COP-Cl. Although, this 
is  a  mismatched  catalyst-substrate  pairing,  (R)-COP-Cl  did  successfully  catalyse  the 
rearrangement in a 68% yield and an excellent 16 : 1 ratio (105a : 105b). The yield also 
compares favourably with PdCl2(MeCN)2 (also 68% in toluene).  44 
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Table 6 - Metal catalysed rearrangement of trichloroacetimidate 104 
For all rearrangements studied during the course of this PhD, the diastereomeric ratio was 
determined by examining the 
1H
 NMR spectra of the products. This is possible because the 
syn-and anti-diastereomers have different NMR spectra, which show dissimilar chemical 
shifts between the two  protons at the chiral centres on each molecule.  In the  example 
below (Figure 7), the protons of the anti-diastereomer 105a are observed at 3.65 ppm (3-H) 
and 4.64 ppm (4-H) respectively, whereas for the syn-diastereomer 105b these protons 
appear at 3.82 ppm (3-H) and 4.75 ppm (4-H). 45 
 
Figure 7 - NMR spectrum of anti-(top) and syn-(bottom) diastereomers 
With  significant  quantities  of  the  anti-(3S,4S)-diastereomer  available,  using  either 
PdCl2(MeCN)2 or (R)-COP-Cl as catalyst for the rearrangement, the synthesis of (2R,3S)-
2-amino-3,4-dihydroxybutyric acid 90 was completed successfully. 
This was achieved in a similar manner as for (2S,3S)-2-amino-3,4-dihydroxybutyric acid 
91,  using  a  ruthenium  catalysed  oxidation  of  allylic  trichloroacetamide  105a,  to  the 
carboxylic  acid  106,  once  again  using  the  Sharpless  procedure  (71%  yield).
46  Initially 
hydrolysis of all protecting groups was attempted using 6M hydrochloric acid as before, 46 
but this reaction was low yielding and gave a complex mixture of products. It proved more 
efficient to cleave the TBDPS group using TBAF and then subject the resulting compound 
to 6M hydrochloric acid to hydrolyse the trichloroacetamide and MOM groups. This gave 
the natural product, (2R,3S)-2-amino-3,4-dihydroxybutyric acid 90,
64 in 44% yield over 2 
steps from 106 (Scheme 34). 
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Scheme 34 - Synthesis of (2R,3S)-2-amino-3,4-dihydroxybutyric acid 
2.1.4  Conclusions 
In  summary,  two  dihydroxylated  allylic  trichloroacetimidates  have  been  successfully 
synthesised and subjected to aza-Claisen rearrangement using a variety of transition metal 
catalysts. Initial problems with loss of the acetonide protecting group were overcome by a 
catalyst screen which demonstrated that a variety of transition metals (including Pd(II), 
Pt(II), Au(III) and Au(I)) could be used as catalysts for this rearrangement. Secondly, it 
was discovered that the chiral catalyst (S)-COP-Cl could be successfully employed for this 
rearrangement in a matched pairing to give the (3R,4S)-syn-diastereomer in an excellent 
yield  and  diastereoselectivity.  Efforts  to  stereoselectively  synthesise  the  (3S,4S)-anti-
diastereomer required for the synthesis of the natural amino acid led to the synthesis of a 
second  orthogonally  protected  allylic  trichloroacetimidate.  This  successfully  underwent 
ether-directed  aza-Claisen  rearrangement  in  good  yield  but  with  moderate 
diastereoselectivity. This was enhanced by the use of (R)-COP-Cl, which in a mismatched 
catalyst-substrate pairing gave the desired products in an excellent 16 : 1 ratio and a good 
68% yield, despite long reaction times. 
These rearranged products are more complex than have previously been synthesised using 
this  approach  and  their  subsequent  conversion  to  the  dihydroxylated  α-amino  acids 
(2R,3S)-2-amino-3,4-dihydroxybutyric acid 90 and its unnatural diastereomer (2S,3S)-2-
amino-3,4-dihydroxybutyric acid 91 highlights the potential of this methodology for the 
synthesis of more complex natural products. 47 
2.2  Investigation of stereocontrol using a stereo-relay effect and a 
solvent  mediated  directing  effect,  the  synthesis  of  γ γ γ γ-hydroxy-α α α α-amino 
acids. 
2.2.1  γ γ γ γ-Hydroxy-α α α α-amino acids 
Previously,  the  Sutherland  group  has  shown  that  chiral  MOM-ether  groups  (at  the  δ-
position) adjacent to the olefin of an allylic trichloroacetimidate 50 can direct the Pd(II) 
catalysed aza-Claisen rearrangement reaction, giving the corresponding amide 51a, with a 
high degree of diastereoselectivity.
43-45  
It was proposed that an allylic trichloroacetimidate 108 with a MOM ether situated at the 
ε-position (one carbon further from the olefin) might rearrange to give the corresponding 
amide  110a  in  higher  stereoselectivity  due  to  the  fact  that  the  rearrangement  should 
proceed via a 6,6-chair like transition state 109 as opposed to the 6,5-transition state 107 
observed with the previous rearrangement substrates (Scheme 35). In addition, should this 
reaction prove to be successful then it would provide a highly efficient synthetic route to γ-
hydroxy-α-amino acids such as γ-hydroxynorvaline 111 (Figure 8). 
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Scheme 35 - Proposed transition states of ether-directed rearrangement 
γ-Hydroxy-α-amino acids are unnatural amino acids that have been isolated from several 
different sources and are components of a number of natural products, including cyclic 48 
peptides.  A  well  known  example  is  (2S,3S,4R)-γ-hydroxyisoleucine  112,  which  is  the 
amino acid component of, the potent cytotoxic alkaloid, funebrine 113 and was isolated in 
1984 from Quararibea funebris.
65 
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Figure 8 - Hydroxylated natural products 
 
New methods for the synthesis of these and similar amino acids would be of significant 
benefit to synthetic chemistry. It would also broaden the scope of the ether-directed aza-
Claisen rearrangement methodology previously developed by the group, allowing it to be 
employed for the synthesis of a wider variety of natural products. 
2.2.2  Synthetic route to allylic trichloroacetimidates 
To investigate this proposal, a synthetic route to ε-substituted allylic trichloroacetimidate 
108  was  developed.  Initially,  poly  (3R)-3-hydroxybutyrate  114  was  hydrolysed  under 
acidic conditions to give the hydroxy ester 115 (Scheme 36). MOM protection of 115 
under standard conditions then gave 116 in good yield (75%). The ester 116 was then 
reduced to the alcohol 117 using two equivalents of DIBAL-H, once again in high yield. A 
one-pot  Swern  oxidation  and  Horner-Wadsworth-Emmons  reaction  under  Masamune-
Roush conditions,
61 then gave exclusively the E-α,β-unsaturated ester 118 in 59% yield 
from the alcohol. Reduction of ester 118 with DIBAL-H provided the allylic alcohol 119 
(in  98%  yield),  which  was  then  converted  to  the  desired  ε-substituted  allylic 
trichloroacetimidate 108. This synthetic route provided the desired rearrangement substrate 
108  in  only  6  steps  using  highly  robust  and  scaleable  chemistry,  allowing  the  desired 
substrate to be obtained in multi-gram quantities. 49 
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Scheme 36 - Synthetic route to a ε ε ε ε-substituted allylic trichloroacetimidate 
2.2.3  Pd(II)-catalysed rearrangement in THF 
Trichloroacetimidate  108  was  then  subjected  to  an  aza-Claisen  rearrangement  using 
PdCl2(MeCN)2 in THF. These are the reaction conditions that had successfully been used 
previously within the group for other MOM ether rearrangement substrates and as such 
would allow a direct comparison of this new substrate with earlier work. Rearrangement 
gave the resulting allylic trichloroacetamide products 110a and 110b in 50% yield (over 2 
steps from 119) and in a 1 : 1 ratio (Scheme 37). 
O HN
CCl3
MOMO O HN
CCl3
MOMO O HN
CCl3
MOMO
110a 110b
+
THF, RT
108
PdCl2(MeCN)2
(10 mol%)
50% yield
(from alcohol 119)
1 : 1  
Scheme 37 - Rearrangement in THF 
 50 
Once  again,  the  diastereomeric  ratio  between  syn-  and  anti-  compounds  could  be 
determined  by  analysis  of  their 
1H  NMR  spectra  (Figure  9).  The  protons  of  the  anti-
diastereomer 110a are observed at 4.00 ppm (3-H) and 4.62 ppm (5-H, underneath CH 
from MOM ether) and the protons of the syn-diastereomer 110b are observed at 3.75 ppm 
(3-H) and 4.45 ppm (5-H) respectively.  
 
Figure 9 - 
1H NMR spectrum of diastereomers 51 
 
The completely unselective rearrangement observed with this substrate was initially very 
puzzling. To gain a better understanding of this process, the reaction was repeated with 
addition of a base (DBU) and an oxidant (p-benzoquinone), whilst a thermal un-catalysed 
rearrangement was also performed in an attempt to eliminate any competing pathways that 
might contribute to an unselective rearrangement (Table 7). 
Catalyst
O HN
CCl3
MOMO O HN
CCl3
MOMO
PdCl2(MeCN)2 ---
DBU
p-benzoquinone
O HN
CCl3
MOMO
K2CO3 ---
PdCl2(MeCN)2
PdCl2(MeCN)2
108 110a 110b
Yield
a (%) Ratio
b (a : b)
38
50
45 1 : 1
1 : 1
1 : 1
a Isolated combined yields of a and b from allylic alcohols.
Entry
1
2
3
b Ratio in crude reaction mixture.
c Reaction performed in p-xylene at 130 
oC.
+
85 1 : 1 4
c
Additive
THF, RT
Pd(II)    
(10 mol%)
 
Table 7 - Attempts to identify the cause of unselective rearrangement 
As all of the above reactions were completely unselective it was initially thought that the 
MOM group was too far away from the olefin to exert a directing effect on the process. 
However, an examination of the two transition states for the rearrangement show that both 
reaction pathways to diastereomers 110a and 110b are equally likely (Scheme 38).  
It is known that metal catalysed aza-Claisen rearrangements adopt a chair-like transition 
state that minimizes steric strain.
66 Typically the transition state that most minimizes any 
steric strain will have any bulky groups in equatorial positions, with small groups (e.g. 
hydrogen)  in  the  axial  positions.  Such  a  transition  state  will  be  the  lowest  energy 
conformer and so is favoured, resulting in the major product of the rearrangement. As any 
energy difference between the transition states increases, then the ratio between the two 
products should also increase. 
 52 
For substrate 108 both conformations 120a and 120b are equally favoured (hence the 1 : 1 
ratio). This is because by moving the directing group from the δ- to the ε-position, there 
are now two hydrogens at the δ-position (previous substrates for the rearrangement had 
one hydrogen and one methyl substituent, see schemes 22 and 35). As both groups (H
a and 
H
b) are the same equally small substituent, they both minimize any steric strain to the same 
extent, meaning it makes no difference which hydrogen is in the axial position. Thus, equal 
quantities of each product are formed. 
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Scheme 38 - Transition states for rearrangement 
As a consequence of this, it was proposed that the introduction of a bulkier group in place 
of one of these hydrogens, would lead to the re-introduction of stereocontrol as the lowest 
energy transition state would be the one with the bulky group in the equatorial position (the 
bulky  group  in  the  axial  position  would  be  higher  energy  so  less  favoured  due  to  an 
increase in steric strain) (see Scheme 41). 
 53 
2.2.4  Stereocontrol using a Stereoselective Relay 
Two new δ-,ε-substituted allylic trichloroacetimidates 133 and 134, were synthesised by a 
similar synthetic route to that used previously for the synthesis of substrate 108 (Scheme 
40).  Methyl  and  benzyl  substituents  were  introduced  in  place  of  hydrogen  by  a 
stereoselective alkylation. This was achieved by treatment of 115 with two equivalents of 
LDA, this forms a di-lithiated chair-like enolate 121 which undergoes alkylation from the 
least hindered face to give the desired erythro products 122 (Scheme 39).
67,68  
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Scheme 39 - Stereoselective alkylation via di-lithiated enolate 
MOM protection of both hydroxy esters 123 and 124 proceeded in excellent yield to give 
125 and 126. DIBAL-H reduction then gave the primary alcohols 127 and 128, once again 
in excellent yield. A one-pot Swern oxidation and Horner-Wadsworth-Emmons reaction 
gave E-α,β-unsaturated esters 129 and 130, which were reduced to the allylic alcohols 131 
and 132 with DIBAL-H and converted to the desired allylic trichloroacetimidates 133 and 
134 in the usual manner.  54 
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Scheme 40 - Synthesis of δ δ δ δ,ε ε ε ε-disubstituted allylic trichloroacetimidates 
With the desired trichloroacetimidates 133 and 134 in hand, they were subjected to Pd(II)-
catalysed aza-Claisen rearrangement in THF (Table 8). As expected, the introduction of 
these  more  bulky  δ-substituents  does  induce  diastereoselectivity.  A  3  :  1  ratio  was 
observed for methyl substituted substrate 133, and a 6 : 1 ratio for the benzyl substrate 134. 
The fact that diastereoselectivity is greatest for the bulkiest group (where R = benzyl) 
demonstrates that this selectivity results from the minimization of any steric strain. Steric 
strain is greater in the transition state where the benzyl is in the axial position; meaning 
that the opposite transition state (benzyl in equatorial position), which is lower in energy, is 
favoured (see Scheme 41). 55 
R
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CCl3
MOMO
R
O HN
CCl3
MOMO
R
H THF
THF
THF
O HN
CCl3
MOMO
R
Solvent
PdCl2(MeCN)2
(10 mol%)
136a 136b
Yield
a (%) Ratio
b (a : b)
Bn
Me
72%
50%
49% 3 : 1
1 : 1
6 : 1
a Isolated combined yields of a and b from allylic alcohols.
Entry
1
2
3
b Ratio in crude reaction mixture.
+
Solvent
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Table 8 - Rearrangement of δ δ δ δ,ε ε ε ε-disubstituted substrates in THF 
Although  diastereoselectivity  can  be  achieved  by  the  introduction  of  methyl  or  benzyl 
groups at the  δ-position, the selectivity was still lower than what had  previously  been 
reported  for  other  substrates.
43,45  Previously,  it  has  been  shown  that  non-coordinating 
solvents  such  as  toluene  can  enhance  the  diastereoselectivity  of  ether-directed 
rearrangements.
47 This is because coordinating solvents such as THF compete with the 
ether group for coordination to the metal catalyst. It was proposed that due to the greater 
distance between the directing group and the olefin, then THF might completely prevent 
stereoselective coordination of the MOM group to the metal catalyst, thus leading to such 
modest diastereoselectivities.  
2.2.5  Rearrangement in Toluene 
The Pd(II)-catalysed rearrangement reactions of allylic trichloroacetimidates 108, 133 and 
134  were  repeated  in  toluene  (Table  9).  By  switching  solvent  to  toluene  there  was  a 
significant increase in diastereoselectivity when compared to the results for THF.  
Firstly, allylic trichloroacetimidate 108 now rearranges in a 3 : 1 ratio (previously 1 : 1 in 
THF),  this  selectivity  can  solely  be  due  to  the  directing  effect  of  the  MOM  group  as 
previously it was shown that there was little difference in steric strain for this substrate. 
Secondly,  the  results  for  allylic  trichloroacetimidates  133  and  134  are  even  more 
impressive with a 13 : 1 ratio for methyl substituted substrate 133 and an 11 : 1 ratio for 
benzyl substrate 134. Yields are also greatly improved. 56 
As can be clearly seen from the table, toluene does indeed enhance selectivity when it is 
used in place of THF as solvent. The use of toluene as solvent appears to “switch on” the 
MOM substrate directing effect and allows excellent diastereoselectivities of up to 13:1 to 
be achieved for these substrates. 
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(10 mol%)
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Yield
a (%) Ratio
b (a : b)
Bn
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a Isolated combined yields of a and b from allylic alcohols.
Entry
1
2
3
b Ratio in crude reaction mixture.
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Table 9 - Rearrangement in Toluene 
2.2.6  Summary of results 
A number of conclusions can be drawn from these results. Firstly, the rearrangement of 
δ,ε-disubstituted  substrates  in  THF  occurs  with  only  moderate  selectivity  because 
selectivity is governed by a number of steric factors and there is no directing effect from 
the  MOM  group  (Scheme  41).  Any  stereoselectivity  occurs  due  to  a  destabilisation  of 
transition  state  137b  by  more  bulky  groups  at  the  δ-position  adopting  an  axial 
conformation.  This  is  unfavoured  so  transition  state  137a,  which  minimizes  steric 
hindrance,  leads  to  formation  of  the  major  diastereomer  136a.  If  both  transition  states 
minimize steric strain equally well then no selectivity is observed, giving an equal ratio of 
the two diastereomers 136a and 136b (as was observed with substrate 108).  57 
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Scheme 41 - Rearrangement in THF 
Rearrangement of the substrates in toluene occurs in much higher diastereoselectivity than 
in THF. This is because there is no competition from the toluene solvent so the MOM 
directing  group  can  coordinate  to  the  palladium  catalyst.  This  introduces  a  substrate- 
directing effect leading to much higher diastereoselectivities (Scheme 42).  
Also coordination of the directing group to the metal catalyst causes the adjacent methyl 
group in transition state 138b to adopt an unfavourable axial position. This explains the 
diastereoselectivity of 3 : 1 that was observed for substrate 108 in toluene. For substrates 
133 and 134 (where the presence of bulky methyl and benzyl groups already resulted in 
diastereoselectivity)  the  axial  methyl  group  causes  transition  state  138b  to  be  further 
destabilised.  This  causes  a  significant  enhancement  in  diastereoselectivity  when  the 
rearrangement is performed in toluene.  
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Scheme 42 - Rearrangement in toluene 58 
The  proposed  transition  states  above  provide  a  possible  explanation  for  the  results 
observed with these substrates. However, it has not been possible to obtain any proof of 
their existence either by kinetic studies or computational analysis. As such, whilst these 
proposed  structures  correlate  well  to  the  available  experimental  data  and  provide 
rationalization  for  the  observed  differences  in  diastereoselectivity  between  the  two 
solvents, alternative transition states cannot be ruled out.  
2.2.7  Synthesis of γ γ γ γ-Hydroxy-α α α α-amino acids 
The  major  trichloroacetamide  products  from  the  rearrangement  (110a,  139a  and  140a) 
were then converted to the corresponding γ-hydroxy-α-amino acids via the same two step 
approach used previously (Section 2.1). Firstly, the trichloroacetamides were subjected to a 
ruthenium catalysed oxidation of the alkene to the carboxylic acids. These carboxylic acids 
(141, 142 and 143) were then heated under acidic conditions to hydrolyse the MOM and 
trichloroacetamido protecting groups (Scheme 43). Thus, three γ-hydroxy-α-amino acids 
were  successfully  synthesised  by  this  method,  natural  products:  (2S,4R)-γ-
hydroxynorvaline  111,
69  (2S,3S,4R)-γ-hydroxyisoleucine  112,
65  and  a  novel  benzyl 
substituted γ-hydroxy-α-amino acid 144. 
CO2H
O HN
CCl3
MOMO
R
CO2H
NH2 OH
R
111 R = H (74%)
112 R = Me (55%) 
144 R = Bn (55%)
141 R = H (65%)
142 R = Me (62%)
143 R = Bn (82%)
O HN
CCl3
MOMO
R
110a R = H
139a R = Me 
140a R = Bn
RuCl3.xH2O, 
NaIO4 6M HCl
∆
CO2H
NH2 OH
CO2H
NH2 OH
CO2H
NH2 OH
(2S,4R)-γ-hydroxynorvaline (2S,3S,4R)-γ-hydroxyisoleucine
111 112
144
 
Scheme 43 - Synthesis of γ γ γ γ-hydroxy-α α α α-amino acids 
 
 59 
This efficient methodology for the synthesis of these three nonproteinogenic amino acids 
further expands the scope of a MOM-ether-directed aza-Claisen rearrangement and also 
allowed the absolute stereochemistry of the major diastereomers from the rearrangements 
to  be  confirmed  by  comparison  of  the  synthesised  amino  acids  to  the  known  natural 
products.
65,69 
2.2.8  Conclusions 
In summary, the role of steric strain on the MOM ether-directed aza-Claisen rearrangement 
has been investigated in two solvents; THF and toluene. In THF which is a coordinating 
solvent, stereocontrol is exerted by a stereo-relay effect and there is no directing effect as 
the  solvent  prevents  coordination  of  the  MOM  group  to  the  catalyst,  and  so, 
diastereoselectivity is very modest. However, when toluene (a non-coordinating solvent) 
was  used,  the  MOM  ether  group  was  able  to  successfully  coordinate  to  the  catalyst, 
switching on a directing effect, which when combined with minimisation of steric strain 
gave  a  significant  increase  in  the  diastereoselectivity.  The  products  from  these 
rearrangements  could  then  be  easily  converted  to  three  γ-hydroxy-α-amino  acids, 
providing a highly efficient and stereoselective route to these amino acids. 
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2.3  Development of a tandem aza-Claisen rearrangement and ring 
closing metathesis reaction. 
2.3.1  Introduction to tandem reactions 
A rapidly growing area of chemistry in the 21
st century is the development of tandem, 
domino and cascade reactions.
70-73 The reason for this is that these processes allow several 
synthetic transformations to be undertaken in one-pot and this has several advantages over 
traditional one step-one-pot procedures. Firstly, there is no requirement to isolate or handle 
reaction  intermediates,  saving  time  in  purification  of  what  can  often  be  unstable 
compounds. Secondly, there are substantial reductions in the waste generated (particularly 
in solvent waste), which significantly reduces the environmental impact of these classes of 
reaction  when  compared  to  traditional  methodologies.
1  In  particular,  as  the  cost  of 
petrochemical feedstocks and their subsequent disposal has risen in recent years, this is an 
area  of  chemistry  that  has  become  increasingly  important  to  the  chemical  and 
pharmaceutical industries. 
Ring closing metathesis has emerged in recent years as an excellent reaction for use in 
organic  synthesis.  It  is  a  highly  versatile  and  mild  reaction  process  that  enables  the 
formation  of  a  variety  of  different  ring  sizes  often  in  excellent  yields.  The  reaction 
proceeds  via  a  well  studied  reaction  mechanism  (Scheme  44)  using  stable  ruthenium 
catalysts that are also commercially available. The importance of this reaction to synthetic 
organic chemistry was highlighted by the award of the Nobel Prize for Chemistry in 2005 
to  Robert  Grubbs,  Richard  Schrock  and  Yves  Chauvin  who  developed  the  metathesis 
process for synthetic chemistry.
74 In addition to RCM there are two other commonly used 
metathesis  processes.  Cross  metathesis  (CM)
74  which  is  the  intermolecular  metathesis 
reaction  (whereas  RCM  is  an  intramolecular  process)  and  Ring  Opening  Metathesis 
(ROM),
74 which is commonly employed in polymerisations. 61 
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Scheme 44 - Mechanism of ring closing metathesis 
The  reaction  is  thermodynamically  driven  to  completion  often  by  the  release  of  a  gas 
(usually ethene) and does not lead to the racemisation of stereogenic centres. As a result of 
all of this, metathesis has also seen extensive use in tandem reactions, for example in 
conjunction  with  dehydrogenation-hydrogenation  reactions,
75  aza-Michael  reactions,
76 
Diels-Alder  reactions,
77  isomerizations,
78  Claisen  rearrangements,
79  Kharasch 
cyclisations,
80 and dihydroxylations.
81  
Recent  work  by  Jamieson  and  Sutherland  demonstrated  the  use  of  both  aza-Claisen 
rearrangement and RCM as key steps in the synthesis of heterocyclic natural products,
57 
and previously it had been shown that ruthenium catalysts do not catalyse the aza-Claisen 
rearrangement.
47 With this in mind, it was decided to attempt to develop a novel tandem 
Pd(II)-catalysed aza-Claisen rearrangement and ruthenium catalysed RCM reaction for the 
one-pot synthesis of cyclic allylic trichloroacetamides 145 (Scheme 45).  
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Scheme 45 - Proposed tandem aza-Claisen rearrangement and RCM reaction 
Cyclic  allylic  trichloroacetamides  145  are  useful  synthetic  intermediates,  having  found 
widespread  applications  e.g.  in  dihydroxylations,
82  epoxidations
83  and  Kharasch 62 
cyclisations.
80 It was hoped that this new methodology would provide a rapid synthesis to a 
variety of these compounds which could then undergo further functionalisation for use in 
the synthesis of natural products. 
2.3.2  Development of a tandem process 
It was decided to attempt to develop this tandem process for the synthesis of 6-membered 
cyclic allylic trichloroacetamide 151. To achieve this, a concise synthetic route to allylic 
alcohol  148  was  required.  This  was  rapidly  achieved  from  commercially  available  5-
hexen-1-ol  146,  using  a  one-pot  Swern  oxidation  and  Horner-Wadsworth-Emmons 
reaction  (once  again  using  Masamune-Roush  conditions)  to  give  the  E-α,β-unsaturated 
ester  147  (Scheme  46).  DIBAL-H  reduction  of  ester  147  gave  allylic  alcohol  148  in 
excellent yield. 
1. (COCl)2, DMSO, 
NEt3
2. DBU, LiCl,
(EtO)2POCH2CO2Et
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Scheme 46 - Concise synthesis of terminal alkene containing allylic alcohol 
Allylic alcohol 148 was then converted to the desired trichloroacetimidate rearrangement 
substrate 149 (Scheme 47). To determine the optimal reaction conditions for development 
of a tandem process, the rearrangement was carried out (3 hours at room temperature) and 
purified, giving the rearranged product 150 in 71% yield. Rearranged product 150 was then 
subjected to RCM using Grubbs I catalyst (12 h under reflux), to provide the desired cyclic 
allylic trichloroacetamide 151 in quantitative yield. Not only did these reactions help in the 
development  of  the  reaction  conditions  for  the  tandem  process,  isolating  the  two 
compounds  150  and  151  provided  reference 
1H  NMR  spectra  for  comparison  when 
performing the tandem process.  
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Scheme 47 - Development of reaction conditions for tandem process 63 
 
Following this, a tandem reaction was then attempted (Scheme 48). Initially, a one-pot 
procedure involving addition of both rearrangement and metathesis catalysts together then 
heating under reflux was attempted. Somewhat surprisingly, analysis of the crude reaction 
product by 
1H NMR showed that the major compound present was rearranged product 150, 
whilst ring-closed product 151 could not be identified. Since the rearrangement is known 
to proceed at room temperature, a second attempt where the reaction was performed at 
room temperature for 3 hours and then heated to reflux was carried out, with the same 
result. As such, it would appear that during the aza-Claisen rearrangement process the 
Grubbs  metathesis  catalyst  is  inactivated  (perhaps  via  ligand  exchange  with 
PdCl2(MeCN)2) meaning that it is no longer able to catalyse the metathesis reaction. It was 
discovered that if the catalysts were added in stepwise fashion then this problem could be 
overcome. This was achieved by initially adding the rearrangement catalyst, leaving the 
reaction for 3 hours to allow the rearrangement to proceed to completion and then adding 
the metathesis catalyst and heating the reaction under reflux. This approach allowed cyclic 
allylic trichloroacetamide 151 to be readily synthesised in excellent yields. 
Three commercially available and frequently used metathesis catalysts were employed for 
the tandem aza-Claisen rearrangement and RCM reaction using these optimised conditions 
(Scheme  48).  All  three  catalysts  gave  the  desired  6-membered  cyclic  allylic 
trichloroacetamide 151 in excellent yields (89-95% over 3 steps). 64 
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Scheme 48 - Tandem aza-Claisen rearrangement and RCM reaction 
2.3.3  Scope of tandem process 
With optimized reactions conditions developed, synthesis of additional ring sizes was then 
investigated. It was decided to continue using Grubbs I as RCM catalyst, even though it 
showed a slightly lower yield for the reaction than the other catalysts. This was due to its 
lower  cost  and  greater  availability  and  since  we  hoped  to  develop  a  robust  synthetic 
methodology for natural product synthesis, it was important to use a catalyst that could be 
employed on a large scale, at reasonable cost. 
Rearrangement  substrates  152-154,  were  synthesized  from  commercially  available 
alcohols using a similar route as for the preparation of substrate 149 (Scheme 49). 65 
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Scheme 49 - Synthesis of additional tandem reaction substrates 
Substrate 152 was then subjected to the optimized tandem aza-Claisen rearrangement and 
ring  closing  metathesis  conditions  to  give  the  expected  5-membered  cyclic  allylic 
trichloroacetamide 155, in excellent yield (84%, over 3 steps) (Scheme 50). 
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Scheme 50 - Synthesis of 5-membered allylic trichloroacetamide 
Tandem aza-Claisen rearrangement and RCM of substrate 153, using the above conditions 
provided  a  mixture  of  the  desired  product  and  a  dimeric  product  (the  result  of  an 
intermolecular  metathesis  reaction)  which  could  not  be  separated  by  column 
chromatography.  Larger  ring  sizes  can  often  form  dimeric  products  as  the  rate  of 
intermolecular  metathesis  can  become  competitive  with  the  rate  of  intramolecular 
metathesis.  A  common  solution  to  this  problem  is  to  perform  the  reaction  at  lower 
concentrations, thus eliminating formation of the dimer.
84 The reaction was then repeated 
under  diluted  conditions  (0.005  M)  and  successfully  yielded  the  desired  7-membered 
allylic trichloroacetamide 156 in an excellent 93% yield over 3 steps (Scheme 51). 66 
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Scheme 51 - 7-Membered cyclic allylic trichloroacetamide 
With synthesis of the 5-, 6- and 7-membered cyclic allylic trichloroacetamides completed 
so  successfully  and  in  high  yields,  attention  turned  to  the  8-membered  allylic 
trichloroacetamide 158. The formation of 8-membered rings is not kinetically favoured, so 
the discovery of new methods to successfully synthesise 8-membered rings in high yields 
is particularly important. 
Initially, substrate 154 was treated according to the diluted reaction conditions previously 
employed for the synthesis of 7-membered product 156. However, instead of the desired 
product 158, only the aza-Claisen product 157 was isolated. The reaction was repeated 
using longer reaction times to attempt to drive the reaction to completion, but without 
success. Grubbs metathesis catalysts are known to have differing substrate specificities and 
it became clear that Grubbs I was unable to catalyse the RCM reaction of this substrate.
85 
Careful  experimentation  using  Grubbs  II  and  Hoveyda/Grubbs  II  catalysts  was  then 
undertaken, in an attempt to discover reaction conditions that would allow the synthesis of 
the 8-membered cyclic trichloroacetamide 158. Eventually it was shown that the Grubbs II 
catalyst could be successfully employed for the synthesis of the 8-membered product 158. 
Optimal reaction conditions required the use of higher catalyst loadings (20 mol%) and 
also  a  lower  substrate  concentration  (0.00013M)  than  for  substrate  153.  Under  these 
reaction conditions, the 8-membered product 158, was successfully synthesized in a 62% 
yield over 3 steps (Scheme 52).  67 
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Scheme 52 - Synthesis of 8-membered allylic amide using Grubbs II 
2.3.4  Development of an asymmetric tandem reaction 
Having demonstrated the scope of this methodology for different ring sizes, an asymmetric 
process for application in natural product synthesis was required.  As  was discussed in 
previous  chapters,  Overman  has  developed  chiral  Pd(II)-COP-Cl  catalysts  for  the  aza-
Claisen  rearrangement  and  these  catalysts  are  commercially  available.
31,34,35  Having 
previously shown that these catalysts could be successfully employed for diastereoselective 
rearrangements during natural product synthesis, attention then turned to their use for the 
development of an asymmetric tandem aza-Claisen rearrangement and RCM reaction.  
Both (R)- and (S)-COP-Cl catalyst were tested in the tandem process for the synthesis of 
the six membered cyclic allylic amides (Scheme 53). This proved to be very successful as 
the tandem process proceeded with excellent yield and enantioselectivity (88% ee) thus, 
allowing  either  the  R  or  S  enantiomer  (159  or  160)  of  the  desired  cyclic  allylic 
trichloroacetamide to be accessed by this approach. The slightly lower yield afforded by 
the (R)-COP-Cl catalysed tandem reaction can be explained by the significantly longer 
reaction  times  when  using  this  catalyst  compared  to  the  (S)-COP-Cl  catalyst.  The  two 
catalysts are pseudo-enantiomers of one another so it is possible that minor differences in 
the catalyst structure could explain the slower rearrangement using (R)-COP-Cl. 68 
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Scheme 53 - Asymmetric tandem process 
The  enantioselectivities  of  these  chiral  catalysed  reactions  were  calculated  using  chiral 
High Performance Liquid Chromatography (HPLC). This was achieved by comparison of 
the reaction products with their corresponding racemic mixtures (Figure 10). 69 
 
Figure 10 - Chiral HPLC trace of racemate (top) and R-compound 160 (bottom) 
To confirm that this asymmetric tandem reaction could be employed widely for other ring 
sizes, substrates 152 and 153 precursors of the 5- and 7-membered amides respectively, 
were employed with the (S)-COP-Cl catalyst. 
The  chiral  catalyst  performed  well  for  both  substrates,  giving  the  5-membered  cyclic 
allylic trichloroacetamide 161 in 88% yield over 3 steps and in 92% ee (Scheme 54). 
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Scheme 54 - 5-Membered cyclic allylic trichloroacetamide 70 
The 7-membered cyclic allylic trichloroacetamide 162 was also synthesised in 81% yield 
over 3 steps and 84% ee (Scheme 55). 
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Scheme 55 - Asymmetric synthesis of 7-membered trichloroacetamide 
2.3.5  Conclusions 
In conclusion, a one-pot tandem aza-Claisen rearrangement and ring closing metathesis 
reaction has been successfully developed, which allows cyclic allylic trichloroacetamides 
to be synthesised in a highly efficient manner and in excellent yield. The process uses a 
palladium(II)-catalysed  rearrangement  which  occurs  rapidly  at  room  temperature.  A 
variety of commercially available metathesis catalysts can be employed for the RCM step, 
although the RCM catalyst must be added after rearrangement is complete; otherwise it is 
inactivated via a side reaction. The scope of this methodology has been demonstrated with 
the successful synthesis of 5-, 6-, 7- and 8-membered rings, whilst an asymmetric tandem 
reaction has also been developed using commercially available COP-Cl catalysts. These 
catalysts work extremely well for this tandem reaction giving the resultant chiral amide in 
both excellent yield and enantioselectivity. 
2.3.6  Future Work 
Future work in this area involves several different aspects. 
Firstly, whilst the tandem process is highly efficient, it would be very desirable to develop 
a true cascade process where both catalysts can be added together, to provide the cyclic 
amide  products  without  subsequent  addition  of  other  catalysts.  This  could  possibly  be 
achieved by the use of polymer supported catalysts which would hopefully prevent the 
RCM catalyst from being inactivated. Should this be achieved, the tandem process could 
also be expanded to include other reactions (Scheme 56). 71 
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Scheme 56 - Possible development of a cascade process 
Secondly, this methodology could be expanded for the synthesis of N-heterocycles 164. At 
present these compounds cannot be directly synthesised by this tandem approach, but the 
synthesis  of  N-substituted  allylic  trichloroacetimidates  163  would  possibly  allow  the 
tandem synthesis of these compounds to be developed (Scheme 57). The use of different 
terminal alkene substituents attached to the nitrogen, would allow the synthesis of various 
ring  sizes  and  as  before,  the  use  of  chiral  rearrangement  catalysts  should  allow  an 
asymmetric process to be developed for use in natural product synthesis.  
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Scheme 57 - Synthesis of N-heterocycles using a tandem rearrangement and RCM reaction 
Finally the existing asymmetric tandem reaction could be employed in natural product 
synthesis. One target currently under investigation is the bicyclic alkaloid, physoperuvine 
165, which was first isolated in 1976 from Physalis peruviana.
86 This could be synthesised 
from  the  7-membered  trichloroacetamide  162,  prepared  previously,  in  only  4  steps 
(Scheme 58). 72 
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Scheme 58 - Proposed synthesis of physoperuvine 
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2.4  Development  of  an  ether-directed  tandem  aza-Claisen 
rearrangement and RCM reaction for natural product synthesis 
2.4.1  Introduction 
Having successfully developed a tandem aza-Claisen rearrangement and RCM reaction, 
attention then turned to further development of the process. It was decided to undertake the 
synthesis of some complex natural products using this methodology to demonstrate its 
application for synthetic chemistry. It was also desirable to combine the tandem process 
with previous work within the group on ether-directed aza-Claisen rearrangements. Not 
only would this provide an excellent extension of the existing asymmetric tandem process 
using chiral  catalysts, but the presence of a second stereogenic centre on the resulting 
cyclic  allylic  trichloroacetamide  products  of  the  reaction  would  provide  an  additional 
handle  for  further  functionalisation,  enabling  the  synthesis  of  more  complex  natural 
products. 
A search of the literature was undertaken to identify suitable synthetic targets. Several 
alkaloids from the amaryllidaceae plant family quickly came to our attention. Alkaloids 
from this plant family include: (+)-γ-lycorane 166, 2-deoxylycoricidine 167, pancratistatin 
64 and narciclasin 168 (Figure 11). All of these compounds possess the galanthane ring 
system, which is widely known to confer various biological activities including antiviral, 
antineoplastic and antimitotic activity.
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Figure 11 - Lycorane type alkaloids 74 
 
It was decided to attempt the synthesis of (+)-γ-lycorane 166, using a novel ether-directed 
tandem  aza-Claisen  rearrangement  and  RCM  reaction.  Although  compound  166  is  not 
known to possess any significant biological activity, this is the core structure of a number 
of alkaloids that do possess potent bioactivity. As such its synthesis might open up possible 
synthetic routes to other alkaloids of the lycorane class and their analogues with more 
potent activities. 
2.4.2  Previous syntheses of (+)-γ γ γ γ-lycorane 
γ-Lycorane  166  has  been  the  target  of  several  racemic  total  syntheses.
88  Many  fewer 
enantioselective approaches have been reported.
89-93 The first asymmetric approach to (+)-
γ-lycorane 166 was reported by Mori and co-workers in 1995.
90 This used an asymmetric 
Pd(0)-catalysed allylic alkylation reaction as the key enantioselective step to give 171. The 
synthesis was then completed by a Pd(0)-catalysed allylic amination reaction to introduce 
the 5-membered ring followed by a Pd(0)-catalysed intramolecular Heck reaction to form 
the final ring of 172 (these two steps could be performed in one-pot), and allowed the 
synthesis of 166 in 23% yield (5 steps) and a modest 46% ee. Recently Ojima and co-
workers have revisited and improved the Mori synthesis (Scheme 59).
89 Using the same 
synthetic  approach  as  reported  by  Mori,  they  focused  upon  improving  the  yield  and 
enantioselectivity of the key Pd(0)-catalysed allylic alkylation. This was achieved by the 
use of chiral monodentate phosphoramidite ligands which could undergo modification to 
provide improved yields and enantioselectivities compared to those in Mori’s synthesis. 
Using these new ligands, the synthesis of (+)-γ-lycorane 166 was achieved in 6 steps (41% 
overall yield and >99% ee) from compounds 169 and 170 (Scheme 59). 75 
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Scheme 59 - Ojima synthesis of (+)-γ γ γ γ-lycorane 
Both of these syntheses provided the target compound in very few steps and in reasonable 
yield,  whilst  the  Ojima  synthesis  also  provides  the  target  compound  in  excellent 
enantioselectivity (>99% ee).  
In  addition  to  the  above  syntheses,  Gong  and  co-workers  have  also  reported  an 
enantioselective  synthesis  of  166.
93  This  was  achieved  by  an  asymmetric  rhodium(II)-
catalysed nitroallylation reaction using an aryl boronic acid 173 and a nitroallyl acetate 174 
(Scheme 60), thus giving 175. The synthesis of (+)-γ-lycorane 166 was then completed in 
four further steps in a 38% overall yield (5 steps) and 98% ee. Once again, this is a very 
concise synthesis providing the target compound with excellent enantioselectivity.  76 
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Scheme 60 - Gong synthesis of (+)-γ γ γ γ-lycorane 
All  of  these  previous  asymmetric  syntheses  of  (+)-γ-lycorane  166,  make  use  of  chiral 
catalysis to perform the key enantioselective steps. We proposed to use the tandem aza-
Claisen rearrangement and RCM reaction in combination with the previously developed 
ether-directed aza-Claisen rearrangement methodology to develop a novel synthesis of (+)-
γ-lycorane 166, which would also allow the synthesis of other amaryllidaceae alkaloids in 
the lycorane family. 
2.4.3  Proposed synthesis of (+)-γ γ γ γ-lycorane 
With these previous syntheses of (+)-γ-lycorane 166 in mind, our new synthetic approach 
is outlined below (Scheme 61). The key step of the proposed synthesis is an ether-directed 
tandem  aza-Claisen  rearrangement  and  ring  closing  metathesis  reaction  of  allylic 
trichloroacetimidate 176, to give the corresponding cyclic allylic trichloroacetamide 177a. 
A  Kharasch  cyclisation  should  introduce  the  required  5-membered  ring  178.
80,94 
Dechlorination followed by cleavage of the MOM ether under acidic conditions would 
allow the introduction of a sulfonate leaving group to give 179. This compound should 
readily undergo elimination upon treatment with base to give the resulting alkene 180. An 
acylation reaction would then introduce the known left hand aromatic fragment 181 to give 
compound 182.
95 A Heck-type cyclisation, similar to that employed by the groups of Mori 
and Ojima should perform the final ring closure to give 183.
89,90 Finally hydrogenation of 
the alkene and reduction of the imide should give (+)-γ-lycorane 166. 77 
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Scheme 61 - Proposed synthesis of (+)-γ γ γ γ-lycorane 
2.4.4  Development of an ether-directed tandem reaction 
The first stage of this synthesis required the synthesis of allylic trichloroacetimidate 176 
which is readily available from the corresponding allylic alcohol 190. This was achieved in 
7 steps from (S)-glycidol 184. Initially, silyl protection of 184 gave the silyl ether 185. A 
regioselective copper(I)-catalysed epoxide opening using allyl magnesium bromide then 
gave 186. MOM protection of the resulting secondary alcohol under standard conditions 
gave 187, which was then treated with TBAF to provide the primary alcohol 188. Primary 
alcohol 188 was subjected to a one-pot Swern oxidation and Horner-Wadsworth-Emmons 
reaction to give the E-α,β-unsaturated ester 189. Finally DIBAL-H reduction gave allylic 
alcohol 190, in an excellent 80% yield over 7 steps (Scheme 62). 78 
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Scheme 62 - Synthesis of allylic alcohol for directed rearrangement 
Compound 190 was converted to the corresponding allylic trichloroacetimidate 176 and 
subjected to tandem aza-Claisen rearrangement followed by RCM, to successfully give 
trichloroacetamides 177a and 177b, as a 5 : 1 ratio of diastereomers and in a reasonable 
45% yield over 3 steps from allylic alcohol 190 (Scheme 63).  
In a similar manner to previous reactions, the diastereomeric ratio of the cyclic products 
could be determined from the 
1H NMR spectrum (Figure 12). The desired cyclic product 
177a, where both stereocentres are syn has protons at 4.05 ppm (1-H) and 4.63 ppm (2-H) 
respectively. The protons for the undesired anti-product 177b are observed at 3.75 ppm (1-
H) and 4.42 ppm (2-H). 79 
 
Figure 12 - 
1H NMR spectrum of cyclic products 177a and 177b  
 The  rather  modest  yields  achieved  for  this  directed  rearrangement  can  perhaps  be 
explained by the much greater complexity of substrate 176 when compared to the previous 
rearrangement  substrate  149  (Section  2.3.2),  this  leads  to  a  slower  aza-Claisen 
rearrangement thus allowing competing side reactions to take place. 80 
Given the intention was to use this methodology for natural product synthesis, an improved 
yield and stereoselectivity was needed to make the tandem process more efficient so that it 
could  provide  the  desired  cyclic  amide  177a  in  multi-gram  quantities.  Previously,  the 
Sutherland  group  have  shown  that  toluene  (which  is  a  non-coordinating  solvent)  can 
enhance  the  yield  and  diastereoselectivity  of  MOM  ether-directed  aza-Claisen 
rearrangements.
47  When  the  tandem  reaction  was  carried  out  in  toluene  (starting  the 
rearrangement at 0 
oC) the yield was much improved and the diastereoselectivity increased 
to 10 : 1 (Scheme 63). 
O
OMOM
HN
CCl3
PdCl2(MeCN)2
(10 mol%)
O
NH
CCl3
H
O
O
[Pd]
O
OMOM Cl3CCN, 
DBU
HN
CCl3
OMOM
OH
HN O
CCl3
HN O
CCl3
+
∆
177a 177b
MOMO MOMO
190 176
Solvent
Reaction conditions yield from 190 (%) ratio (a : b)
45 5 : 1
10 : 1 60
DCM, RT
Toluene, 0
 oC to RT
Grubbs I 
(10 mol%)
 
Scheme 63 - Ether-directed tandem aza-Claisen rearrangement and RCM reaction 
2.4.5  Application towards the synthesis of (+)-γ γ γ γ-lycorane 
After  successful  synthesis  of  cyclic  allylic  trichloroacetamide  177a  in  multi-gram 
quantities, attention then turned to the Kharasch cyclisation which is the second key step in 
the synthesis of (+)-γ-lycorane 166.  
A  Kharasch  cyclisation  is  a  Ru(II)-catalysed  reaction  that  proceeds  via  a  radical 
mechanism  (Scheme  64),  where  ruthenium(II)  attacks  the  trichloroacetyl  group  191 
forming a radical 192 and Ru(III)-Cl. The radical 192 then attacks the alkene and forms the 81 
new C-C bond of the 5-membered ring 193. The reaction is terminated by reintroduction of 
Ru(III)-Cl which introduces a chloride to the face opposite the new 5-membered ring (the 
top face as shown in the diagram), thus providing the Kharasch product 194 and recycling 
of the Ru(II)-catalyst.
94 The groups of Snapper and Itoh have previously reported Kharasch 
cyclisations upon similar substrates to 177a, with the resulting products isolated in high 
yields.
80,94  In  addition,  both  groups  showed  that  the  reaction  proceeds  to  produce 
exclusively  the  cis-ring  junction  between  the  5-  and  6-membered  rings,  which  is  the 
required stereochemistry for the synthesis of (+)-γ-lycorane 166. 
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Scheme 64 - Radical mechanism of Kharasch cyclisation 
Originally, it was planned to follow the experimental procedure described by Snapper, 
which  uses  Grubbs  I  catalyst  as  the  ruthenium  catalyst.  This  would  have  potentially 
introduced an extra step to the tandem process as the Kharasch cyclisation occurs at much 
higher temperatures than the preceding RCM reaction. So it is possible that simply heating 
the reaction mixture of the tandem process to approximately 150 
oC would provide the 
desired Kharasch product 178, without the requirement for purification. When the allylic 
trichloroacetamide  177a  was  treated  with  Grubbs  I  catalyst  in  toluene  at  155 
oC,  the 
desired Kharasch product 178 was not isolated; instead a tricyclic product 195 was formed 
in a rather disappointing 24% yield (Scheme 65). 
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Scheme 65 - Kharasch cyclisation using Grubbs catalyst 82 
With  Grubbs  catalyst  failing  to  provide  the  desired  product,  it  was  decided  instead  to 
continue  our  efforts  using  the  simpler  RuCl2(PPh3)3  catalyst  and  reaction  conditions 
previously reported by Itoh.
94 By switching catalyst, a mixture of the desired Kharasch 
product  178  and  tricyclic  product  195  were  synthesized,  both  in  rather  modest  yields. 
Careful experimentation to optimize the yield of 178 showed that concentrated reaction 
conditions  (0.1  M)  and  elevated  temperatures  (>150 
oC)  were  required  to  ensure  the 
reaction proceeded to completion as rapidly as possible. If the reaction was performed at 
lower concentrations or temperatures and over lengthy reaction times, only the tricyclic 
product  195  and  other  decomposition  products  were  isolated.  Eventually,  using  the 
reaction  conditions  shown  in  scheme  66,  synthesis  of  Kharasch  product  178,  was 
successfully achieved in a reasonable 42% yield (10% of product 195 was also isolated). 
Scale-up  was  then  attempted  to  generate  sufficient  quantities  of  178  to  complete  the 
synthesis of (+)-γ-lycorane 166. Unfortunately this yielded only a very small quantity of 
178, instead mostly 195 was isolated.  
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Scheme 66 - Kharasch cyclisation using RuCl2(PPh3)3 
Investigation into the causes of these problems with the Kharasch cyclisation was then 
undertaken.  Radical  processes  typically  occur  quickly  so  it  is  likely  that  the  Kharasch 
cyclisation occurs first to introduce the desired 5-membered ring 178. Unfortunately this 
product can then undergo attack of the MOM-ether from the nitrogen of the amide, thus 
leading to the formation of the tricyclic product 195 observed. This unwanted side reaction 
is likely mediated by acid (HCl), which could form at these elevated reaction temperatures 
through decomposition of the metal catalyst or the reaction of Cl radicals with the solvent. 
The previous examples reported by Snapper and Itoh were less complex than substrate 
177a and lacked acid sensitive groups such as the MOM ether, and so, they would be less 
sensitive to the formation of these by-products. It was proposed that if a method could be 
found for trapping any acid produced during the reaction, then the side reaction leading to 
the tricyclic product 195 would be prevented. Hopefully, compound 178 could then be 
isolated in good yields.  83 
An acid scavenger was required that would trap any acid produced during the reaction and 
yet  not  interfere  with  the  ruthenium-catalysed  radical  process.  After  a  search,  three 
possible  additives  were  identified:  DBU,  K2CO3  and  molecular  sieves  (4Å).  All  three 
reagents  were  then  separately  examined  as  additives  to  the  Kharasch  cyclisation.  The 
addition of DBU yielded only the starting material 177a, whilst K2CO3 appeared to have 
little  effect  as  it  yielded  a  mixture  of  the  two  products  (178  and  195).  However,  the 
reaction using molecular sieves gave the desired product 178 in an encouraging 56% yield. 
Further  optimisation  of  this  reaction  was  undertaken  and  after  switching  to  powdered 
molecular sieves (4Å), which presents a greater surface area to trap any acid; the yield of 
reaction was increased to 75% and could be reliably performed on a reasonable scale (0.5 
g) (Scheme 67).  
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Scheme 67 - Optimised reaction conditions for Kharasch cyclisation 
Previously  Snapper  and  Itoh  have  shown  that  the  Kharasch  cyclisation  occurs  to  give 
exclusively  the  cis  ring  junction.
80,94  This  was  confirmed  for  compound  178  by  nOe 
studies, which showed a positive nOe between protons 3a and 7a (1.8%), thus proving that 
this compound also had the cis ring junction (Figure 13). In addition, an enhancement of 
proton 7 (1.0% nOe) was observed upon irradiation of proton 7a, confirming the all cis 
geometry between protons 3a, 7a and 7. Finally the stereochemistry at C-4 was confirmed 
by irradiation of proton 3a, as expected there was no enhancement of proton 4 proving that 
the chlorine was on the top face of the molecule. 
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Figure 13 - nOe studies confirming cis ring junction 84 
With the problem encountered with the Kharasch cyclisation successfully overcome, the 
reductive  dechlorination  of  both  Kharasch  products  178  and  195  was  successfully 
completed. This was performed using Raney-Nickel and a procedure described by Barrero 
and co-workers,
96 resulting in formation of the desired dechlorinated products 196 and 197 
in good yields (Scheme 68). 
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Scheme 68 - Dechlorination using Raney-Nickel 
The next stage was to prepare methanesulfonate 179. This was achieved by hydrolysis of 
the MOM group of 197 under acidic conditions, followed by introduction of the mesylate 
under standard conditions, giving 179 in an excellent 88% yield over 2 steps (Scheme 69). 
2M HCl
HN
O
MOMO
179
HN
O
HO
MsCl, DMAP,
Et3N
40 
oC RT, 88%
HN
O
MsO
197
(2 steps)
 
Scheme 69 - Synthesis of mesylate 
Elimination of mesylate 179 was then attempted. Initially, the strong base potassium tert-
butoxide (tBuOK) was used. However, this reagent led to decomposition of the starting 
material and no product was formed. Consequently, it was decided to use a milder base in 
an attempt to overcome this decomposition. DBU was chosen as base due to the fact that 
this hindered base is milder than tBuOK so should hopefully lead to elimination of the 
mesylate without causing decomposition. The reaction was heated to 60 
oC for 24 h, but 
only starting material was present. Elevation of temperature to 120 
oC for a further 24 h 
showed  that  the  starting  material  had  begun  to  decompose  (Scheme  70).  Elimination 85 
reactions require the leaving group and the hydrogen atom, which is to be removed by 
base, to have an anti-periplanar conformation. It is possible that the rigid 6,5-ring system 
of 179, prevents it from adopting such a conformation, hence the lack of reactivity. It was 
decided in the light of this to pursue an alternative synthetic strategy. 
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Scheme 70 - Attempts to eliminate mesylate 
Fujioka and co-workers have  recently reported  the synthesis of  (-)-γ-lycorane 202 (the 
unnatural enantiomer of 166) which uses a Friedel-Crafts alkylation to close the final ring 
to give compound 201. The substrate for this reaction 200, was synthesised by an acylation 
reaction of known aromatic chloride 199 and bromo compound 198 (Scheme 71).
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Scheme 71 - Synthesis of (-)-γ γ γ γ-lycorane 
It  was  hoped  that  a  simple  nucleophilic  SN2  reaction  of  mesylate  179  or  an  activated 
intermediate of alcohol 204 would provide 203 (the enantiomer of 198), thus allowing the 
use of similar chemistry to complete the synthesis of (+)-γ-lycorane 166. The mesylate 179 
or alcohol 204 was therefore treated under a variety of bromination conditions to attempt to 
synthesise 203 (Scheme 72). 86 
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Scheme 72 - Attempts at bromination 
Unfortunately,  none  of  these  procedures  was  successful.  It  was  hypothesised  that  the 
hydrogen of the amide might interfere with the substitution reaction, so it was decided 
instead to perform the acylation reaction prior to bromination, as the introduction of the 
aromatic substituent should block this position and hopefully then allow the substitution to 
proceed. 
Initial attempts to perform the acylation using mesylate 179 were unsuccessful. The 
1H 
NMR  showed  a  complex  mixture  of  compounds  and  none  of  the  desired  product  was 
observed. In addition, the signals associated with the mesylate were no longer present, and 
so, it appeared that the strong base (NaH) employed to de-protonate the amide was not 
compatible with the mesylate. Instead, it was decided to re-order the synthetic steps and 
perform the acylation prior to introduction of the mesylate. The MOM protected compound 
197  was  subjected  to  the  acylation  reaction,  under  the  reaction  conditions  as  reported 
previously  by  Fujioka  and  co-workers,
97  using  bromide  205.
98  With  a  more  stable 
protecting group in place, the reaction proceeded smoothly to give the desired product in 
an excellent 90% yield (Scheme 73). Cleavage of the MOM protecting group gave the 
alcohol 207 in quantitative yield, which was then subjected to conditions in an attempt to 
introduce the bromide, unfortunately without success (Scheme 73).  87 
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Scheme 73 - Acylation to introduce aromatic substituent 
The exact reasons why various attempts to synthesise the bromide have been unsuccessful 
are unclear and could involve a combination of factors.  
In a final attempt to complete the synthesis, the alcohol 207 was converted to the mesylate 
209 (Scheme 74). It was hoped that the mesylate might act as a better leaving group and so 
undergo conversion to the desired bromide 208. Unfortunately, when this reaction was 
attempted no product was formed, despite the elevated temperatures and extended reaction 
times (Scheme 74). 88 
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Scheme 74 - A further attempt to introduce the bromide 
Mesylates have previously been shown to undergo Friedel-Crafts reactions.
99,100  It was 
decided to attempt the Friedel-Crafts reaction on the mesylate 209 in the hope that it might 
indeed yield the ring closed product 210. The reaction was attempted twice under different 
reaction conditions (Scheme 75), without formation of the desired product.  
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Scheme 75 - Attempts at Friedel-Crafts reaction 
Due to time and material constraints, work was halted at this stage and although there are a 
number  of  alternatives  that  could  still  be  attempted,  it  appears  that  conversion  of  the 
hydroxyl group to the bromide either directly or via the mesylate, will not be successful. It 
is not clear why this is the case as in theory the reaction is fairly straightforward; however, 
in  practice  this  transformation  has  proved  incredibly  challenging  and  an  alternative 
strategy might yield more encouraging results.  89 
2.4.6  Conclusions 
In  conclusion,  the  tandem  aza-Claisen  rearrangement  and  RCM  reaction  that  was 
developed in section 2.3 has been successfully combined with the previously developed 
ether-directed  methodology,  to  give  a  MOM  ether-directed  tandem  aza-Claisen 
rearrangement  and  RCM  reaction.  This  reaction  provides  chiral  cyclic  allylic 
trichloroacetamides in good yield and in high diastereoselectivity. The synthesis of (+)-γ-
lycorane 166 has been attempted using this methodology to introduce the required six-
membered  ring.  A  ruthenium(II)-catalysed  Kharasch  cyclisation  was  then  employed  to 
introduce the fused 5-membered ring. The nitrogen of the amide was successfully acylated 
with the known aromatic component 205, but efforts to perform the final ring closure via a 
Friedel-Crafts reaction were unsuccessful. Significant progress towards the synthesis of 
(+)-γ-lycorane 166 has been made, although problems encountered with the final steps of 
the route prevented the successful synthesis of the target within the timeframe of this PhD 
project. Modifications to the final synthetic steps should then allow the synthesis of (+)-γ-
lycorane 166 and other amaryllidaceae alkaloids, to be completed. 
2.4.7  Future Work 
An alternative synthetic strategy is outlined below (Scheme 76). Given the success of the 
acylation  of  MOM  compound  197,  acylation  using  the  aromatic  component  189  as 
originally proposed, should provide 211 in good yield. With this in hand, conversion of the 
protected hydroxyl group to the mesylate 212 should be straightforward. Elimination of the 
mesylate under basic conditions could then be successful as with the amide protected by 
the aromatic group it should no longer interfere with the elimination process, although 
questions remain as to whether the compound is able to adopt the syn- or anti-periplanar 
conformation  required  for  it  to  react  successfully.  Assuming  that  alkene  182  can  be 
successfully  synthesised  then  a  Heck  type  cyclisation  should  provide  the  ring  closed 
product 183, in a similar way to that originally proposed and demonstrated previously by 
Mori and Ojima.
89,90 Thus, the synthesis of (+)-γ-lycorane 166, should still be achievable 
using this highly successful ether-directed tandem aza-Claisen rearrangement and RCM 
methodology. 90 
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Scheme 76 - Proposed final steps for the total synthesis of (+)-γ γ γ γ-lycorane 
Upon successful synthesis of (+)-γ-lycorane 166, the ether-directed tandem reaction could 
then be applied for the synthesis of other alkaloids in the amaryllidaceae family. One such 
compound is (+)-2-deoxylycoricidine 167, which has only previously been synthesised in 
racemic form.
101 This compound is a more challenging synthetic target, but its asymmetric 
synthesis  could  also  be  achieved  from  allylic  trichloroacetamide  177a  (Scheme  77). 
Conversion  of  177a  to  the  oxazolidinone  213,  followed  by  dihydroxylation  would 
introduce the syn-diol require for the target compound. After protection of the diol, the 
oxazolidinone  would  be  hydrolysed  to  provide  the  amino  alcohol  214.  The  final  steps 
would be similar to the synthesis of (+)-γ-lycorane (166, above): acylation to introduce the 
aromatic  component  would  give  215,  which  would  be  converted  to  216.  This  would 
undergo  a  Heck-type  cyclisation  which  would  provide,  after  deprotection,  the  first 
asymmetric synthesis of (+)-2-deoxylycoricidine 167. 91 
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Scheme 77 - Proposed synthesis of (+)-2-deoxylycoricidine 
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3.0  Experimental Section 
General Experimental 
All reagents and starting materials were obtained from commercial sources and used as 
received. Dry solvents were purified using a PureSolv 500 MD solvent purification system 
or  THF  and  diethyl  ether  were  distilled  from  sodium  and  benzophenone,  whilst 
dichloromethane (DCM) was distilled from calcium hydride. All reactions were performed 
under  an  atmosphere  of  argon  or  nitrogen  unless  otherwise  mentioned.  Flash  column 
chromatography  was  carried  out  using  Fisher  matrix  silica  60.  Macherey-Nagel 
aluminium-backed plates pre-coated with silica gel 60 (UV254) were used for thin layer 
chromatography and were visualised by staining with KMnO4. 
1H NMR and 
13C NMR 
spectra were recorded on a Bruker DPX 400 spectrometer with chemical shift values in 
ppm relative to TMS (δH 0.00 and δC 0.0) or residual chloroform (δH 7.28 and δC 77.2) as 
standard.  Mass  spectra  were  obtained  using  a  JEOL  JMS-700  spectrometer.  Infrared 
spectra were obtained using a JASCO FTIR 410 using a Golden Gate apparatus. Optical 
rotations were determined as solutions irradiating with the sodium D line (λ = 589 nm) 
using an Autopol V polarimeter. [α]D values are given in units 10
-1 deg cm
2 g
-1. Chiral 
HPLC was performed on a Agilent 1100 series instrument and were calibrated with the 
appropriate racemic mixture. 
 
General  Procedure  1:  One  pot  Swern  oxidation-Horner/Wadsworth/Emmons 
reaction. 
 
Dimethyl sulfoxide (2.5 equiv.) was added to a stirred solution of oxalyl chloride (1.4 
equiv.) in DCM (100 mL) at -78 
oC. The reaction mixture was stirred for 0.3 h before the 
alcohol (1.0 equiv.) in DCM (50 mL) was slowly added. The mixture was stirred for a 
further 0.3 h before triethylamine (5 equiv.) was added. This reaction mixture was stirred 
for 0.5 h at -78 
oC and then allowed to warm to room temperature and stirred for a further 2 
h. Meanwhile, a solution of lithium chloride (1.8 equiv.), triethylphosphonoacetate (1.8 
equiv.) and 1,8-diazabicyclo[5,4,0]undec-7-ene (1.8 equiv.) in acetonitrile (100 mL) was 
prepared and stirred for 1.0 h. The Swern solution was concentrated in vacuo, then the 
Wadsworth Emmons solution was added  and the reaction mixture was  stirred at room 
temperature overnight. The reaction was quenched by the addition of a saturated solution 
of ammonium chloride (50 mL) and concentrated to give an orange residue, which was 
then extracted with diethyl ether (4 x 75 mL). The organic layers were combined, dried 93 
(MgSO4)  and  concentrated  to  give  an  orange  oil.  Purification  by  flash  column 
chromatography using diethyl ether : petroleum ether as eluent gave the pure product. 
  
General Procedure 2: DIBAL-H reduction to allylic alcohol. 
 
The  ester  (1.0  equiv.)  was  dissolved  in  diethyl  ether  (100  mL)  and  cooled  to  -78 
oC. 
DIBAL-H (1 M in hexane) (2.2 equiv.) was added dropwise and the reaction mixture was 
stirred at -78 
oC for 3 h, before warming to room temperature. The solution was cooled to 0 
oC and quenched by the addition of a saturated solution of ammonium chloride (10 mL) 
and  warmed  to  room  temperature  with  vigorous  stirring  over  1  h  producing  a  white 
precipitate. The precipitate was filtered through a pad of Celite
® and washed with diethyl 
ether  (400  mL).  The  filtrate  was  then  dried  (MgSO4)  and  concentrated  in  vacuo. 
Purification was carried out by flash column chromatography eluting with diethyl ether : 
petroleum ether.  
 
General procedure 3: MOM protection of secondary alcohol. 
 
N,N-Diisopropylethylamine (1.5 equiv.) and bromomethyl methyl ether (1.5 equiv.) were 
added to a solution of the alcohol (5.0 mmol) in DCM (20 mL). The reaction mixture was 
then heated under reflux for 12 h before being diluted with DCM (50 mL) and washed with 
2  M  hydrochloric  acid  solution  (25  mL).  The  organic  layer  was  dried  (MgSO4)  and 
concentrated in vacuo. Purification was carried out by flash column chromatography using 
diethyl ether : petroleum ether to give the desired compounds as colourless oils. 
 
General procedure 4: Synthesis of allylic trichloroacetimidate and subsequent metal 
catalysed aza-Claisen rearrangement.  
 
Allylic  alcohol  (1.0  equiv.)  was  dissolved  in  DCM  (20  mL)  and  cooled  to  0 
oC.  1,8-
Diazabicyclo[5.4.0]undec-7-ene (0.25 equiv.) was then added to the solution followed by 
trichloroacetonitrile (1.5 equiv.). The reaction mixture was warmed to room temperature 
and stirred for 2 h under an argon atmosphere. The reaction mixture was then filtered 
through a short pad of silica gel and washed with diethyl ether (100 mL). The resulting 
filtrate  was  then  concentrated  to  give  the  allylic  trichloroacetimidate,  which  was  used 
without  further  purification  in  the  rearrangements  that  followed.  The  allylic 
trichloroacetimidate was then dissolved in THF, toluene or DCM (10 mL) under an argon 
atmosphere. The metal catalyst (0.1 equivalent, 10 mol%) was then added to the solution 94 
and the mixture was stirred at room temperature until the reaction was observed to reach 
completion by 
1H NMR spectroscopy. The mixture was then filtered through a short pad of 
Celite
￿  and  washed  with  diethyl  ether  (100  mL).  Concentration  of  the  filtrate  and 
purification by flash column chromatography (elution with petroleum ether : diethyl ether) 
gave the pure trichloroamide products as brown oils. 
 
General  procedure  5:  Synthesis  of  allylic  trichloroacetimidate  and  subsequent 
thermal rearrangement. 
 
Allylic  alcohol  (1.0  equiv.)  was  dissolved  in  DCM  (20  mL)  and  cooled  to  0 
oC.  1,8-
Diazabicyclo[5.4.0]undec-7-ene (0.25 equiv.) was then added to the solution followed by 
trichloroacetonitrile (1.5 equiv.). The reaction mixture was warmed to room temperature 
and stirred for 2 h under an argon atmosphere. The reaction mixture was then filtered 
through a short pad of silica gel and washed with diethyl ether (100 ml). The resulting 
filtrate  was  then  concentrated  to  give  the  allylic  trichloroacetimidate,  which  was  used 
without  further  purification  in  the  rearrangements  that  followed.  The  crude 
trichloroacetimidate was dissolved in p-xylene (20 mL) and heated to 140 
oC until reaction 
was  complete  as  observed  by 
1H  NMR  spectroscopy.  The  reaction  mixture  was 
concentrated in vacuo to give a brown oil. Purification by chromatography (elution with 
petroleum ether : diethyl ether) gave the trichloroamide products as brown oils. 
 
General  Procedure  6:  Synthesis  of  allylic  trichloroacetimidate  and  subsequent 
tandem aza-Claisen rearrangement - Ring Closing Metathesis.  
 
Allylic  alcohol  (1  equiv.)  was  dissolved  in  DCM  (20  mL)  and  cooled  to  0 
oC.  1,8-
Diazabicyclo[5.4.0]undec-7-ene  (0.25  equiv.)  was  added  to  the  solution  followed  by 
trichloroacetonitrile (1.5 equiv.). The solution was then warmed to room temperature and 
stirred for 2 h. The reaction mixture was filtered through a short pad of silica gel and 
washed with diethyl ether (100 mL). The resulting filtrate was then concentrated to give 
the  allylic  trichloroacetimidate,  which  was  used  without  further  purification.  Allylic 
trichloroacetimidate  (1  equiv.)  was  then  dissolved  in  DCM  (10  mL)  under  an  argon 
atmosphere.  The  rearrangement  catalyst  (0.1  equivalent,  10  mol%)  was  added  to  the 
solution and the reaction mixture was stirred at room temperature for 3 h. Grubbs catalyst 
(1
st Generation) (0.1 equivalent, 10 mol%) was then added and the reaction mixture was 
heated  under  reflux  overnight.  The  mixture  was  cooled  to  room  temperature  and  then 
filtered  through  a  short  pad  of  Celite
￿  and  washed  with  diethyl  ether  (100  mL). 95 
Concentration  of  the  filtrate  followed  by  flash  column  chromatography  gave  the  pure 
cyclic allylic amides as white solids. 
 
General procedure 7: Ruthenium trichloride catalysed oxidation to carboxylic acid. 
 
The  trichloroacetamide  (1  mmol)  was  dissolved  in  carbon  tetrachloride  (14  mL)  and 
acetonitrile (14 mL). Sodium metaperiodate (4.1 equiv.) in water (21 mL) was then added 
followed  by  ruthenium  trichloride  hydrate  (5  mol%).  The  reaction  mixture  was  stirred 
vigorously for 6 h before a further portion of sodium metaperiodate (1 equiv.) was added. 
The reaction mixture was stirred vigorously for 12 h and then extracted with DCM (3 x 40 
mL).  The  organic  layers  were  combined,  dried  (MgSO4)  and  concentrated  to  give  the 
carboxylic acid as a viscous oil. 
 
General procedure 8: Acidic hydrolysis of protecting groups to provide target amino 
acid. 
 
The carboxylic acid (1 mmol) was dissolved in 6 M hydrochloric acid (10 mL) and heated 
under reflux for 12 h. The reaction mixture was then cooled before being extracted with 
diethyl  ether  (10  mL).  The  aqueous  layer  was  concentrated  to  give  a  brown  liquid. 
Purification by ion-exchange chromatography on Dowex
® 50WX8-100 (elution with 0.5 M 
ammonium hydroxide solution) gave the amino acid products as white solids. 
 
1,2,5,6-Di-O-isopropylidene-D-mannitol (94).
102 
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D-Mannitol 92 (15.0 g, 82.3 mmol) was dissolved in dimethyl sulfoxide (30 mL). 2,2-
Dimethoxypropane  93  (25.3  mL,  206.0  mmol)  and  p-toluenesulfonic  acid  (0.75  g,  0.9 
mmol)  were  then  added  and  the  reaction  mixture  was  stirred  at  room  temperature 
overnight. The mixture was washed with a 5% solution of sodium hydrogen carbonate (30 
mL) and then extracted with ethyl acetate (3 x 20 mL). The organic layer was washed 
again with (5%) sodium hydrogen carbonate solution (25 mL), then dried (MgSO4) and 
concentrated in vacuo to give the crude product as a white solid. Re-crystallisation from 
petroleum ether and ethyl acetate, yielded the title product 94 as a crystalline white solid 96 
(12.55 g, 58%). mp 114-118
  oC, lit.
102 115-119 
oC; δH (400 MHz, CDCl3) 1.29 (6H, s, 
CH3), 1.35 (6H, s, CH3), 2.51 (2H, br s, 2 x OH), 3.67 (2H, d, J 6.7 Hz, 3-H and 4-H), 3.92 
(2H, dd, J 8.4, 5.3 Hz, 1-HH and 6-HH), 4.00-4.14 (4H, m, 1-HH, 2-H, 5-H and 6-HH); δC 
(100 MHz, CDCl3) 25.2 (CH3), 26.7 (CH3), 66.8 (CH2), 71.2 (CH), 76.3 (CH), 109.4 (C); 
m/z (CI) 263 (MH
+), 205 (28%). 
 
Ethyl (2E,4S)-4,5-(O-isopropylidene)-4,5-dihydroxypentan-2-enoate (95).
103  
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1,2,5,6-Di-O-isopropylidene-D-mannitol  94  (7.0  g,  26.7  mmol)  was  suspended  in  5% 
sodium hydrogen carbonate solution (75.0 mL) and cooled to 0 
oC. Sodium periodate (6.9 
g, 32.2 mmol) in water (15.0 mL) was added dropwise to the suspension and the reaction 
mixture  was  stirred  at  room  temperature  for  1  h  before  cooling  to  0 
oC.  Triethyl 
phosphonoacetate (11.7 mL, 58.8 mmol) and a potassium carbonate solution (6 M) (80.0 
mL) were then added to the mixture, which was stirred overnight at room temperature. The 
reaction was extracted with DCM (4 x 40 mL), washed with saturated sodium chloride 
solution  (50  mL)  and  dried  (MgSO4).  Concentration  under  vacuum  gave  a  clear  oil. 
Purification by flash column chromatography (elution with petroleum ether : ethyl acetate, 
10 : 1) gave the title compound 95, as a clear oil (7.5 g, 70%). Spectroscopic data in 
accordance  with  literature.
103  [α]D
25  +43.1  (c  1.0,  CHCl3),  lit.
103  [α]D
25  +43.3  (c  1.0, 
CHCl3); δH (400 MHz, CDCl3) 1.22 (3H, t, J 7.2 Hz, OCH2CH3), 1.34 (3H, s, CH3), 1.38 
(3H, s, CH3), 3.61 (1H, dd, J 7.9, 7.5 Hz, 5-HH), 4.09-4.17 (3H, m, OCH2 and 5-HH), 
4.57-4.62 (1H, m, 4-H), 6.03 (1H, dd, J 15.6, 1.2 Hz, 2-H), 6.80 (1H, dd, J 15.6, 5.6 Hz, 3-
H); δC (100 MHz, CDCl3) 14.2 (CH3), 25.4 (CH3) 26.4 (CH3), 60.6 (CH2), 68.8 (CH2), 74.9 
(CH), 110.2 (C), 122.4 (CH), 144.6 (CH), 166.0 (C); m/z (CI) 201 (MH
+, 100%), 183 
(37%), 143 (19), 81 (6). 
 
 
 
 
 
 
 
 97 
(2E,4S)-4,5-(O-Isopropylidene)-4,5-dihydroxyprop-2-en-1-ol (96).
104 
 
OH
O
O
 
 
Reaction was carried out according to general procedure 2 using ethyl  (2E,4S)-4,5-(O-
isopropylidene)-4,5-dihydroxypentan-2-enoate 95 (0.50 g, 2.5 mmol). Purification by flash 
column chromatography (eluting with petroleum ether : diethyl ether, 5 : 1), gave the title 
compound as a colourless oil (0.37 g, 94%). [α]D
25 +31.0 (c 1.6, CHCl3), lit.
104 [α]D
24 
+33.9 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 1.40 (3H, s, CH3), 1.43 (3H, s, CH3), 3.61 
(1H, dd, J 8.1, 7.6 Hz, 5-HH), 4.10 (1H, dd, J 8.1, 6.1 Hz, 5-HH), 4.16 (2H, d, J 5.0 Hz, 1-
H2), 4.51-4.58 (1H, m, 4-H), 5.72 (1H, dd, J 15.5, 7.5 Hz, 3-H), 5.95 (1H, dt, J 15.5, 5.0 
Hz, 2-H); δC (100 MHz, CDCl3) 25.9 (CH3), 26.7 (CH3), 62.5 (CH2), 69.4 (CH2), 76.5 
(CH), 109.4 (C), 128.3 (CH), 133.2 (CH); m/z (CI) 159 (MH
+, 100%), 141 (27), 83 (49). 
 
Synthesis  of  (3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-(O-
isopropylidene)-4,5-dihydroxypenta-1-ene  (98a),  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4,5-(O-isopropylidene)-4,5-dihydroxypenta-1-ene 
(98b) and (2E,4S)-1-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-dihydroxypent-2-ene 
(98c) using PdCl2(MeCN)2 as catalyst.  
 
HO
HO
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The  reaction  was  carried  out  according  to  general  procedure  4  using  (2E,4S)-4,5-(O-
isopropylidene)-4,5-dihydroxyprop-2-en-1-ol  96  (0.20  g,  1.3  mmol)  and 
bis(acetonitrile)palladium(II) chloride (0.03 g, 3 mol%) was used as catalyst. The reaction 
mixture was stirred at 38 
oC for 3 days. Purification by flash column chromatography 
(elution with petroleum ether : diethyl ether, 9 : 1) yielded 98b followed by 98a as brown 
oils (0.14 g, 36% combined yield) and in a ratio of 7 : 1 (98a : 98b). Further elution 
(petroleum ether : diethyl ether, 1 : 9) gave 98c also as a brown oil (0.11 g, 32% yield). 
Data for 98a and 98b: υmax/cm
-1 (neat) 3418 (NH), 2988 (CH), 1719 (CO), 1506 (C=C), 
1373,  1217,  1068;  (3R,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-(O-98 
isopropylidene)-4,5-dihydroxypenta-1-ene 98b: [α]D
25 +34.4 (c 1.0, CHCl3); δH (400 MHz, 
CDCl3) 1.30 (3H, s, CH3), 1.41 (3H, s, CH3), 3.64 (1H, dd, J 8.6, 6.5 Hz, 6-HH), 4.04 (1H, 
dd, J 8.6, 6.5 Hz, 5-HH), 4.28 (1H, td, J 6.5, 2.4 Hz, 4-H), 4.41-4.46 (1H, m, 3-H), 5.22-
5.31 (2H, m, 1-H2), 5.81 (1H, ddd, J 17.1, 10.5, 5.7 Hz, 2-H), 6.98 (1H, br s, NH); δC (100 
MHz, CDCl3) 24.7 (CH3), 26.4 (CH3), 53.9 (CH), 66.4 (CH2), 76.6 (CH), 92.6 (C), 110.0 
(C), 117.7 (CH2), 133.9 (CH), 162.0 (C); m/z (CI) 306.0055 (MH
+. C10H15O3N
35Cl
37Cl2 
requires 306.0062), 293 (40%), 244 (75), 210 (80), 176 (100) 71 (60). Data for (2S,3R)- 
(3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-(O-isopropylidene)-4,5-
dihydroxypenta-1-ene 98a: δH (400 MHz, CDCl3) 1.30 (3H, s, CH3), 1.41 (3H, s, CH3), 
3.78 (1H, dd, J 9.1, 5.1 Hz, 5-HH), 4.02 (1H, dd, J 9.1, 5.1 Hz, 5-HH), 4.22-4.27 (1H, m, 
4-H), 4.40-4.46 (1H, m, 3-H), 5.25-5.32 (2H, m, 1-H2), 5.78 (1H, ddd, J 15.8, 10.3, 6.2 Hz, 
2-H), 7.00 (1H, br s, NH); δC (100 MHz, CDCl3) 24.7 (CH3), 26.1 (CH3), 55.8 (CH), 65.5 
(CH2),  76.1  (CH),  92.5  (C),  110.2  (C),  119.3  (CH2),  131.6  (CH),  161.5  (C).  Data  for 
(2E,4S)-1-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-dihydroxypent-2-ene 98c: υmax/cm
-
1 (neat) 3510 (OH), 3417 (NH), 2985 (CH), 1720 (CO), 1512 (C=C), 1311, 1068; [α]D
25 
+1.5 (c 1.0, CHCl3), δH (400 MHz, CDCl3) 1.89 (2H, br s, 2 x OH), 4.20 (2H, dd, J 5.0, 1.2 
Hz, 1-H2), 4.36 (1H, dd, J 8.5, 8.3 Hz, 5-HH), 4.78 (1H, dd, J 9.8, 8.3 Hz, 5-HH), 4.88-
4.95 (1H, m, 4-H), 5.77 (1H, ddt, J 15.5, 7.3, 1.2 Hz, 3-H), 5.95 (1H, dt, J 15.5, 5.0 Hz, 2-
H); δC (100 MHz, CDCl3) 62.5 (CH2), 67.9 (CH2), 76.1 (CH), 88.1 (C), 128.2 (CH), 133.3 
(CH),  163.3  (C);  m/z  (CI)  261.9726  (MH
+,  C7H11NO3
35Cl3  requires  261.9729),  244 
(100%), 228 (41), 210 (38), 192 (15), 118 (95). 
 
Synthesis  of  (3S,4S,)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-(O-
isopropylidene)-4,5-dihydroxypenta-1-ene  (98a),  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4,5-(O-isopropylidene)-4,5-dihydroxypenta-1-ene 
(98b) and (2E,4S)-1-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-dihydroxypent-2-ene 
(98c) using PtCl2 as catalyst.  
 
The  reaction  was  carried  out  according  to  general  procedure  4  using  (2E,4S)-4,5-(O-
isopropylidene)-4,5-dihydroxyprop-2-en-1-ol  96  (0.10  g,  0.6  mmol)  and  platinum(II) 
chloride (0.017 g, 10 mol%) was used as catalyst. The reaction mixture was stirred at 38 
oC 
for 5 days. Purification by flash column chromatography (elution with petroleum ether : 
diethyl ether, 9 : 1) yielded 98b followed by 98a as brown oils (0.06 g, 31% combined 
yield) and in a 4 : 1 ratio (98a : 98b). Further elution (petroleum ether: diethyl ether, 1 : 9) 
gave 98c also as a brown oil (0.13 g, 66%). Spectroscopic data as reported above. 
 99 
Synthesis  of  (3S,4S,)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-(O-
isopropylidene)-4,5-dihydroxypenta-1-ene  (98a),  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4,5-(O-isopropylidene)-4,5-dihydroxypenta-1-ene 
(98b) and (2E,4S)-1-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-dihydroxypent-2-ene 
(98c) using HAuCl4.3H2O as catalyst.  
 
The  reaction  was  carried  out  according  to  general  procedure  4  using  (2E,4S)-4,5-(O-
isopropylidene)-4,5-dihydroxyprop-2-en-1-ol  96  (0.10  g,  0.6  mmol)  and  hydrogen 
tetrachloroaurate(III)  hydrate  (0.025  g,  10  mol%)  was  used  as  catalyst.  The  reaction 
mixture was stirred at 38 
oC for 5 days. Purification by flash column chromatography 
(elution with petroleum ether : diethyl ether, 9 : 1) yielded 98b followed by 98a as brown 
oils  (0.05  g,  25%  combined  yield)  and  in  a  2  :  1  ratio  (98a  :  98b).  Further  elution 
(petroleum  ether:  diethyl  ether,  1  :  9)  gave  98c  also  as  a  brown  oil  (0.07  g,  36%). 
Spectroscopic data as reported above. 
 
Synthesis  of  (3S,4S,)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-(O-
isopropylidene)-4,5-dihydroxypenta-1-ene  (98a),  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4,5-(O-isopropylidene)-4,5-dihydroxypenta-1-ene 
(98b) and (2E,4S)-1-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-dihydroxypent-2-ene 
(98c) using AuCl as catalyst.  
 
The  reaction  was  carried  out  according  to  general  procedure  4  using  (2E,4S)-4,5-(O-
isopropylidene)-4,5-dihydroxyprop-2-en-1-ol 96 (0.10 g, 0.6 mmol) and gold(I) chloride 
(0.015 g, 10 mol%) was used as catalyst. The reaction mixture was stirred at 38 
oC for 4 
days. Purification by flash column chromatography (elution with petroleum ether : diethyl 
ether, 9 : 1) yielded 98b followed by 98a as brown oils (0.06 g, 31% combined yield) and 
in a 2 : 1 ratio (98a : 98b). Further elution (petroleum ether: diethyl ether, 1 : 9) gave 98c 
also as a brown oil (0.13 g, 68%). Spectroscopic data as reported above. 
 
Synthesis  of  (3S,4S,)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-(O-
isopropylidene)-4,5-dihydroxypenta-1-ene  (98a),  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4,5-(O-isopropylidene)-4,5-dihydroxypenta-1-ene 
(98b), using (S)-COP-Cl as catalyst.  
 
The  reaction  was  carried  out  according  to  general  procedure  4  using  (2E,4S)-4,5-(O-
isopropylidene)-4,5-dihydroxyprop-2-en-1-ol 96 (1.00 g, 6.3 mmol) and di-µ-chlorobis[η
5-100 
(S)-(pR)-2-(2`-(4`-isopropyl)oxazolinylcycloentadienyl,1-C,3`-N))-(η
4-tetraphenylcyclo-
butadiene)cobalt]dipalladium [(S)-COP-Cl] (0.20 g, 3 mol%) was used as catalyst. The 
reaction  mixture  was  stirred  at  38 
oC  for  7  days.  Purification  by  flash  column 
chromatography (elution with petroleum ether : diethyl ether, 9 : 1) yielded 98b followed 
by 98b, as brown oils (1.55 g, 81% combined yield) and in a 52 : 1 ratio (98b : 98a). 
Spectroscopic data as reported above. 
 
Synthesis  of  (3S,4S,)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-(O-
isopropylidene)-4,5-dihydroxypenta-1-ene  (98a),  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4,5-(O-isopropylidene)-4,5-dihydroxypenta-1-ene 
(98b) and (2E,4S)-1-(2’,2’,2’-trichloromethylcarbonylamino)-4,5-dihydroxypent-2-ene 
(98c) using (R)-COP-Cl as catalyst.  
 
The  reaction  was  carried  out  according  to  general  procedure  4  using  (2E,4S)-4,5-(O-
isopropylidene)-4,5-dihydroxyprop-2-en-1-ol  96  (0.10  g,  0.6  mmol)  and  [bis[µ-
chloro]dipalladium]bis[(η
4-1,3-cyclobutadiene-1,2,3,4-tetrayl)tetrakis[benzene]]bis[µ-[(1-
η:1,2,3,4,5-η)-2-[(4R)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]-2,4-cyclopentadien-1-
ylidene]]dicobalt  [(R)-COP-Cl]  (0.023  g,  3  mol%)  was  used  as  catalyst.  The  reaction 
mixture was stirred at 38 
oC for 14 days. Purification by flash column chromatography 
(elution with petroleum ether : diethyl ether, 9 : 1) yielded 98b followed by 98a as brown 
oils  (0.044  g,  23%  combined  yield)  and  in  a  6  :  1  ratio  (98a  :  98b).  Further  elution 
(petroleum  ether:  diethyl  ether,  1  :  9)  gave  98c  also  as  a  brown  oil  (0.027  g,  16%). 
Spectroscopic data as reported above. 
 
(2S,3S)-2-(2’,2’,2’-Trichloromethylcarbonylamino)-3,4-(O-isopropylidene)-4,5-
dihydroxybutanoic acid (99). 
 
CO2H
O
O
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The reaction was carried out according to general procedure 7 using (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4,5-(O-isopropylidene)-4,5-dihydroxypenta-1-ene  98b 
(0.50 g, 1.7 mmol). Purification through a plug of silica gel (elution with diethyl ether : 
petroleum ether, 9 : 1) gave the title compound 99 (0.25 g, 47% yield) as a brown oil. 101 
υmax/cm
-1 (neat) 3423 (NH and OH), 2990 (CH), 1694 (CO); [α]D
21 -58.0 (c 0.25, MeOH); 
δH (400 MHz, CD3OD) 1.35 (3H, s, CH3), 1.44 (3H, s, CH3), 3.84 (1H, dd, J 8.9, 5.7 Hz, 4-
HH), 4.19 (1H, dd, J 8.9, 6.6 Hz, 4-HH), 4.59 (1H, d, J 4.3 Hz, 2-H) 4.68-4.73 (1H, m, 3-
H); δC (100 MHz, CD3OD) 25.1 (CH3), 26.8 (CH3), 56.8 (CH), 67.8 (CH2), 76.2 (CH), 
93.6 (C), 111.0 (C), 164.0 (C), 171.4 (C); m/z (CI) 321.9835 (MH
+. C9H13O5N
35Cl2
37Cl 
requires 321.9831), 264 (100%), 228 (50). 
 
(2S,3S)-2-Amino-3,4-dihydroxybutyric acid (91).
105  
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The reaction was carried out according to general procedure 8 using (2S,3S)-2-(2’,2’,2’-
trichloromethylcarbonylamino)-3,4-(O-isopropylidene)-4,5-dihydroxybutanoic  acid  99 
(0.16 g, 0.5 mmol). Purification by ion exchange  chromatography  (elution with 0.5 M 
NH4OH solution) yielded (2S,3S)-2-amino-3,4-dihydroxybutyric acid 91 as a white solid 
(0.07 g, 100% yield). Spectroscopic data in agreement with literature.
105 [α]D
18 -9.6 (c 1.0, 
H2O); lit.
105 [α]D
26 -10.0 (c 1.0, H2O); δH (400 MHz, D2O) 3.59-3.68 (3H, m, 3-H and 4-
H2), 4.03-4.08 (1H, m, 2-H); δC (100 MHz, D2O) 56.7 (CH), 63.3 (CH2), 69.3 (CH), 172.7 
(C); m/z (CI) 136 (MH
+, 6%), 123 (13), 91 (30), 83 (100), 69 (76), 67 (48). 
 
Ethyl (2E,4S)-4,5-dihydroxypent-2-enoate (100).
106 
 
CO2Et
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HO
 
 
Ethyl  (2E,4S)-4,5-(O-isopropylidene)-4,5-dihydroxypentan-2-enoate  95  (2.00  g,  10.0 
mmol) was dissolved in ethanol (20 mL). 2 M Hydrochloric acid (10 mL) was then added 
and the solution was stirred at room temperature for 3 h. The reaction was quenched by 
addition of sodium hydrogen carbonate (6.0 g). Following filtration, the reaction mixture 
was concentrated in vacuo. After a second filtration the solution was dried (MgSO4) and 
purified through a short pad of silica gel to give the title compound 100 as a clear oil (1.51 
g, 94%). [α]D
24 -5.0 (c 0.5, CHCl3), lit.
106 [α]D
25 -5.8 (c 1.6, CHCl3); δH (400 MHz, CDCl3) 
1.29 (3H, t, J 7.1 Hz, OCH2CH3), 2.60 (2H, br s, 2 x OH), 3.53 (1H, dd, J 11.5, 7.1 Hz, 5-
HH), 3.74 (1H, dd, J 11.5, 3.4 Hz, 5-HH), 4.19 (2H, q, J 7.1 Hz, OCH2CH3), 4.39-4.45 102 
(1H, m, 4-H), 6.12 (1H, dd, J 15.7, 1.8 Hz, 2-H), 6.90 (1H, dd, J 15.7, 4.4 Hz, 3-H); δC 
(100 MHz, CDCl3), 14.2 (CH3), 60.8 (CH2), 65.6 (CH2), 71.7 (CH), 121.9 (CH), 146.3 
(CH), 166.7 (C); m/z (CI) 161 (MH
+, 100%), 99 (57), 75 (30). 
 
Ethyl (2E,4S)-4-hydroxy-5-(tert-butyldiphenylsilyloxy)pent-2-enoate (101). 
107 
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Ethyl (2E,4S)-4,5-dihydroxypent-2-enoate 100 (1.00 g, 6.3 mmol) was dissolved in THF 
(40 mL). tert-Butyldiphenylchlorosilane (2.40 g, 8.7 mmol) and imidazole (0.90 g, 13.0 
mmol) were then added and the solution was stirred at room temperature overnight. The 
solution was then diluted with ethyl acetate (50 mL) and washed with water (50 mL). The 
organic  extracts  were  dried  (MgSO4)  and  concentrated  in  vacuo.  Flash  column 
chromatography (petroleum ether : diethyl ether, 10 : 1) yielded ethyl (2E,4S)-4-hydroxy-
5-(tert-butyldiphenylsilyloxy)pent-2-enoate 101, as a clear oil (2.48 g, 100%). [α]D
25 -17.8 
(c 1.6, CHCl3), lit.
107 [α]D
22 -16.4 (c 0.17, CHCl3); δH (400 MHz, CDCl3) 1.08 (9H, s, 
C(CH3)3), 1.27 (3H, t, J 7.2 Hz, OCH2CH3), 2.74 (1H, br d, J 4.2 Hz, 4-OH), 3.55 (1H, dd, 
J  10.2,  4.0  Hz,  5-HH),  3.76  (1H,  dd,  J  10.2,  2.1  Hz,  5-HH),  4.19  (2H,  q,  J  7.2  Hz, 
OCH2CH3), 4.38-4.42 (1H, m, 4-H), 6.14 (1H, dd, J 15.7, 2.2 Hz, 2-H), 6.80 (1H, dd, J 
15.7, 4.3 Hz, 3-H), 7.37-7.47 (6H, m, Ph), 7.62-7.68 (4H, m, Ph); δC (100 MHz, CDCl3), 
14.3 (CH3), 19.3 (C), 26.9 (CH3), 60.5 (CH2), 67.0 (CH2), 71.5 (CH), 122.0 (CH), 127.9 
(CH), 130.0 (CH), 132.8 (C), 135.6 (CH), 145.8 (CH), 166.3 (C); m/z (CI) 381 (MH
+-OH, 
14%), 321 (100), 257 (5), 217 (4), 143 (8). 
 
Ethyl  (2E,4S)-4-(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-2-enoate 
(102).
107  
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The  reaction  was  carried  out  according  to  general  procedure  3  using  ethyl  (2E,4S)-4-
hydroxy-5-(tert-butyldiphenylsilyloxy)pent-2-enoate  101  (0.10  g,  0.3  mmol)  and  N,N-
diisopropylethylamine  (5.0  equiv.)  and  bromomethyl  methyl  ether  (5.0  equiv.).  Flash 
column chromatography (petroleum ether : diethyl ether, 5 : 1) yielded the title compound 
102 as a brown oil (0.13 g, 86%). [α]D
25 +11.7 (c 2.9, CHCl3), lit.
107 [α]D
21 +12.3 (c 1.7, 
CHCl3); δH (400 MHz, CDCl3) 1.06 (9H, s, C(CH3)3), 1.30 (3H, t, J 7.2 Hz, OCH2CH3), 
3.38 (3H, s, OCH3), 3.69 (1H, dd, J 11.1, 5.0 Hz, 5-HH), 3.77 (1H, dd, J 11.1, 6.2 Hz, 5-103 
HH), 4.22 (2H, q, J 7.2 Hz, OCH2CH3), 4.35-4.40 (1H, m, 4-H), 4.67 (1H, d, J 7.1 Hz, 
OCHHO), 4.72 (1H, d, J 7.1 Hz, OCHHO), 5.68 (1H, dd, J 16.3, 2.0 Hz, 2-H), 6.90 (1H, 
dd, J 16.3, 6.4 Hz, 3-H), 7.34-7.48 (6H, m, Ph), 7.56-7.72 (4H, m, Ph); δC (100 MHz, 
CDCl3), 14.3 (CH3), 19.3 (C), 26.8 (CH3), 55.6 (CH3), 60.5 (CH2), 66.1 (CH2), 75.9 (CH), 
95.2 (CH2), 122.8 (CH), 127.9 (CH), 129.8 (CH), 133.1 (CH), 145.1 (CH), 166.1 (C); m/z 
(CI) 443 (MH
+, 2%), 381 (100), 321 (7), 257 (16), 243 (15), 143 (10). 
  
(2E,4S)-4-(Methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol (103). 
 
OMOM
OH
TBDPSO
 
 
The  reaction  was  carried  out  according  to  general  procedure  2  using  ethyl  (2E,4S)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-2-enoate  102  (2.80  g,  6.0  mmol). 
Purification by flash column chromatography (eluting with petroleum ether : diethyl ether, 
1  :  1)  yielded  (2E,4S)-4-(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol 
103, as a yellow oil (2.19 g, 86%). υmax/cm
-1 (neat) 3422 (OH), 3071 (CH), 2931 (CH), 
1589 (C=C), 1428, 1112 (C-O), 704; [α]D
28 +31.2 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 
1.05 (9H, s, C(CH3)3), 1.29 (1H, br s, OH), 3.37 (3H, s, OCH3), 3.63 (1H, dd, J 11.1, 6.0 
Hz, 5-HH), 3.74 (1H, dd, J 11.1, 7.6 Hz, 5-HH), 4.12 (2H, br d, J 5.0 Hz, 1-H2), 4.18-4.24 
(1H, m, 4-H), 4.64 (1H, d, J 7.1 Hz, OCHHO), 4.70 (1H, d, J 7.1 Hz, OCHHO), 5.58 (1H, 
ddt, J 16.3, 8.0, 2.1 Hz, 3-H), 5.89 (1H, dtd, J 16.3, 5.0, 1.0 Hz, 2-H), 7.37-7.45 (6H, m, 
Ph), 7.67-7.71 (4H, m, Ph); δC (100 MHz, CDCl3), 19.3 (C), 26.8 (CH3), 55.4 (CH3), 63.0 
(CH2), 66.8 (CH2), 76.8 (CH), 94.4 (CH2), 127.7 (CH), 128.5 (CH), 129.7 (CH), 132.9 
(CH), 133.5 (C), 135.7 (CH); m/z (CI) 401 (MH
+, 3%), 339 (100), 261 (24), 209 (25), 167 
(21), 143 (19), 117 (29).  
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Synthesis  of  (3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)-
5-(tert-butyldiphenylsilyloxy)pent-1-ene  (105a)  and  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-
butyldiphenylsilyloxy)pent-1-ene  (105b)  using  bis-acetonitrile-dichloropalladium(II) 
catalysed aza-Claisen rearrangement in THF. 
 
OMOM
TBDPSO
HN O
CCl3
OMOM
TBDPSO
HN O
CCl3
+
 
 
The  reaction  was  carried  out  according  to  general  procedure  4  using  (2E,4S)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol  103  (0.15  g,  0.4  mmol) 
and  the  aza-Claisen  rearrangement  was  performed  in  THF  using  bis-acetonitrile 
dichloropalladium(II)  (0.01  g,  0.04  mmol)  as  catalyst.  Flash  column  chromatography 
(petroleum  ether  :  diethyl  ether,  20  :  1)  gave  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-1-
ene  105b  followed  by  (3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-1-ene 105a as brown oils (0.063 g, 
32% combined yield over 2 steps) and in a 3 : 1 ratio (105a : 105b). υmax/cm
-1 (neat) 3393 
(NH), 3072 (CH), 2931 (CH), 1717 (CO), 1645 (C=C), 1509, 1113, 1032, 822. (3R,4S)-3-
(2’,2’,2’-Trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-
butyldiphenylsilyloxy)pent-1-ene 105b: [α]D
25 +5.7 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 
1.09 (9H, s, C(CH3)3), 3.30 (3H, s, OCH3), 3.65 (1H, dd, J 11.1, 8.0 Hz, 5-HH), 3.74 (1H, 
dd, J 11.1, 7.3 Hz, 5-HH), 3.88-3.92 (1H, m, 4-H), 4.61 (1H, d, J 7.1 Hz, OCHHO), 4.67 
(1H, d, J 7.1 Hz, OCHHO), 4.81-4.84 (1H, m, 3-H), 5.29-5.36 (2H, m, 1-H2), 5.91 (1H, 
ddd, J 17.1, 10.6, 5.1 Hz, 2-H), 7.16 (1H, br d, J 8.2 Hz, NH), 7.47-7.55 (6H, m, Ph); 7.77-
7.81 (4H, m, Ph); δC (100 MHz, CDCl3) 19.2 (C), 26.8 (CH3), 53.5 (CH), 55.9 (CH3), 63.0 
(CH2), 78.0 (CH), 93.0 (C), 96.6 (CH2), 116.8 (CH2), 127.8 (CH), 129.9 (CH), 132.9 (C), 
134.6 (CH), 135.6 (CH), 161.5 (C). (3S,4S)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-1-ene  (105a):  [α]D
25  -28.1  (c  1.0, 
CHCl3); δH (400 MHz, CDCl3) 1.10 (9H, s, C(CH3)3), 3.40 (3H, s, OCH3), 3.65-3.82 (3H, 
m, 5-H2 and 4-H), 4.60-4.76 (3H, m, OCH2O and 3-H), 5.28-5.35 (2H, m, 1-H2), 5.79 (1H, 
ddd, J 17.1, 10.3, 6.6 Hz, 2-H), 7.39-7.48 (6H, m, Ph), 7.67-7.70 (4H, m, Ph), 8.04 (1H, br 
d, J 7.9 Hz, NH); δC (100 MHz, CDCl3) 19.2 (C), 26.9 (CH3), 54.4 (CH), 55.9 (CH3), 63.8 
(CH2), 81.7 (CH), 93.1 (C), 97.7 (CH2), 118.8 (CH2), 127.8 (CH), 129.9 (CH), 131.6 (C), 105 
132.9 (CH), 135.6 (CH), 161.4 (C). m/z (CI) 544.1249 (MH
+ C12H33O4N
35Cl3Si requires 
544.1244), 512 (100%), 478, (35), 448 (20), 344 (16), 257 (10). 
 
Synthesis  of  (3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)-
5-(tert-butyldiphenylsilyloxy)pent-1-ene  (105a)  and  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-
butyldiphenylsilyloxy)pent-1-ene  (105b)  using  bis-acetonitrile-dichloropalladium(II) 
catalysed aza-Claisen rearrangement in toluene. 
 
The  reaction  was  carried  out  according  to  general  procedure  4  using  (2E,4S)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol  103  (0.14  g,  0.3  mmol) 
and bis-acetonitrile-dichloropalladium(II) (10 mol%) as catalyst in toluene (10 mL). Flash 
column chromatography (petroleum ether : diethyl ether, 20 : 1) gave (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-1-
ene  105b  followed  by  (3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-1-ene  105a  as  brown  oils  (0.09  g, 
68% combined yield over two steps) and in a 4 : 1 ratio (105a : 105b). Spectroscopic data 
as reported above. 
 
Synthesis  of  (3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)-
5-(tert-butyldiphenylsilyloxy)pent-1-ene  (105a)  and  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-
butyldiphenylsilyloxy)pent-1-ene  (105b)  by  PtCl2  catalysed  aza-Claisen 
rearrangement. 
 
The  reaction  was  carried  out  according  to  general  procedure  4,  using  (2E,4S)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol  103  (0.18  g,  0.5  mmol) 
and platinum(II) chloride (10 mol%) as catalyst. Flash column chromatography (elution 
with  petroleum  ether  :  diethyl  ether,  20  :  1)  gave  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-1-
ene  105b  followed  by  (3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-1-ene  105a  as  brown  oils  (0.04  g, 
25% yield over two steps) and in a 4 : 1 ratio (105a : 105b). Spectroscopic data as reported 
above. 
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Synthesis  of  (3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)-
5-(tert-butyldiphenylsilyloxy)pent-1-ene  (105a)  and  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-
butyldiphenylsilyloxy)pent-1-ene  (105b)  using  hydrogen  tetrachloroaurate(III) 
hydrate catalysed aza-Claisen rearrangement. 
 
The  reaction  was  carried  out  according  to  general  procedure  4  using  (2E,4S)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol  103  (0.05  g,  0.1  mmol) 
and hydrogen tetrachloroaurate(III) hydrate (10 mol%) was used as catalyst in toluene (10 
mL). Flash column chromatography (petroleum ether : diethyl ether, 20 : 1) gave (3R,4S)-
3-(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-
butyldiphenylsilyloxy)pent-1-ene  105b  followed  by  (3S,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-1-
ene 105a as brown oils (0.03 g, 49% combined yield over two steps) and in a 2 : 1 ratio 
(105a : 105b). Spectroscopic data as reported above. 
 
Synthesis  of  (3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)-
5-(tert-butyldiphenylsilyloxy)pent-1-ene  (105a)  and  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-
butyldiphenylsilyloxy)pent-1-ene (105b) using gold(I) chloride catalysed aza-Claisen 
rearrangement. 
 
The  reaction  was  carried  out  according  to  general  procedure  4,  using  (2E,4S)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol  103  (0.10  g,  0.5  mmol) 
and  gold(I)  chloride  (10  mol%)  as  catalyst  in  toluene  (10  mL).  Flash  column 
chromatography  (elution  with  petroleum  ether  :  diethyl  ether,  20  :  1)  gave  (3R,4S)-3-
(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-
butyldiphenylsilyloxy)pent-1-ene  105b  followed  by  (3S,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-1-
ene 105a as brown oils (0.06 g, 40% combined yield over two steps) and in a 3 : 1 ratio 
(105a : 105b). Spectroscopic data as reported above. 
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Synthesis  of  (3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)-
5-(tert-butyldiphenylsilyloxy)pent-1-ene  (105a)  and  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-
butyldiphenylsilyloxy)pent-1-ene (105b) using gold(III) chloride catalysed aza-Claisen 
rearrangement. 
 
The  reaction  was  carried  out  according  to  general  procedure  4,  using  (2E,4S)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol  103  (0.10  g,  0.5  mmol) 
and  gold(III)  chloride  (10  mol%)  as  catalyst  in  toluene  (10  mL).  Flash  column 
chromatography  (elution  with  petroleum  ether  :  diethyl  ether,  20  :  1)  gave  (3R,4S)-3-
(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-
butyldiphenylsilyloxy)pent-1-ene  105b  followed  by  (3S,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-1-
ene 105a as brown oils (0.04 g, 26% combined yield over two steps) and in a 2 : 1 ratio 
(105a : 105b). Spectroscopic data as reported above. 
 
Synthesis  of  (3S,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)-
5-(tert-butyldiphenylsilyloxy)pent-1-ene  (105a)  and  (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-
butyldiphenylsilyloxy)pent-1-ene  (105b)  using  (R)-COP-Cl  catalysed  aza-Claisen 
rearrangement. 
 
The  reaction  was  carried  out  according  to  general  procedure  4,  using  (2E,4S)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol  103  (0.10  g,  0.5  mmol) 
and  [bis[µ-chloro]dipalladium]bis[(η
4-1,3-cyclobutadiene-1,2,3,4-
tetrayl)tetrakis[benzene]]bis[µ-[(1-η:1,2,3,4,5-η)-2-[(4R)-4,5-dihydro-4-(1-methylethyl)-2-
oxazolyl]-2,4-cyclopentadien-1-ylidene]]dicobalt  [(R)-COP-Cl]  (10  mol%)  was  used  as 
catalyst, in DCM (10 mL). Flash column chromatography (elution with petroleum ether : 
diethyl  ether,  20  :  1)  gave  (3R,4S)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-
(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-1-ene 105b followed by (3S,4S)-3-
(2’,2’,2’-trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-
butyldiphenylsilyloxy)pent-1-ene 105a as brown oils (0.13 g, 68% combined yield over 
two steps) and in a 16 : 1 ratio (105a : 105b). Spectroscopic data as reported above. 
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(2R,3S)-2-(2’,2’,2’-Trichloromethylcarbonylamino)-3-methoxymethoxy-4-(tert-
butyldiphenylsilyloxy)butanoic acid (106). 
 
CO2H
OMOM
TBDPSO
HN O
CCl3  
 
The reaction was carried out according to general procedure 7 using (3R,4S)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-(methoxymethoxy)-5-(tert-butyldiphenylsilyloxy)pent-1-
ene 105a (0.20 g, 0.4 mmol). The crude product was dissolved in an aqueous solution of 
sodium hydrogen carbonate (10 mL), extracted with ethyl acetate (2 x 10 mL) and re-
acidified by addition of 2 M hydrochloric acid (15 mL). The aqueous phase was extracted 
with ethyl acetate (5 x 10 mL), dried (MgSO4) and concentrated in vacuo to give (2R,3S)-
2-(2’,2’,2’-trichloromethylcarbonylamino)-3-methoxymethoxy-4-(tert-
butyldiphenylsilyloxy)butanoic  acid  106  (0.15  g,  71%  yield)  as  a  brown  oil.  υmax/cm
-1 
(neat) 3334 (NH and OH), 2958 (CH), 1774 (CO); [α]D
24 -12.5 (c 1.5, MeOH); δH (400 
MHz, CD3OD) 0.98 (9H, s, C(CH3)3), 3.24 (3H, s, OCH3), 3.85 (1H, dd, J 10.8, 6.3 Hz, 4-
HH), 3.92 (1H, dd, J 10.8, 4.6 Hz, 4-HH), 3.98-4.02 (1H, m, 3-H), 4.50 (1H, d, J 3.0 Hz, 2-
H), 4.56 (1H, d, J 6.8 Hz, OCHHO), 4.58 (1H, d, J 6.8 Hz, OCHHO), 7.22-7.35 (6H, m, 
Ph), 7.59-7.63 (4H, m, Ph); δC (100 MHz, CD3OD) 20.1 (C), 27.2 (CH3), 56.4 (CH3), 57.8 
(CH), 65.8 (CH2), 80.5 (CH), 93.8 (C), 98.2 (CH2), 128.6 (CH), 130.9 (CH), 134.5 (C), 
136.8 (CH), 163.0 (C), 173.3 (C); m/z (CI) 547 (MH
+-CH4, 3%), 376 (5), 325, (10), 274 
(100), 196 (30). 
 
(2R,3S)-2-Amino-3,4-dihydroxybutyric acid (90).
64  
 
CO2H
OH
HO
NH2  
 
(2R,3S)-2-(2’,2’,2’-Trichloromethylcarbonylamino)-3-methoxymethoxy-4-(tert-
butyldiphenylsilyloxy)butanoic acid 106 (0.12 g, 0.2 mmol) was dissolved in THF (10 
mL). Tetrabutylammonium fluoride (1.0 M solution in THF) (0.73 mL, 0.7 mmol) was 
then  added  and  the  solution  was  stirred  at  room  temperature  overnight.  The  reaction 
mixture  was  concentrated  and  the  residue  re-dissolved  in  ethyl  acetate  (15  mL)  then 
washed with water (15 mL). The organic layer was dried (MgSO4) and concentrated to 109 
give a brown oil (0.1g), which was then dissolved in 6 M hydrochloric acid solution (10 
mL) and heated under reflux overnight. After cooling to room temperature the reaction 
mixture  was  extracted  with  diethyl  ether  (10  mL).  The  aqueous  phase  was  then 
concentrated  in  vacuo  to  give  the  crude  product.  Purification  by  ion  exchange 
chromatography  (eluting  with  0.5  M  NH4OH  solution),  yielded  (2R,3S)-2-amino-3,4-
dihydroxybutyric acid 90 as a white solid (11 mg, 44% over two steps). Spectroscopic data 
in agreement with literature.
64 [α]D
24 +10.6 (c 0.5, H2O), lit.
64 [α]D
24 +11.3 (c 7.0, H2O); δH 
(400 MHz, D2O) 3.66-3.71 (2H, m, 4-H2), 3.84-3.88 (1H, m, 3-H), 4.07-4.11 (1H, m, 2-H); 
m/z (CI) 136 (MH
+, 5%), 130 (100), 114 (32), 69 (30). 
 
Ethyl (3R)-3-hydroxybutanoate (115).
108 
 
CO2Et
OH
 
 
Poly-(3R)-3-hydroxybutanoate 114 (9.0 g, 0.1 mol), ethanol (100 mL), 1,2-dichloroethane 
(75 mL) and concentrated sulphuric acid (10 mL) were heated under reflux for 7 days. 
Further sulphuric acid (8 mL) was then added and the reaction mixture was heated for an 
additional  5  days.  The  solution  was  then  filtered  through  Celite
￿  and  the  filtrate  was 
washed  with  a  saturated  sodium  chloride  solution  (75  mL),  dried  (MgSO4)  and 
concentrated to give the crude product. Distillation under vacuum gave the title compound 
115 as a colourless oil (6.9 g, 52%). [α]D
21 -39.6 (c 1.0, CHCl3), lit.
108 [α]D
25 -42.0 (c 1.0, 
CHCl3);  δH  (400  MHz,  CDCl3)  1.23  (3H,  d,  J  6.1  Hz,  4-H3),  1.28  (3H,  t,  J  7.0  Hz, 
OCH2CH3), 2.42 (1H, dd, J 9.7, 6.1 Hz, 2-HH), 2.50 (1H, dd, J 9.7, 2.5 Hz, 2-HH), 3.10 
(1H, br s, OH), 4.15-4.21 (3H, m, OCH2CH3 and 3-H); m/z (CI) 133 (MH
+, 100%), 115 
(9), 87 (8). 
 
Ethyl (3R)-3-methoxymethoxybutanoate (116).
109  
 
CO2Et
MOMO
 
 
Reaction  was  carried  out  according  to  general  procedure  3  using  ethyl  (3R)-3-
hydroxybutanoate 115 (5.00 g, 0.04 mol). Purification by flash column chromatography 
(elution  with  petroleum  ether  :  ethyl  acetate,  9  :  1)  yielded  ethyl  (3R)-3-
methoxymethoxybutanoate 116, as a clear oil (5.27 g, 75%). [α]D
22 -10.4 (c 1.5, CHCl3), 110 
lit.
109 [α]D
25 -11.7 (c 0.7, CHCl3); δH (400 MHz, CDCl3) 1.25 (3H, d, J 6.1 Hz, 4-H3), 1.27 
(3H, t, J 7.0 Hz, OCH2CH3), 2.41 (1H, dd, J 15.2, 5.5 Hz, 2-HH), 2.59 (1H, dd, J 15.2, 7.0 
Hz, 2-HH), 3.36 (3H, s, OCH3), 4.12-4.19 (3H, m, OCH2CH3 and 3-H), 4.65 (1H, d, J 6.9 
Hz, OCHHO), 4.68 (1H, d, J 6.9 Hz, OCHHO); δC (100 MHz, CDCl3) 14.2 (CH3), 20.6 
(CH3), 42.4 (CH2), 55.4 (CH3), 60.4 (CH2), 70.4 (CH), 95.4 (CH2), 171.3 (C); m/z (CI) 177 
(MH
+, 8%), 145 (100), 115 (5). 
 
(3R)-3-Methoxymethoxybutan-1-ol (117).
110  
 
OH
OMOM
 
 
The  reaction  was  carried  out  according  to  general  procedure  2  using  ethyl  (3R)-3-
methoxymethoxybutanoate  116  (5.00  g,  30.0  mmol).  Flash  column  chromatography 
(elution with petroleum ether : diethyl ether, 3 : 2) gave (3R)-3-methoxymethoxybutan-1-ol 
117 as a light yellow oil (3.0 g, 80%). Spectroscopic data in agreement with literature.
110 
[α]D
21 -91.3 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 1.22 (3H, d, J 6.3 Hz, 4-H3), 1.71-1.79 
(2H, m, 2-H2), 2.39 (1H, br s, OH), 3.40 (3H, s, OCH3), 3.70-3.85 (2H, m, 1-H2), 3.90-3.98 
(1H, m, 3-H), 4.64 (1H, d, J 6.8 Hz, OCHHO), 4.72 (1H, d, J 6.8 Hz, OCHHO); δC (100 
MHz, CDCl3) 20.2 (CH3), 39.2 (CH2), 55.5 (CH3), 60.2 (CH2), 72.2 (CH), 95.0 (CH2); m/z 
(CI) 135 (MH
+, 30%), 103 (100), 73 (8). 
 
Ethyl (2E,5R)-5-methoxymethoxyhex-2-enoate (118).
 
 
OMOM
CO2Et 
 
Reaction  carried  out  according  to  general  procedure  1  using  (3R)-3-
methoxymethoxybutan-1-ol 117 (1.00 g, 7.5 mmol). Purification of the crude material by 
flash column chromatography (eluting with petroleum ether : diethyl ether, 1 : 1) gave the 
title compound 118 as a yellow oil (0.9 g, 59% yield). υmax/cm
-1 (neat) 2974 (CH), 1716 
(CO), 1655 (C=C), 1454, 1373; [α]D
22 +3.3 (c 1.7, CHCl3); δH (400 MHz, CDCl3) 1.20 
(3H, d, J 6.3 Hz, 6-H3), 1.28 (3H, t, J 7.0 Hz, OCH2CH3), 2.32-2.49 (2H, m, 4-H2), 3.36 
(3H, s, OCH3), 3.81-3.89 (1H, m, 5-H), 4.19 (2H, q, J 7.0 Hz, OCH2CH3), 4.62 (1H, d, J 
7.0 Hz, OCHHO), 4.69 (1H, d, J 7.0 Hz, OCHHO), 5.88 (1H, dt, J 15.7, 1.4 Hz, 2-H), 6.96 
(1H, dt, J 15.7, 7.4 Hz, 3-H); δC (100 MHz, CDCl3) 14.3 (CH3), 20.3 (CH3), 39.6 (CH2), 111 
55.4 (CH3), 60.2 (CH2), 71.8 (CH), 94.9 (CH2), 123.6 (CH), 145.1 (CH), 166.3 (C); m/z 
(CI) 203.1285 (MH
+. C10H19O4 requires 203.1283), 171 (100%), 141 (10).  
 
(2E,5R)-5-Methoxymethoxyhex-2-en-1-ol (119). 
   
OMOM
OH 
 
The  reaction  was  done  according  to  general  procedure  2  using  ethyl  (2E,5R)-5-
methoxymethoxyhex-2-enoate  118  (1.20  g,  6.0  mmol).  Purification  by  flash  column 
chromatography  (elution  with  petroleum  ether  :  diethyl  ether,  3  :  1)  gave  (2E,5R)-5-
methoxymethoxyhex-2-en-1-ol 119 as  a light  yellow oil (0.9 g, 98%).  υmax/cm
-1 (neat) 
3410 (OH), 2931 (CH), 1662 (C=C), 1450, 1381; [α]D
22 +6.3 (c 1.5, CHCl3); δH (400 MHz, 
CDCl3) 1.18 (3H, d, J 6.2 Hz, 6-H3), 1.60 (1H, br s, OH), 2.19-2.36 (2H, m, 4-H2), 3.36 
(3H, s, OCH3), 3.76 (1H, sextet, J 6.2 Hz, 5-H), 4.10-4.22 (2H, m, 1-H2), 4.64 (1H, d, J 6.9 
Hz, OCHHO), 4.68 (1H, d, J 6.9 Hz, OCHHO), 5.70-5.73 (2H, m, 2-H and 3-H); δC (100 
MHz, CDCl3) 20.0 (CH3), 39.7 (CH2), 55.3 (CH3), 63.6 (CH2), 72.7 (CH), 94.9 (CH2), 
128.8  (CH),  131.7  (CH);  m/z  (CI)  161.1179  (MH
+.  C8H17O3  requires  161.1178),  143 
(12%), 129 (100), 99 (30), 89 (40), 81 (22). 
 
(3S,5R)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-5-methoxymethoxyhex-1-ene 
(110a)  and  (3R,5R)-3-(2’,2’,2’-trichloromethylcarbonylamino)-5-
methoxymethoxyhex-1-ene (110b). 
 
MOMO O HN
CCl3
MOMO O HN
CCl3
+
 
 
The  reaction  was  carried  out  according  to  general  procedure  4  using  (5R)-5-
methoxymethoxyhex-2-en-1-ol 119 (0.09 g, 0.6 mmol) in THF (10 mL). Flash column 
chromatography  (elution  with  petroleum  ether  :  diethyl  ether,  17  :  3)  yielded  the  title 
compounds as brown oils (0.08 g, 50% combined yield over 2 steps), in a 1 : 1 ratio (110a : 
110b).  (3S,5R)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-5-methoxymethoxyhex-1-ene 
110a: υmax/cm
-1 (neat) 3336 (NH), 2931 (CH), 1709 (CO), 1647 (C=C), 1516; [α]D
22 +9.9 
(c 1.0, CHCl3); δH (400 MHz, CDCl3) 1.26 (3H, d, J 6.1 Hz, 6-H3), 1.81 (1H, ddd, J 15.0, 
6.2, 3.0 Hz, 4-HH), 1.95 (1H, ddd, J 15.0, 10.1, 4.0 Hz, 4-HH), 3.39 (3H, s, OCH3), 3.96-112 
4.05 (1H, m, 5-H), 4.60-4.66 (2H, m, OCHHO and 3-H), 4.76 (1H, d, J 6.8 Hz, OCHHO), 
5.23-5.29 (2H, m, 1-H2), 5.85 (1H, ddd, J 17.3, 10.1, 5.0 Hz, 2-H), 8.12 (1H, br s, NH); δC 
(100 MHz, CDCl3) 20.3 (CH3), 40.2 (CH2), 51.5 (CH), 56.0 (CH3), 71.0 (CH), 93.0 (C), 
95.1 (CH2), 115.8 (CH2), 135.7 (CH), 161.2 (C); m/z (CI) 304.0270 (MH
+. C10H17NO3
35Cl3 
requires  304.0274),  272  (100%),  201  (20),  114  (26),  45  (80).  (3R,5R)-3-(2’,2’,2’-
Trichloromethylcarbonylamino)-5-methoxymethoxyhex-1-ene  110b:  [α]D
22  -9.1  (c  1.0, 
CHCl3); δH (400 MHz, CDCl3) 1.27 (3H, d, J 6.1 Hz, 6-H3), 1.80 (1H, ddd, J 14.3, 6.0, 4.1 
Hz, 4-HH), 1.90 (1H, dt, J 14.3, 8.1 Hz, 4-HH), 3.39 (3H, s, OCH3), 3.81-3.87 (1H, m, 5-
H), 4.40-4.49  (1H, m,  3-H), 4.63  (1H, d, J 7.0 Hz, OCHHO), 4.73 (1H, d, J 7.0 Hz, 
OCHHO), 5.22 (1H, dt, J 10.4, 1.1, 1-HH), 5.28 (1H, dt, J 17.5, 1.1 Hz, 1-HH), 5.85 (1H, 
ddd, J 17.5, 10.4, 6.0 Hz, 2-H), 7.15 (1H, br s, NH); δC (100 MHz, CDCl3) 20.9 (CH3), 
41.5 (CH2), 52.3 (CH), 55.6 (CH3), 71.9 (CH), 93.0 (C), 95.4 (CH2), 116.1 (CH2), 136.6 
(CH),  161.2  (C);  m/z  (CI)  304.0271  (MH
+.  C10H17NO3
35Cl3  requires  304.0274),  272 
(100%), 242 (51), 224 (66), 201 (25), 45 (84). 
 
Synthesis  of  (3S,5R)-3-(2’,2’,2’-trichloromethylcarbonylamino)-5-
methoxymethoxyhex-1-ene  (110a)  and  (3R,5R)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-5-methoxymethoxyhex-1-ene (110b) using palladium 
catalysed rearrangement with addition of DBU. 
 
The  reaction  was  carried  out  according  to  general  procedure  4  using  (5R)-5-
methoxymethoxyhex-2-en-1-ol  119  (0.18  g,  1.1  mmol)  in  THF  (10  mL).  1,8-
Diazabicyclo[5.4.0]undec-7-ene (DBU) (1 equiv.) was also added to the reaction mixture. 
Flash column chromatography (elution with petroleum ether : diethyl ether, 17 : 3) yielded 
the title compounds as brown oils (0.13 g, 41% combined yield over 2 steps) and in a 2 : 1 
ratio (110a : 110b). Spectroscopic data as reported above. 
 
Synthesis  of  (3S,5R)-3-(2’,2’,2’-trichloromethylcarbonylamino)-5-
methoxymethoxyhex-1-ene  (110a)  and  (3R,5R)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-5-methoxymethoxyhex-1-ene (110b) using palladium 
catalysed rearrangement with addition of ￿-benzoquinone. 
 
The  reaction  was  carried  out  according  to  general  procedure  4  using  (5R)-5-
methoxymethoxyhex-2-en-1-ol 119 (0.18 g, 1.1 mmol) in THF (10 mL). ￿-Benzoquinone 
(2 equiv.) was also added to the reaction mixture. Flash column chromatography (elution 
with petroleum ether : diethyl ether, 17 : 3) yielded the title compounds as brown oils (0.13 113 
g, 41% combined yield over 2 steps) and in a 2 : 1 ratio (110a : 110b). Spectroscopic data 
as reported above. 
 
Synthesis  of  (3S,5R)-3-(2’,2’,2’-trichloromethylcarbonylamino)-5-
methoxymethoxyhex-1-ene  (110a)  and  (3R,5R)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-5-methoxymethoxyhex-1-ene  (110b)  using  thermal 
rearrangement. 
 
The  reaction  was  carried  out  according  to  general  procedure  5  using  (5R)-5-
methoxymethoxyhex-2-en-1-ol  119  (0.09  g,  0.6  mmol).  Flash  column  chromatography 
(elution  with  petroleum  ether  :  diethyl  ether,  10  :  1)  yielded  (3S,5R)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-5-methoxymethoxyhex-1-ene  110a  and  (3R,5R)-3-
(2’,2’,2’-trichloromethylcarbonylamino)-5-methoxymethoxyhex-1-ene 110b as brown oils 
(0.11g, 66% combined yield over 2 steps) in a 1 : 1 ratio (110a : 110b). Spectroscopic data 
as reported above. 
 
Synthesis  of  (3S,5R)-3-(2’,2’,2’-trichloromethylcarbonylamino)-5-
methoxymethoxyhex-1-ene  (110a)  and  (3R,5R)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-5-methoxymethoxyhex-1-ene (110b) using palladium 
catalysed rearrangement in toluene. 
 
The  reaction  was  carried  out  according  to  general  procedure  4  using  (5R)-5-
methoxymethoxyhex-2-en-1-ol 119 (0.05 g, 0.3 mmol) in toluene (10 mL). Flash column 
chromatography  (elution  with  petroleum  ether  :  diethyl  ether,  17  :  3)  yielded  the  title 
compounds as brown oils (0.06 g, 71% combined yield over 2 steps) and in a 3 : 1 ratio 
(110a : 110b). Spectroscopic data as reported above. 
 
 
 
 
 
 
 
 
 
 114 
(2S,4R)-2-(2’,2’,2’-Trichloromethylcarbonylamino)-4-methoxymethoxypentanoic acid 
(141). 
 
CO2H
MOMO O HN
CCl3
 
 
The reaction was carried out according to general procedure 7 using (3S,5R)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-5-methoxymethoxyhex-1-ene 110a (0.15 g, 0.5 mmol) to 
give (2S,4R)-2-(2’,2’,2’-trichloromethylcarbonylamino)-4-methoxymethoxypentanoic acid 
141, as a brown oil (0.11 g, 65% yield). υmax/cm
-1 (neat) 3335 (NH and OH), 2931 (CH), 
1774 (CO), 1706 (CO), 1523; [α]D
25 +4.6 (c 1.1, CHCl3); δH (400 MHz, CDCl3) 1.21 (3H, 
d, J 6.1 Hz, 5-H3), 2.02 (1H, ddd, J 15.0, 9.8, 4.2 Hz, 3-HH), 2.11 (1H, ddd, J 15.0, 6.2, 3.0 
Hz, 3-HH), 3.34 (3H, s, OCH3), 3.90-3.95 (1H, m, 4-H), 4.56-4.63 (2H, m, OCHHO and 2-
H), 4.71 (1H, d, J 7.0 Hz, OCHHO), 8.29 (1H, br d, J 7.0 Hz, NH), 9.70 (1H, br s, OH); δC 
(100 MHz, CDCl3) 20.1 (CH3), 37.2 (CH2), 52.4 (CH), 56.1 (CH3), 71.6 (CH), 92.2 (C), 
95.0 (CH2), 162.0 (C), 174.9 (C); m/z (CI) 323.9975 (MH
+. C9H15NO5
35Cl2
37Cl) requires 
323.9982), 290 (65%), 260 (100), 226 (24). 
 
 (2S,4R)-2-Amino-4-hydroxypentanoic acid (111).
69 
 
CO2H
OH NH2
 
 
(2S,4R)-2-(2’,2’,2’-trichloromethylcarbonylamino)-4-methoxymethoxypentanoic  acid  141 
(0.09 g, 0.3 mmol) was deprotected according to general procedure 8. Purification gave 
(2S,4R)-2-amino-4-hydroxypentanoic acid 111, as a white solid (0.026 g, 74%). [α]D
25 -
32.6 (c 1.5, H2O), lit.
69 [α]D -30.5 (c 0.75, H2O); δH (400 MHz, D2O) 1.10 (3H, d, J 7.1, 
Hz, 5-H3), 1.78-1.92 (2H, m, 3-H2), 3.77 (1H, dd, J 6.0, 4.3 Hz, 2-H), 3.82-3.87 (1H, m, 4-
H); m/z (CI) 134 (MH
+, 22%), 116 (100). 
 
 
 
 
 
 115 
Ethyl (2R,3R)-2-methyl-3-hydroxybutanoate (123).
111 
 
CO2Et
OH
 
 
Diisopropylamine (11.0 mL, 0.08 mol) was dissolved in THF (70 mL) and cooled to 0 
oC. 
Butyllithium (2.5 M, 31.0 mL, 0.08 mol) was then added dropwise to the solution and 
stirred for 1 h. The solution was cooled to -78 
oC and ethyl (3R)-3-hydroxybutanoate 115 
(4.00 g, 0.03 mol) in THF (10 mL) was added slowly. After stirring for a further 2 h, 
methyl iodide (4.8 mL, 0.08 mol) was added. The reaction mixture was stirred at -78 
oC for 
1h before warming to room temperature and stirring for a further 1h. A saturated solution 
of ammonium chloride (40 mL) was then added and the solution was acidified to pH 2 by 
addition of 2 M hydrochloric acid (40 mL). The solution was extracted with ethyl acetate 
(4 x 75 mL), dried (MgSO4) and concentrated in vacuo. Flash column chromatography 
(elution  with  petroleum  ether  :  ethyl  acetate,  4  :  1)  gave  ethyl  (2R,3R)-2-methyl-3-
hydroxybutanoate 123 as a colourless oil (3.54 g, 78%). [α]D
22 -28.8 (c 0.5, CHCl3), lit.
111 
[α]D
22 -30.3 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 1.21 (3H, d, J 7.0 Hz, 2-CH3), 1.24 (3H, 
d, J 6.2 Hz, 4-H3), 1.30 (3H, t, J 7.3 Hz, OCH2CH3), 2.42-2.51 (1H, m, 2-H), 2.75 (1H, br 
s, OH), 3.90 (1H, quin, J 6.2 Hz, 3-H), 4.20 (2H, q, J 7.3 Hz, OCH2CH3); m/z (CI) 147 
(MH
+, 100%), 129 (10), 101 (12). 
 
 Ethyl (2R,3R)-2-methyl-3-methoxymethoxybutanoate (125).
112  
 
OMOM
CO2Et
 
 
The  reaction  was  carried  out  according  to  general  procedure  3  using  ethyl  (2R,3R)-2-
methyl-3-hydroxybutanoate  123  (3.50  g,  0.024  mol).  Flash  column  chromatography 
(elution  with  petroleum  ether  :  ethyl  acetate,  5  :  1)  yielded  ethyl  (2R,3R)-2-methyl-3-
methoxymethoxybutanoate 125 as a clear oil (4.26 g, 93%). [α]D
22 -28.8 (c 1.0, CHCl3), 
lit.
112 -28.0 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 1.15 (3H, d, J 7.2 Hz, 2-CH3), 1.21 (3H, 
d, J 6.3 Hz, 4-H3), 1.28 (3H, t, J 7.1 Hz, OCH2CH3), 2.62 (1H, quin, J 7.2 Hz, 2-H), 3.38 
(3H, s, OCH3), 3.90-3.98 (1H, m, 3-H), 4.17 (2H, dq, J 7.1, 1.2 Hz, OCH2CH3), 4.65 (1H, 
d, J 6.9 Hz, OCHHO), 4.69 (1H, d, J 6.9 Hz, OCHHO); m/z (CI) 191 (MH
+, 6%), 159 
(100), 101 (8), 73 (43). 116 
(2S,3R)-2-Methyl-3-methoxymethoxybutan-1-ol (127).
113 
 
OH
OMOM
 
 
The  reaction  was  carried  out  according  to  general  procedure  2  using  ethyl  (2S,3R)-2-
methyl-3-methoxymethoxybutanoate  125  (4.20  g,  0.020  mol).  Flash  column 
chromatography (elution with petroleum ether : diethyl ether, 1 : 1) yielded (2S,3R)-2-
methyl-3-methoxymethoxybutan-1-ol 127 as a clear oil (3.2 g, 99%). Spectroscopic data in 
agreement with literature.
113 [α]D
22 -73.8 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.96 (3H, 
d, J 7.0 Hz, 2-CH3), 1.22 (3H, d, J 6.3 Hz, 4-H3), 1.72-1.80 (1H, m, 2-H), 2.70 (1H, br s, 
OH), 3.41 (3H, s, OCH3), 3.59 (1H, ddd, J 11.3, 6.1, 1.0 Hz, 1-HH), 3.64-3.76 (2H, m, 1-
HH and 3-H), 4.63 (1H, d, J 6.9, Hz, OCHHO), 4.75 (1H, d, J 6.9, Hz, OCHHO); δC (100 
MHz, CDCl3) 13.9 (CH3), 17.9 (CH3), 41.1 (CH), 55.7 (CH3), 66.1 (CH2), 75.8 (CH), 95.1 
(CH2); m/z (CI) 149 (MH
+, 9%), 117 (100), 105 (13), 87 (12). 
 
Ethyl (2E,4S,5R)-4-methyl-5-methoxymethoxyhex-2-enoate (129). 
 
OMOM
CO2Et
 
 
Reaction  carried  out  according  to  general  procedure  1  using  (2S,3R)-2-methyl-3-
methoxymethoxybutan-1-ol  127  (0.50  g,  3.4  mmol).  Purification  by  flash  column 
chromatography  (eluting  with  petroleum  ether  :  diethyl  ether,  5  :  1)  gave  the  title 
compound as a light yellow oil (0.73 g, 74%). υmax/cm
-1 (neat) 2982 (CH), 1738 (CO), 
1653 (C=C), 1446, 1392; [α]D
22 -26.1 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 1.15 (3H, d, J 
6.9 Hz, 4-CH3), 1.15 (3H, d, J 6.3 Hz, 6-H3), 1.30 (3H, t, J 7.1 Hz, OCH2CH3), 2.44-2.53 
(1H, m, 4-H), 3.39 (3H, s, OCH3), 3.69 (1H, quin, J 6.3 Hz, 5-H), 4.20 (2H, q, J 7.1 Hz, 
OCH2CH3), 4.60 (1H, d, J 6.9 Hz, OCHHO), 4.71 (1H, d, J 6.9 Hz, OCHHO), 5.85 (1H, 
dd, J 15.8, 1.0 Hz, 2-H), 6.98 (1H, dd, J 15.8, 7.9 Hz, 3-H); δC (100 MHz, CDCl3) 14.3 
(CH3), 15.0 (CH3), 17.4 (CH3), 42.2 (CH), 55.5 (CH3), 60.2 (CH2), 75.8 (CH), 95.1 (CH2), 
121.5  (CH),  150.9  (CH),  166.6  (CO);  m/z  (CI)  217.1431  (MH
+.  C11H21O4  requires 
217.1440), 185 (100%), 141 (28), 73 (27). 
 
 117 
(2E,4S,5R)-4-Methyl-5-methoxymethoxyhex-2-en-1-ol (131). 
   
OMOM
OH
 
 
The reaction was done according to general procedure 2 using ethyl (2E,4S,5R)-4-methyl-
5-methoxymethoxyhex-2-enoate 129 (1.70 g, 8.0 mmol). Flash column chromatography 
(petroleum ether : diethyl ether, 3 : 2) gave (2E,4S,5R)-4-methyl-5-methoxymethoxyhex-2-
en-1-ol 131 as a light yellow oil (1.15 g, 84%). υmax/cm
-1 (neat) 3409 (OH), 2971 (CH), 
1663 (C=C), 1453, 1377; [α]D
22 -25.5 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 1.06 (3H, d, J 
7.0 Hz, 4-CH3), 1.13 (3H, d, J 6.1 Hz, 6-H3), 1.45 (1H, br s, OH), 2.30-2.41 (1H, m, 4-H), 
3.39 (3H, s, OCH3), 3.60-3.68 (1H, m, 5-H), 4.12-4.17 (2H, m, 1-H2), 4.64 (1H, d, J 6.9 
Hz, OCHHO), 4.71 (1H, d, J 6.9 Hz, OCHHO), 5.67-5.71 (2H, m, 2-H and 3-H); δC (100 
MHz, CDCl3) 15.7 (CH3), 17.4 (CH3), 41.9 (CH), 55.4 (CH3), 63.8 (CH2), 76.5 (CH), 95.2 
(CH2),  129.5  (CH),  134.8  (CH);  m/z  (CI)  157.1236  (MH
+-H2O.  C19H17O2  requires 
157.1229), 175 (20%), 157 (80), 143 (96), 113 (90), 99 (100), 69 (63).  
 
(3S,4S,5R)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4-methyl-5-
methoxymethoxyhex-1-ene  (139a)  and  (3R,4S,5R)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-methyl-5-methoxymethoxyhex-1-ene (139b). 
 
MOMO O HN
CCl3
MOMO O HN
CCl3
+
 
 
The reaction was carried out according to general procedure 4 using (2E,4S,5R)-4-methyl-
5-methoxymethoxyhex-2-en-1-ol 131 (0.15 g, 0.9 mmol) in THF (10 mL) was used for the 
rearrangement. Flash column chromatography (elution with petroleum ether : diethyl ether, 
20 : 1) yielded the title compounds as brown oils (0.13 g, 49% combined yield over 2 
steps)  and  in  a  3  :  1  ratio  (139a  :  139b).  (3S,4S,5R)-3-(2’,2’,2’-
Trichloromethylcarbonylamino)-4-methyl-5-methoxymethoxyhex-1-ene  (139a):  υmax/cm
-1 
(neat) 3342 (NH), 2932 (CH), 1715 (CO), 1644 (C=C), 1509, 1459, 1379; [α]D
22 +18.1 (c 
1.0, CHCl3); δH (400 MHz, CDCl3) 0.91 (3H, d, J 7.0 Hz, 4-CH3), 1.17 (3H, d, J 6.1 Hz, 6-
H3), 1.82-1.88 (1H, m, 4-H), 3.31 (3H, s, OCH3), 3.57 (1H, dq, J 9.3, 6.1 Hz, 5-H), 4.36-
4.42 (1H, m, 3-H), 4.55 (1H, d, J 6.9 Hz, OCHHO), 4.69 (1H, d, J 6.9 Hz, OCHHO), 5.16-118 
5.23 (2H, m, 1-H2), 5.71-5.80 (1H, m, 2-H), 8.22 (1H, br d, J 6.0 Hz, NH); δC (100 MHz, 
CDCl3) 14.4 (CH3), 18.3 (CH3), 42.4 (CH), 55.8 (CH), 56.4 (CH), 76.2 (CH3), 93.1 (C), 
95.3 (CH2), 115.9 (CH2), 136.1 (CH), 161.4 (C); m/z (CI) 318.0423 (MH
+. C11H19NO3
35Cl3 
requires  318.0431),  286  (100%),  256  (38),  238  (80),  204  (39).  (3R,4S,5R)-3-(2’,2’,2’-
Trichloromethylcarbonylamino)-4-methyl-5-methoxymethoxyhex-1-ene  (139b):  [α]D
22  -
16.3 (c 0.8, CHCl3); δH (400 MHz, CDCl3) 0.95 (3H, d, J 7.0 Hz, 4-CH3), 1.18 (3H, d, J 
6.2 Hz, 6-H3), 1.89-1.95 (1H, m, 4-H), 3.30 (3H, s, OCH3), 3.64 (1H, quin, J 6.2 Hz, 5-H), 
4.47-4.56 (2H, m, 3-H and OCHHO), 4.64 (1H, d, J 6.9 Hz, OCHHO), 5.10-5.19 (2H, m, 
1-H2), 5.86 (1H, ddd, J 17.2, 10.5, 5.6 Hz, 2-H), 7.46 (1H, br d, J 6.0 Hz, NH); δC (100 
MHz, CDCl3) 14.5 (CH3), 18.3 (CH3), 42.5 (CH), 55.8 (CH), 56.4 (CH), 76.3 (CH3), 93.1 
(C),  95.3  (CH2),  115.9  (CH2),  136.1  (CH)  161.5  (C);  m/z  (CI)  318.0426  (MH
+. 
C11H19NO3
35Cl3 requires 318.0428), 288 (90%), 286 (95), 258 (77), 238 (84), 188 (100). 
 
Synthesis  of  (3S,4S,5R)-3-(2’,2’,2’-trichloromethylcarbonylamino)-4-methyl-5-
methoxymethoxyhex-1-ene  (139a)  and  (3R,4S,5R)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-methyl-5-methoxymethoxyhex-1-ene  (139b)  using 
palladium catalysed rearrangement in toluene. 
 
The reaction was carried out according to general procedure 4 using (2E,4S,5R)-4-methyl-
5-methoxymethoxyhex-2-en-1-ol 131 (0.05 g, 0.3 mmol) in toluene (10 mL). Flash column 
chromatography (petroleum ether : diethyl ether, 20 : 1) yielded the title compounds as 
brown oils (0.066 g, 66% combined yield over 2 steps) and in a 13 : 1 ratio (139a : 139b). 
Spectroscopic data as reported above. 
 
(2S,3S,4R)-2-(2’,2’,2’-Trichloromethylcarbonylamino)-3-methyl-4-
methoxymethoxypentanoic acid (142). 
 
CO2H
MOMO O HN
CCl3
 
 
The reaction was carried out according to general procedure 7 using (3S,4S,5R)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-methyl-5-methoxymethoxyhex-1-ene  139a  (0.20  g,  0.6 
mmol). The crude product was then dissolved in a saturated solution of sodium hydrogen 
carbonate (10 mL), extracted with ethyl acetate (2 x 10 mL), then re-acidified by addition 
of 2 M hydrochloric acid (15 mL). Extraction with ethyl acetate (4 x 10 mL) followed by 119 
concentration  in  vacuo  gave  (2S,3S,4R)-2-(2’,2’,2’-trichloromethylcarbonylamino)-3-
methyl-4-methoxymethoxypentanoic acid 142 (0.143 g, 62%) as a brown oil. υmax/cm
-1 
(neat) 3334 (NH and OH), 2981 (CH), 1774 (CO), 1523; [α]D
25 +13.0 (c 0.6, CHCl3); δH 
(400 MHz, CDCl3) 1.02 (3H, d, J 7.2 Hz, 3-CH3), 1.21 (3H, d, J 6.2 Hz, 5-H3), 2.12-2.20 
(1H, m, 3-H), 3.31 (3H, s, OCH3), 3.57 (1H, qd, J 6.2, 2.8 Hz, 4-H), 4.59 (1H, d, J 6.9 Hz, 
OCHHO), 4.66-4.72 (2H, m, OCHHO and 2-H), 7.80 (1H, br d, J 6.4 Hz, NH), 9.10 (br s, 
OH); δC (100 MHz, CDCl3) 13.3 (CH3), 18.6 (CH3), 41.3 (CH), 55.8 (CH), 56.0 (CH), 76.9 
(CH3),  93.5  (C)  96.1  (CH2),  162.0  (C),  174.8  (C);  m/z  (CI)  336.0175  (MH
+. 
C10H17NO3
35Cl3 requires 336.0173), 319 (100%), 238 (40) and 188 (19).  
 
(2S,3S,4R)-2-Amino-3-methyl-4-hydroxypentanoic acid (112).
65 
 
CO2H
OH NH2
 
 
The reaction was carried out according to general procedure 8 using (2S,3S,4R)-2-(2’,2’,2’-
trichloromethylcarbonylamino)-3-methyl-4-methoxymethoxypentanoic  acid  142  (0.10  g, 
0.3 mmol). Purification  by ion  exchange chromatography (elution with 0.5 M NH4OH 
solution)  yielded  (2S,3S,4R)-2-amino-3-methyl-4-hydroxypentanoic  acid  112  as  a  white 
solid (0.023 g, 55%). [α]D
27 +2.6 (c 1.0, H2O), lit.
65 [α]D
27 +2.9 (c 1.0, H2O); δH (400 MHz, 
D2O) 0.89 (3H, d, J 7.2 Hz, 3-CH3), 1.19 (3H, d, J 6.3 Hz, 5-H3), 2.04 (1H, quin d, J 6.8, 
2.7 Hz, 3-H), 3.72 (1H, quin, J 6.8 Hz, 4-H), 3.93 (1H, d, J 2.7 Hz, 2-H); m/z (CI) 148 
(MH
+, 24%), 130 (100), 85 (15), 74 (12). 
 
Ethyl (2R,3R)-2-benzyl-3-hydroxybutanoate (124). 
 
CO2Et
OH
 
 
Diisopropylamine (0.91 mL, 6.4 mmol) was dissolved in THF (10 mL) and cooled to 0 
oC. 
Butyllithium (2.5 M in hexane) (2.50 mL, 6.4 mmol) was then added dropwise to the 
solution and stirred for 1 h. The solution was then cooled to -78 
oC and ethyl (3R)-3-
hydroxybutanoate 115 (0.30 g, 2.8 mmol) in THF (10 mL) was added slowly. After stirring 
for a further 2 h at -78 
oC, benzyl bromide (0.75 mL, 6.4 mmol) was added. The reaction 120 
mixture was stirred at -78 
oC for 1 h before warming to room temperature and stirring 
overnight. A saturated solution of ammonium chloride (10 mL) was then added and the 
solution was acidified to pH 2 by addition of 2 M hydrochloric acid (10 mL). The solution 
was extracted with ethyl acetate (4 x 30 mL), dried (MgSO4) and concentrated in vacuo to 
yield the crude product (a viscous oil). Kugelrohr distillation removed unreacted starting 
material, then flash column chromatography (elution with petroleum ether : ethyl acetate, 5 
:  1)  gave  ethyl  (2R,3R)-2-benzyl-3-hydroxybutanoate  124,  as  a  colourless  oil  (0.29  g, 
58%). υmax/cm
-1 (neat) 3448 (OH), 3029 (CH), 1729 (CO), 1496, 1377; [α]D
25 +39.4 (c 3.7, 
CHCl3); δH (400 MHz, CDCl3) 1.12 (3H, t, J 7.1 Hz, OCH2CH3), 1.25 (3H, d, J 6.4 Hz, 4-
H3), 2.63-2.79 (2H, m, 2-H and OH), 2.98 (2H, d, J 7.8 Hz, 2-CH2Ph), 3.92 (1H, qd, J 6.4, 
4.9 Hz, 3-H), 4.07 (2H, q, J 7.1 Hz, OCH2CH3), 7.18-7.31 (5H, m, Ph); δC (100 MHz, 
CDCl3) 14.1 (CH3), 21.8 (CH3), 35.6 (CH2), 54.2 (CH), 60.6 (CH2), 67.7 (CH), 126.5 
(CH), 128.4 (CH), 129.0 (CH), 138.8 (C), 174.8 (C); m/z (CI) 223.1343 (MH
+. C12H19O3 
requires 223.1334), 204 (15%), 177 (17), 131 (10), 69 (20). 
 
 Ethyl (2R,3R)-2-benzyl-3-methoxymethoxybutanoate (126). 
 
CO2Et
OMOM
 
 
The reaction was done according to general procedure 3 using ethyl (2R,3R)-2-benzyl-3-
hydroxybutanoate  124  (3.20  g,  14.0  mmol).  Flash  column  chromatography  (petroleum 
ether : diethyl ether, 5 : 1) yielded ethyl (2R,3R)-2-benzyl-3-methoxymethoxybutanoate 
126, as a clear oil (3.26 g, 85%). υmax/cm
-1 (neat) 3029 (CH), 1731 (CO), 1495, 1379; 
[α]D
25 +47.7 (c 1.8, CHCl3); δH (400 MHz, CDCl3) 1.06 (3H, t, J 7.1 Hz, OCH2CH3), 1.29 
(3H, d, J 6.3 Hz, 4-H3), 2.79-2.90 (3H, m, 2-CH2Ph and 2-H), 3.38 (3H, s, OCH3), 3.98 
(1H, qd, J 6.3, 1.2 Hz, 3-H), 4.00 (2H, q, J 7.1 Hz OCH2CH3), 4.64 (1H, d, J 6.9 Hz, 
OCHHO), 4.70 (1H, d, J 6.9 Hz, OCHHO), 7.16-7.29 (5H, m, Ph);￿ δC (100 MHz, CDCl3) 
14.2 (CH3), 18.0 (CH3), 34.1 (CH2), 54.4 (CH), 55.6 (CH3), 60.3 (CH2), 74.3 (CH), 95.5 
(CH2),  126.3  (CH),  128.4  (CH),  128.9  (CH),  139.2  (C),  173.3  (C);  m/z  (CI)  267.1593 
(MH
+. C15H23O4 requires 267.1596), 235 (100%), 223 (28), 177 (7), 85 (37), 69 (52). 
 
 
 121 
(2S,3R)-2-Benzyl-3-methoxymethoxybutan-1-ol (128). 
 
OMOM
OH
 
 
The  reaction  was  carried  out  according  to  general  procedure  2  using  ethyl  (2R,3R)-2-
benzyl-3-methoxymethoxybutanoate 126 (2.00 g, 7.5 mmol). Purification by flash column 
chromatography (eluting with petroleum ether : diethyl ether, 1 : 1) gave (2S,3R)-2-benzyl-
3-methoxymethoxybutan-1-ol 128, as a clear yellow oil (1.56 g, 93%). ￿max/cm
-1 (neat) 
3453 (OH), 3026 (CH), 1496, 1454, 1370; [α]D
25 -21.4 (c 2.7, CHCl3); δH (400 MHz, 
CDCl3) 1.29 (3H, d, J 6.3 Hz, 4-H3), 1.74-1.81 (1H, m, 2-H), 2.62 (1H, br s, OH), 2.76 
(2H, dd, J 6.2, 2.5 Hz, 2-CH2Ph), 3.42 (3H, s, OCH3), 3.50 (1H, dd, J 11.4, 4.8 Hz, 1-HH), 
3.83-3.90 (2H, m, 1-HH and 3-H), 4.63 (1H, d, J 6.8 Hz, OCHHO), 4.74 (1H, d, J 6.8 Hz, 
OCHHO), 7.17-7.31 (5H, m, Ph); δC (100 MHz, CDCl3) 18.6 (CH3), 34.8 (CH2), 48.0 
(CH), 55.8 (CH3), 60.3  (CH2), 76.4 (CH), 95.5  (CH2), 126.1 (CH), 128.4 (CH), 129.2 
(CH), 140.5 (C); m/z (CI) 225.1489 (MH
+. C13H21O3 requires 225.1491), 193 (100%), 175 
(35), 145 (34). 
 
Ethyl (2E,4S,5R)-4-benzyl-5-methoxymethoxyhex-2-enoate (130). 
 
MOMO
CO2Et
 
 
The reaction was carried out according to general procedure 1 using (2S,3R)-2-benzyl-3-
methoxymethoxybutan-1-ol 128 (1.00 g, 4.5 mmol). Column chromatography (petroleum 
ether : diethyl ether, 5 : 1) gave the title compound 130, as a light yellow oil (1.19 g, 91% 
yield from the alcohol). υmax/cm
-1 (neat) 3027 (CH), 1715 (CO), 1654 (C=C), 1495, 1370; 
[α]D
25 +93.7 (c 2.6, CHCl3); δH (400 MHz, CDCl3) 1.22 (3H, d, J 6.4 Hz, 6-H3), 1.26 (3H, 
t, J 7.1 Hz, OCH2CH3), 2.50-2.58 (1H, m, 4-H), 2.72 (1H, dd, J 13.7, 8.7 Hz, 4-CHHPh), 
2.96 (1H, dd, J 13.7, 5.7 Hz, 4-CHHPh), 3.40 (3H, s, OCH3), 3.77 (1H, qd, J 6.4, 2.8 Hz, 
5-H), 4.16 (2H, q, J 7.1 Hz, OCH2CH3), 4.62 (1H, d, J 6.9 Hz, OCHHO), 4.73 (1H, d, J 6.9 
Hz, OCHHO), 5.67 (1H, dd, J 15.8, 1.2 Hz, 2-H), 6.93 (1H, dd, J 15.8, 9.4 Hz, 3-H), 7.11-122 
7.29 (5H, m, Ph); δC (100 MHz, CDCl3) 14.3 (CH3), 18.5 (CH3), 37.0 (CH2), 50.7 (CH), 
55.7 (CH3), 60.2 (CH2), 74.6 (CH), 95.5 (CH2), 123.5 (CH), 126.2 (CH), 128.4 (CH), 
129.1 (CH), 139.7 (C), 148.2 (CH), 166.2 (C); m/z (CI) 293.1752 (MH
+. C17H25O4 requires 
293.1753), 261 (100%), 248 (15), 217 (53), 191 (12). 
 
(2E,4S,5R)-4-Benzyl-5-methoxymethoxyhex-2-en-1-ol (132). 
 
MOMO
OH
 
 
The reaction was done according to general procedure 2 using ethyl (2E,4S,5R)-4-benzyl-
5-methoxymethoxyhex-2-enoate  130  (1.15  g,  3.9  mmol).  Purification  by  flash  column 
chromatography (elution with petroleum ether : diethyl ether, 2 : 3) gave (2E,4S,5R)-4-
benzyl-5-methoxymethoxyhex-2-en-1-ol  132,  as  a  yellow  oil  (0.69  g,  70%).  υmax/cm
-1 
(neat) 3408 (OH), 2930 (CH), 1603 (C=C), 1495, 1375; [α]D
25 +50.5 (c 0.6, CHCl3); δH 
(400 MHz, CDCl3) 1.16 (3H, d, J 6.3 Hz, 6-H3), 1.23 (1H, br s, OH), 2.40 (1H, tdd, J 9.0, 
5.6, 3.3 Hz, 4-H), 2.65 (1H, dd, J 13.5, 9.0 Hz, 4-CHHPh), 2.91 (1H, dd, J 13.5, 5.6 Hz, 4-
CHHPh), 3.41 (3H, s, OCH3), 3.73 (1H, qd, J 6.3, 3.3 Hz, 5-H), 4.03 (2H, dd, J 5.7, 1.0 
Hz, 1-H2), 4.62 (1H, d, J 6.8 Hz, OCHHO), 4.72 (1H, d, J 6.8 Hz, OCHHO), 5.46 (1H, dt, 
J 15.5, 5.7 Hz, 2-H), 5.62 (1H, ddt, J 15.5, 9.0, 1.0 Hz, 3-H), 7.10-7.28 (5H, m, Ph); δC 
(100 MHz, CDCl3) 18.3 (CH3), 37.5 (CH2), 50.5 (CH), 55.6 (CH3), 63.6 (CH2), 75.3 (CH), 
95.6 (CH2), 119.1 (CH), 125.9 (CH), 128.2 (CH), 129.3 (CH), 131.9 (CH), 140.6 (C); m/z 
(CI) 233.1537 (MH
+-OH. C15H21O2 requires 233.1542), 219 (83%), 201 (50), 189 (40), 
171 (75), 157 (100).  
 
 
 
 
 
 
 
 
 123 
(3R,4S,5R)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4-benzyl-5-
methoxymethoxyhex-1-ene  (140a)  and  (3S,4S,5R)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-benzyl-5-methoxymethoxyhex-1-ene (140b). 
 
MOMO O HN
CCl3
MOMO O HN
CCl3
+
 
 
The reaction was carried out according to general procedure 4 using (2E,4S,5R)-4- 
benzyl-5-methoxymethoxyhex-2-en-1-ol 132 (0.20 g, 0.8 mmol) in THF (10 mL). Flash 
column chromatography (elution with petroleum ether : diethyl ether, 20 : 1) gave the title 
compounds as light brown oils (0.36 g, 72% combined yield over two steps) and in a 6 : 1 
ratio  (140a  :  140b).  υmax/cm
-1  (neat)  3368  (NH),  2925  (CH),  1718  (CO),  1497,  1455; 
(3S,4S,5R)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4-benzyl-5-methoxymethoxyhex-1-
ene 140a: [α]D
25 +52.5 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 1.35 (3H, d, J 6.1 Hz, 6-H3), 
2.09-2.17 (1H, m, 4-H), 2.54 (1H, dd, J 14.2, 8.9 Hz, 4-CHHPh), 2.79 (1H, dd, J 14.2, 5.6 
Hz, 4-CHHPh), 3.41 (3H, s, OCH3), 3.80 (1H, dq, J 8.3, 6.1 Hz, 5-H), 4.41-4.50 (1H, m, 3-
H), 4.62 (1H, d, J 6.9 Hz, OCHHO), 4.77 (1H, d, J 6.9 Hz, OCHHO), 5.26-5.35 (2H, m, 1-
H2), 5.89 (1H, ddd, J 16.9, 10.5, 6.3 Hz, 2-H), 7.16-7.34 (5H, m, Ph), 8.21 (1H, br d, J 6.8 
Hz, NH); δC (100 MHz, CDCl3) 19.0 (CH3), 34.1 (CH2), 49.5 (CH), 54.4 (CH), 56.4 (CH3), 
76.0 (CH), 93.2 (C), 96.0 (CH2), 118.2 (CH2), 126.7 (CH), 128.8 (CH), 128.9 (CH), 133.2 
(CH),  139.1  (C),  160.7  (C).  (3R,4S,5R)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4-
benzyl-5-methoxymethoxyhex-1-ene  140b:  [α]D
25  -19.4  (c  0.5,  CHCl3);  δH  (400  MHz, 
CDCl3) 1.28 (3H, d, J 6.0 Hz, 6-H3), 2.02-2.07 (1H, m, 4-H), 2.67 (1H, dd, J 13.9, 8.7 Hz, 
4-CHHPh), 2.74 (1H, dd, J 13.9, 6.1 Hz, 4-CHHPh), 3.38 (3H, s, OCH3), 3.83-3.90 (1H, 
m, 5-H), 4.50 (1H, d, J 6.8 Hz, OCHHO), 4.61-4.65 (1H, m, 3-H), 4.71 (1H, d, J 6.8 Hz, 
OCHHO), 5.03-5.11 (2H, m, 1-H2), 5.89 (1H, ddd, J 17.2, 10.6, 4.4 Hz, 2-H), 7.10-7.34 
(5H, m, Ph), 7.92 (1H, br d, J 8.1 Hz, NH); δC (100 MHz, CDCl3) 20.1 (CH3), 37.1 (CH2), 
50.0 (CH), 54.6 (CH), 56.0 (CH3), 76.5 (CH), 93.1 (C), 95.5 (CH2), 114.6 (CH2), 126.6 
(CH), 128.9 (CH), 129.2 (CH), 137.1 (CH), 139.6 (C), 161.6 (C); m/z (CI) 394.0747 (MH
+. 
C17H23NO3
35Cl3 requires 394.0744), 362 (100%), 314 (24), 280 (10), 171 (21). 
 
 124 
(3S,4S,5R)-3-(2’,2’,2’-Trichloromethylcarbonylamino)-4-benzyl-5-
methoxymethoxyhex-1-ene  (140a)  and  (3R,4S,5R)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-benzyl-5-methoxymethoxyhex-1-ene  (140b)  using 
toluene.  
 
The reaction was carried out according to general procedure 4 using (2E,4S,5R)-4- 
benzyl-5-methoxymethoxyhex-2-en-1-ol  132  (0.067  g,  0.27  mmol) in  toluene  (10  mL). 
Flash column chromatography (elution with petroleum ether : diethyl ether, 20 : 1) gave 
the title compounds as light brown oils (0.09 g, 82% combined yield over 2 steps) and in a 
11 : 1 ratio (140a : 140b). Spectroscopic data as described above. 
 
(2S,3S,4R)-2-(2’,2’,2’-Trichloromethylcarbonylamino)-3-benzyl-4-
methoxymethoxypentanoic acid (143). 
 
CO2H
MOMO O HN
CCl3
 
 
The reaction was carried out according to general procedure 7 using (3S,4S,5R)-3-(2’,2’,2’-
trichloromethylcarbonylamino)-4-benzyl-5-methoxymethoxyhex-1-ene  140a  (0.37  g,  0.9 
mmol). The crude product was then dissolved in an aqueous solution of sodium hydrogen 
carbonate (10 mL), extracted with ethyl acetate (2 x 10 mL) then re-acidified by addition 
of 2 M hydrochloric acid (15 mL). Extraction with ethyl acetate (4 x 10 mL) followed by 
concentration  in  vacuo  gave  the  product,  (2S,3S,4R)-2-(2’,2’,2’-
trichloromethylcarbonylamino)-3-benzyl-4-methoxymethoxypentanoic  acid  143  (0.32  g, 
82%), as a brown oil. υmax/cm
-1 (neat) 3387 (NH and OH), 2937 (CH), 1716 (CO), 1514, 
1455; [α]D
25 +40.4 (c 1.1, CHCl3); δH (400 MHz, CDCl3) 1.29 (3H, d, J 6.3 Hz, 5-H3), 
2.34-2.41 (1H, m, 3-H), 2.74 (1H, dd, J 14.1, 8.2 Hz, 3-CHHPh), 2.85 (1H, dd, J 14.1, 7.2 
Hz, 3-CHHPh), 3.32 (3H, s, OCH3), 3.71 (1H, quin, J 6.3 Hz, 4-H), 4.54 (1H, d, J 6.9 Hz, 
OCHHO), 4.63-4.68 (2H, m, OCHHO and 2-H), 5.85 (1H, br s, OH), 7.12-7.29 (5H, m, 
Ph), 7.87 (1H, br d, J 6.3 Hz, NH); δC (100 MHz, CDCl3) 19.3 (CH3), 33.8 (CH2), 48.4 
(CH), 53.9 (CH), 56.1 (CH3), 75.6 (CH), 93.3 (C), 96.6 (CH2), 127.0 (CH), 128.9 (CH), 
129.1 (CH), 138.2 (C), 161.7 (C), 174.9 (C); m/z (CI) 416.0431 (MH
+. C16H21NO5
35Cl
37Cl2 
requires 416.0433), 380 (100%), 350 (84), 346 (20), 316 (15). 125 
(2S,3S,4R)-2-Amino-3-benzyl-4-hydroxypentanoic acid (144). 
 
CO2H
OH NH2
 
 
The reaction was carried out according to general procedure 8 using (2S,3S,4R)-2-(2’,2’,2’-
trichloromethylcarbonylamino)-3-benzyl-4-methoxymethoxypentanoic  acid  143  (0.11  g, 
0.3 mmol). Purification  by ion  exchange chromatography (elution with 0.5 M NH4OH 
solution) yielded (2S,3S,4R)-2-amino-3-benzyl-4-hydroxypentanoic acid 144, as a white 
solid (0.033 g, 55%). υmax (KBr) 3400 (NH2), 3225 (OH), 2970 (CH), 1652 (CO), 1477; 
[α]D
25 +23.0 (c 0.2, H2O); δH (400 MHz, D2O) 1.08 (3H, d, J 6.5, Hz, 5-H3), 2.10-2.16 (1H, 
m,  3-H),  2.56  (1H,  dd,  J  13.6,  5.1  Hz,  3-CHHPh),  2.62  (1H,  dd,  J  13.6,  10.0  Hz,  3-
CHHPh), 3.78 (1H, qd, J 6.5, 3.8 Hz, 4-H), 3.92 (1H, d, J 2.1 Hz, 2-H), 7.14-7.26 (5H, m, 
Ph); δC (100 MHz, D2O) 20.8 (CH3), 32.1 (CH2), 46.3 (CH), 54.6 (CH), 66.7 (CH), 126.6 
(CH),  128.7  (CH),  129.3  (CH),  139.3  (C),  173.9  (C);  m/z  (EI)  205.1101  (M
+-H2O. 
C12H15NO2 requires 205.1103), 131 (80%), 114 (33), 91 (70), 70 (100). 
 
Ethyl (2E)-2,7-octadienoate (147).
114  
 
CO2Et
 
 
Reaction was carried out according to general procedure 1, using 5-hexen-1-ol 146 (4.00 g, 
0.04 mol). Flash column chromatography (petroleum ether : diethyl ether, 10 : 1) yielded 
ethyl (2E)-2,7-octadienoate 147 (4.6  g, 69%  yield) as a  yellow oil. Spectroscopic data 
entirely  consistent  with  literature.
114  δH  (400  MHz,  CDCl3)  1.28  (3H,  t,  J  7.1  Hz, 
OCH2CH3), 1.52-1.58 (2H, m, 5-H2), 2.06-2.12 (2H, m, 6-H2), 2.18-2.25 (2H, m, 4-H2), 
4.17 (2H, q, J 7.1 Hz, OCH2CH3), 4.96-5.06 (2H, m, 8-H2), 5.73-5.96 (2H, m, 2-H and 7-
H), 6.95 (1H, dt, J 15.5, 6.9 Hz, 3-H); δC (100 MHz, CDCl3) 14.3 (CH3), 27.1 (CH2), 31.5 
(CH2), 33.1 (CH2), 60.2 (CH2), 115.1 (CH2), 121.5 (CH), 138.0 (CH), 149.0 (CH), 166.7 
(C);  m/z  (CI)  169.1232  (MH
+.  C10H17O2  requires  169.1229),  141  (90%),  123  (75),  95 
(100), 81 (53), 55 (32). 
 
 
 126 
Ethyl (2E)-2,6-heptadienoate.
115 
 
CO2Et 
 
Reaction was carried out according to general procedure 1, using 4-penten-1-ol (0.50 g, 5.8 
mmol). Flash column chromatography (petroleum ether : diethyl ether, 20 : 1)  yielded 
ethyl  (2E)-2,6-heptadienoate  (0.69  g,  77%  yield)  as  a  yellow  oil.  Spectroscopic  data 
consistent with literature.
115 δH (400 MHz, CDCl3) 1.29 (3H, t, J 7.1 Hz, OCH2CH3), 1.99-
2.25 (2H, m, 5-H2), 2.27-2.34 (2H, m, 4-H2), 4.19 (2H, q, J 7.1 Hz, OCH2CH3), 4.99-5.09 
(2H, m, 7-H2), 5.75-5.80 (1H, m, 6-H), 5.81-5.86 (1H, m, 2-H), 6.96 (1H, dt, J 15.6, 6.8 
Hz, 3-H); δC (100 MHz, CDCl3) 14.3 (CH3), 31.5 (CH2), 32.0 (CH2), 60.2 (CH2), 115.5 
(CH2), 121.7 (CH), 137.1 (CH), 148.3 (CH), 166.7 (C); m/z (CI) 155.1075 (MH
+. C9H15O2 
requires 155.1072), 137 (16%), 107 (17), 73 (22). 
 
Ethyl (2E)-2,8-nonadienoate.
116 
  
CO2Et 
 
Reaction was carried out according to general procedure 1, using 6-hepten-1-ol (1.00 g, 8.8 
mmol). Flash column chromatography (petroleum ether : diethyl ether, 97 : 3)  yielded 
ethyl  (2E)-2,8-nonadienoate  (1.15  g,  72%  yield)  as  a  yellow  oil.  Spectroscopic  data 
consistent with literature.
116 δH (400 MHz, CDCl3) 1.28 (3H, t, J 7.1 Hz, OCH2CH3), 1.38-
1.52 (4H, m, 5-H2 and 6-H2), 2.06 (2H, q, J 7.2 Hz, 7-H2), 2.21 (2H, qd, J 7.2, 1.5 Hz, 4-
H2), 4.18 (2H, q, J 7.1 Hz, OCH2CH3), 4.93-4.97 (1H, m, 9-HH), 4.97-5.04 (1H, m, 9-HH), 
5.74-5.78 (1H, m, 8-H), 5.79-5.85 (1H, m, 2-H), 6.96 (1H, dt, J 15.6, 6.9 Hz, 3-H); δC (100 
MHz, CDCl3) 14.3 (CH3), 27.5 (CH2), 28.4 (CH2), 32.0 (CH2), 33.5 (CH2), 60.2 (CH2), 
114.7 (CH2), 121.4 (CH), 138.6 (CH), 149.3 (CH), 166.8 (C); m/z (CI) 183.1382 (MH
+. 
C11H19O2 requires 183.1385), 113 (8%), 97 (7), 81 (13), 71 (15). 
 
Ethyl (2E)-2,9-decadienoate.
117 
 
CO2Et
 
 
Reaction was carried out according to general procedure 1, using 7-octen-1-ol (1.50 g, 12.0 
mmol). Flash column chromatography (petroleum ether : diethyl ether, 50 : 1)  yielded 
ethyl (2E)-2,9-decadienoate (2.06 g, 90% yield) as a pale yellow oil. Spectroscopic data 127 
consistent with literature.
117 δH (400 MHz, CDCl3) 1.29 (3H, t, J 7.1 Hz, OCH2CH3), 1.31-
1.51 (6H, m, 5-H2, 6-H2 and 7-H2), 2.05 (2H, q, J 7.1 Hz, 8-H2), 2.21 (2H, qd, J 7.1, 1.5 
Hz, 4-H2), 4.18 (2H, q, J 7.1 Hz, OCH2CH3), 4.92-4.96 (1H, m, 10-HH), 4.97-5.03 (1H, m, 
10-HH), 5.75-5.86 (2H, m, 2-H and 9-H), 6.96 (1H, dt, J 15.6, 6.9 Hz, 3-H); δC (100 MHz, 
CDCl3) 14.3 (CH3), 27.9 (CH2), 28.6  (CH2), 28.7 (CH2) 32.2  (CH2),  33.7 (CH2), 60.2 
(CH2), 114.4 (CH2), 121.3 (CH), 138.9 (CH), 149.4 (CH), 166.8 (C); m/z (CI) 197.1540 
(MH
+. C12H21O2 requires 197.1542), 123 (11%), 111 (7). 
 
(2E)-Octa-2,7-dien-1-ol (148).
114 
  
OH
 
 
The  reaction  was  carried  out  according  to  general  procedure  2,  using  ethyl  (2E)-2,7-
octadienoate 147 (1.00 g, 6.0 mmol). Flash column chromatography (petroleum ether : 
diethyl ether, 1 : 4) yielded, (2E)-octa-2,7-dien-1-ol 148 (0.65 g, 87% yield) as a colourless 
oil. Spectroscopic data consistent with literature.
114 δH (400 MHz, CDCl3) 1.34 (1H, br s, 
OH), 1.46-1.51 (2H, m, 5-H2), 2.02-2.10 (4H, m, 4-H2 and 6-H2), 4.07 (2H, d, J 4.6 Hz, 1-
H2), 4.94-4.97 (1H, m, 8-HH), 5.01 (1H, dq, J 17.0, 1.7, 8-HH), 5.60-5.73 (2H, m, 2-H and 
3-H), 5.80 (1H, ddt, J 17.0, 10.2, 6.7 Hz, 7-H); δC (100 MHz, CDCl3) 28.3 (CH2), 31.6 
(CH2), 33.2 (CH2), 63.8 (CH2), 114.6 (CH2), 129.2 (CH), 133.0 (CH), 138.6 (CH); m/z (CI) 
109.1009 (M
+-OH. C8H13 requires 109.1017), 95 (16%), 81 (12), 67 (47). 
 
(2E)-Hepta-2,6-dien-1-ol.
115  
 
OH
 
 
The  reaction  was  carried  out  according  to  general  procedure  2,  using  ethyl  (2E)-2,6-
heptadienoate  (1.54  g,  10.0  mmol).  Flash  column  chromatography  (petroleum  ether  : 
diethyl ether, 7 : 3) yielded, (2E)-hepta-2,6-dien-1-ol (0.92 g, 82% yield) as a colourless 
oil. Spectroscopic data consistent with literature.
115 δH (400 MHz, CDCl3) 1.42 (1H, br s, 
OH), 2.10-2.15 (4H, m, 4-H2 and 5-H2), 4.08 (2H, d, J 4.8 Hz, 1-H2), 4.96-5.03 (2H, m, 7-
H2), 5.62-5.71 (2H, m, 2-H and 3-H), 5.72-5.89 (1H, m, 6-H); δC (100 MHz, CDCl3) 31.5 
(CH2), 33.3 (CH2), 63.7 (CH2), 114.9 (CH2), 129.4 (CH), 132.4 (CH), 138.1 (CH); m/z (CI) 
113.0964 (MH
+. C7H13O requires 113.0966), 95 (100%), 81 (14), 73 (13). 128 
(2E)-Nona-2,8-dien-1-ol.
116 
  
OH
 
 
The  reaction  was  carried  out  according  to  general  procedure  2,  using  ethyl  (2E)-2,8-
nonadienoate (1.00 g, 5.5 mmol). Flash column chromatography (petroleum ether : diethyl 
ether,  7  :  3)  yielded,  (2E)-nona-2,8-dien-1-ol  (0.77  g,  100%  yield)  as  a  colourless  oil. 
Spectroscopic data consistent with literature.
116 δH (400 MHz, CDCl3) 1.22 (1H, br s, OH), 
1.38-1.42 (4H, m, 5-H2 and 6-H2), 2.02-2.10 (4H, m, 4-H2 and 7-H2), 4.09 (2H, t, J 4.9 Hz, 
1-H2), 4.92-4.96 (1H, m, 9-HH), 5.00 (1H, dq, J 17.0, 1.6 Hz, 9-HH), 5.60-5.74 (2H, m, 2-
H and 3-H), 5.81 (1H, ddt, J 17.0, 10.2, 6.7 Hz, 8-H); δC (100 MHz, CDCl3) 26.9 (CH2), 
27.1 (CH2), 30.6 (CH2), 32.2 (CH2), 62.4 (CH2), 112.9 (CH2), 127.5 (CH), 131.9 (CH), 
137.4 (CH); m/z (CI) 123.1169 (MH
+-H2O. C9H15 requires 123.1174), 109 (16%), 95 (12), 
81 (63), 67 (17). 
 
(2E)-Deca-2,9-dien-1-ol.
118 
 
OH
 
 
The  reaction  was  carried  out  according  to  general  procedure  2,  using  ethyl  (2E)-2,9-
decadienoate (1.50 g, 7.7 mmol). Flash column chromatography (petroleum ether : diethyl 
ether,  7  :  3)  yielded,  (2E)-deca-2,9-dien-1-ol  (0.97  g,  81%  yield)  as  a  colourless  oil. 
Spectroscopic data consistent with literature.
118 δH (400 MHz, CDCl3) 1.25-1.46 (7H, m, 5-
H2, 6-H2, 7-H2 and OH), 2.01-2.10 (4H, m, 4-H2 and 8-H2), 4.09 (2H, d, J 4.6 Hz, 1-H2), 
4.92-4.96 (1H, m, 10-HH), 4.97-5.05 (1H, m, 10-HH), 5.58-5.74 (2H, m, 2-H and 3-H), 
5.81 (1H, ddt, J 17.1, 10.1, 6.7 Hz, 9-H); δC (100 MHz, CDCl3) 28.7 (CH2), 28.8 (CH2), 
29.0 (CH2), 32.2 (CH2), 33.8 (CH2), 63.9 (CH2), 114.3 (CH2), 128.9 (CH), 133.5 (CH), 
139.1 (CH); m/z (CI) 137.1324 (MH
+-H2O. C10H17 requires 137.1330), 113 (25%), 95 (49), 
81 (100), 69 (88), 67 (59). 
 
 
 
 
 129 
3-(2’,2’,2’-Trichloromethylcarbonylamino)octa-1,7-diene (150). 
 
HN O
CCl3 
 
The reaction was carried out according to general procedure 4, using (2E)-octa-2,7-dien-1-
ol 148 (0.07 g, 0.5 mmol). PdCl2(MeCN)2 was used to catalyse the rearrangement, which 
was carried out in DCM (10 mL) and stirred at room temperature for 3 h. Purification by 
column  chromatography  (petroleum  ether  :  diethyl  ether,  10  :  1)  gave  3-(2’,2’,2’-
trichloromethylcarbonylamino)octa-1,7-diene 150 as a brown oil (0.10 g, 71% yield over 2 
steps). δH (400 MHz, CDCl3) 1.43-1.52 (2H, m, 5-H2), 1.55-1.73 (2H, m, 4-H2), 2.06-2.14 
(2H, m, 6-H2), 4.40-4.50 (1H, m, 3-H), 4.95 (1H, ddt, J 10.2, 2.0, 1.5 Hz, 8-HH), 5.00 (1H, 
ddt, J 17.1, 3.6, 1.5 Hz, 8-HH), 5.20 (1H, ddd, J 10.5, 1.2, 0.8 Hz, 1-HH), 5.24 (1H, ddd, J 
17.2, 1.5, 1.2 Hz, 1-HH), 5.73-5.85 (2H, m, 2-H and 7-H), 6.52 (1H, br s, NH). 
 
1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclohexa-2-ene (151).
21 
 
HN CCl3
O  
 
3-(2’,2’,2’-Trichloromethylcarbonylamino)octa-1,7-diene  150  (0.10  g,  0.4  mmol)  was 
dissolved in DCM (10 mL). Grubbs I catalyst (10 mol %) (0.03 g, 0.04 mmol) was added 
and the reaction mixture was heated under reflux for 12 h. The reaction was cooled and 
filtered  through  Celite
®.  Flash  column  chromatography  (elution  with  petroleum  ether  : 
diethyl  ether,  20  :  1)  yielded  1-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-2-ene 
151 as a white solid (0.09 g, 100% yield). mp 85-86 
oC, lit.
21 85.5-87 
oC; δH (400 MHz, 
CDCl3) 1.62-1.79 (3H, m, 5-H2 and 6-H), 1.94-2.03 (1H, m, 6-H), 2.03-2.16 (2H, m, 4-H2), 
4.42-4.54 (1H, m, 1-H), 5.65 (1H, ddt, J 10.0, 4.0, 2.2 Hz, 2-H), 5.98 (1H, dtd, J 10.0, 4.0, 
1.9 Hz, 3-H), 6.60 (1H, br s, NH); δC (100 MHz, CDCl3) 19.4 (CH2), 24.7 (CH2), 28.6 
(CH2),  46.9  (CH),  92.7  (C),  125.7  (CH),  132.7  (CH),  161.1  (C);  m/z  (CI)  261.0144 
(M+NH4)
+. C8H14N2O
35Cl2
37Cl requires 261.0143), 259 (100%), 242 (23), 225 (9), 206 
(21), 81 (10). 130 
 
Synthesis of 1-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-2-ene (151),
21 using 
Grubbs I catalyst. 
 
The reaction was carried out according general procedure 6 using (2E)-octa-2,7-dien-1-ol 
148 (0.10 g, 0.8 mmol) and bis(acetonitrile)palladium(II) chloride (0.020 g, 0.08 mmol) 
was  used  to  catalyze  the  aza-Claisen  rearrangement.  Purification  by  flash  column 
chromatography  (elution with petroleum ether : diethyl  ether, 97 : 3)  gave 1-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohexa-2-ene 151 as a white solid (0.17 g, 89% yield 
over 3 steps). Spectroscopic data as reported above. 
 
Synthesis of 1-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-2-ene (151),
21 using 
Grubbs II catalyst. 
 
The reaction was carried out according general procedure 6 using (2E)-octa-2,7-dien-1-ol 
148 (0.08 g, 0.6 mmol), bis(acetonitrile)palladium(II) chloride (0.015 g, 0.06 mmol) was 
used to catalyze the aza-Claisen rearrangement and Grubbs II catalyst (0.05 g, 0.06 mmol) 
was used to catalyze the RCM. Purification by flash column chromatography (elution with 
petroleum  ether  :  diethyl  ether,  97  :  3)  gave  1-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohexa-2-ene 151, as a white solid (0.14 g, 95% yield 
over 3 steps). Spectroscopic data as reported above. 
 
Synthesis of 1-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-2-ene (151),
21 using 
Grubbs/Hoveyda II catalyst. 
 
The reaction was carried out according general procedure 6 using (2E)-octa-2,7-dien-1-ol 
148 (0.08 g, 0.6 mmol), bis(acetonitrile)palladium(II) chloride (0.08 g, 0.6 mmol) was used 
to catalyze the aza-Claisen rearrangement and Grubbs/Hoveyda II catalyst (0.04 g, 0.06 
mmol)  was  used  to  catalyze  the  RCM.  Purification  by  flash  column  chromatography 
(elution  with  petroleum  ether  :  diethyl  ether,  97  :  3)  gave  1-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohexa-2-ene 151, as a white solid (0.14 g, 95% yield 
over 3 steps). Spectroscopic data as reported above. 
 
 
 
 131 
1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclopenta-2-ene (155). 
 
HN CCl3
O  
 
The reaction was carried out according general procedure 6 using (2E)-hepta-2,6-dien-1-ol 
(0.10 g, 0.9 mmol) and bis(acetonitrile)palladium(II) chloride (0.04 g, 0.2 mmol) was used 
to catalyze the rearrangement. Purification by flash column chromatography (elution with 
petroleum  ether  :  diethyl  ether,  24  :  1)  gave  1-(2’,2’,2’-
trichloromethylcarbonylamino)cyclopenta-2-ene 155 as a white solid (0.17 g, 84% yield 
over 3 steps). mp 81-82 
oC; ￿max/cm
-1 (NaCl) 3291 (NH), 1684 (CO), 1528 (C=C), 823; δH 
(400 MHz, CDCl3) 1.67-1.75 (1H, m, 4-HH) 2.34-2.57 (3H, m, 4-HH and 5-H2), 4.92-5.01 
(1H, m, 1-H), 5.72-5.76 (1H, m, 2-H), 6.05-6.09 (1H, m, 3-H), 6.68 (1H, br s, NH); δC 
(100 MHz, CDCl3) 28.9 (CH2), 29.4 (CH2), 56.0 (CH), 90.8 (C), 127.5 (CH), 134.2 (CH), 
159.3 (C); m/z (CI) 229.9718 (MH
+. C7H9NO
35Cl2
37Cl requires 229.9718), 228 (100%), 
194 (22), 162 (5), 67 (13).  
 
1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclohepta-2-ene (156).
82 
 
HN CCl3
O  
 
The reaction was carried out according general procedure 6 (at a concentration of 0.005 M) 
using  (2E)-nona-2,8-dien-1-ol  (0.10  g,  0.7  mmol)  and  bis(acetonitrile)palladium(II) 
chloride  (0.02  g,  0.08  mmol)  was  used  to  catalyze  the  aza-Claisen  rearrangement. 
Purification by flash column chromatography (elution with petroleum ether : DCM, 5 : 2) 
gave  1-(2’,2’,2’-trichloromethylcarbonylamino)cyclohepta-2-ene  156,  as  a  white  solid 
(0.17 g, 93% yield over 3 steps). mp 104-105 
oC, lit.
82 105 
oC; δH (400 MHz, CDCl3) 1.39-
1.49 (1H, m, 6-HH), 1.66-1.79 (3H, m, 6-HH and 7-H2), 1.85-1.98 (2H, m, 5-H2), 2.10-
2.29 (2H, m, 4-H2), 4.54-4.62 (1H, m, 1-H), 5.55-5.62 (1H, m, 2-H), 5.88-5.95 (1H, m, 3-
H), 6.72 (1H, br s, NH); δC (100 MHz, CDCl3) 24.6 (CH2), 25.2 (CH2), 26.5 (CH2), 31.1 
(CH2), 50.5 (CH), 90.8 (C), 130.5 (CH), 131.8 (CH), 158.8 (C); m/z (CI) 256.0060 (MH
+. 
C9H13NO
35Cl3 requires 256.0063), 258 (97%), 222 (18), 95 (12). 132 
1-(2’,2’,2’-Trichloromethylcarbonylamino)cycloocta-2-ene (158). 
 
HN CCl3
O  
 
The reaction was carried out according general procedure 6 (at a concentration of 0.0013 
M)  using  (2E)-deca-2,8-dien-1-ol  (0.10  g,  0.7  mmol).  Bis(acetonitrile)palladium(II) 
chloride (0.008 g, 0.03 mmol) was used to catalyze the aza-Claisen rearrangement and 
Grubbs  II  catalyst  (0.05  g,  0.06  mmol,  20  mol  %)  was  used  to  catalyze  the  RCM. 
Purification by flash column chromatography (elution with petroleum ether : DCM, 5 : 2) 
gave  1-(2’,2’,2’-trichloromethylcarbonylamino)cycloocta-2-ene  158,  as  a  white  solid 
(0.044 g, 62% yield over 3 steps). mp 126-127 
oC; ￿max/cm
-1 (NaCl) 3314 (NH), 1684 
(CO), 1529 (C=C), 824; δH (400 MHz, CDCl3) 1.39-1.49 (7H, m, 5-H2, 6-H2, 7-H2 and 8-
HH), 1.98 (1H, ddt, J 13.1, 8.9, 4.4 Hz, 8-HH), 2.11-2.20 (1H, m, 4-HH), 2.25-2.36 (1H, 
m, 4-HH), 4.75-4.79 (1H, m, 1-H), 5.31-5.38 (1H, m, 2-H), 5.79 (1H, dtd, J 10.5, 7.5, 1.4 
Hz, 3-H), 6.65 (1H, br s, NH); δC (100 MHz, CDCl3) 22.1 (CH2), 23.9 (CH2), 24.4 (CH2), 
26.8 (CH2), 33.7 (CH2), 47.9 (CH), 90.7 (C), 127.3 (CH), 129.5 (CH), 158.9 (C); m/z (CI) 
270.0216 (MH
+. C10H15NO
35Cl3 requires 270.0219), 272 (92%), 236 (58), 234 (85), 109 
(47), 67 (28).  
 
(1S)-1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclohexa-2-ene (159). 
 
HN CCl3
O  
 
The reaction was carried out according general procedure 6 using (2E)-octa-2,7-dien-1-ol 
148 (0.08 g, 0.6 mmol) and (S)-COP-Cl (0.04 g, 0.03 mmol) as rearrangement catalyst. 
Purification by flash column chromatography (elution with petroleum ether : diethyl ether, 
97  :  3)  gave  (1S)-1-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-2-ene  159  as  a 
white solid (0.15 g, 90% yield over 3 steps). 88% ee determined by HPLC analysis using 
CHIRALPAK IB column (0.5% iPrOH : hexane at 0.75 mL/min), retention time: tS= 8.2 
min,  and  tR=  9.2  min;  [α]D
23  -95.3  (c  2.1,  CHCl3).  All  other  spectroscopic  data  as 133 
previously  reported  for  1-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-2-ene  151 
above. 
 
(1R)-1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclohexa-2-ene (160).  
 
HN CCl3
O  
 
The reaction was carried out according general procedure 6 using (2E)-octa-2,7-dien-1-ol 
148 (0.08 g, 0.6 mmol) and (R)-COP-Cl (0.04 g, 0.03 mmol) as the catalyst for aza-Claisen 
rearrangement. Purification by flash column chromatography (elution with petroleum ether 
: diethyl ether 97 : 3) gave (1R)-1-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-2-ene 
160  as  a  white  solid  (0.12  g,  75%  yield  over  3  steps).  88%  ee  determined  by  HPLC 
analysis using CHIRALPAK-IB column (0.5% iPrOH : hexane at 0.75 mL/min), retention 
time: tS= 8.3 min, and tR= 9.4 min; [α]D
23 +97.4 (c 1.3, CHCl3). All other spectroscopic 
data as previously reported for 1-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-2-ene 
151 above. 
 
(1S)-1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclopenta-2-ene (161).  
 
HN CCl3
O  
 
The reaction was carried out according general procedure 6 using (2E)-hepta-2,6-dien-1-ol 
152 (0.08 g, 0.7 mmol) and (S)-COP-Cl (0.05 g, 0.03 mmol) as rearrangement catalyst. 
Purification by flash column chromatography (elution with petroleum ether : DCM, 70 : 
30) gave (1S)-1-(2’,2’,2’-trichloromethylcarbonylamino)cyclopenta-2-ene 161 as a white 
solid  (0.13  g,  88%  yield  over  3  steps).  92%  ee  determined  by  HPLC  analysis  using 
CHIRALPAK IB column (0.5% iPrOH : hexane at 0.75 mL/min), retention time: tS= 12.7 
min,  and  tR=  14.5  min;  [α]D
23  -86.6  (c  1.0,  CHCl3).  All  other  spectroscopic  data  as 
previously  reported  for  1-(2’,2’,2’-trichloromethylcarbonylamino)cyclopenta-2-ene  155 
above. 
 134 
(1S)-1-(2’,2’,2’-Trichloromethylcarbonylamino)cyclohepta-2-ene (162). 
 
HN CCl3
O  
 
The reaction was carried out according general procedure 6 using (2E)-nona-2,8-dien-1-ol 
153 (0.08 g, 0.5 mmol) and (S)-COP-Cl (0.04 g, 0.03 mmol) as rearrangement catalyst. 
Purification by flash column chromatography (elution with petroleum ether : DCM, 70 : 
30) gave (1S)-1-(2’,2’,2’-trichloromethylcarbonylamino)cyclohepta-2-ene 162 as a white 
solid  (0.11  g,  81%  yield  over  3  steps).  84%  ee  determined  by  HPLC  analysis  using 
CHIRALPAK IB column (0.5% iPrOH : hexane at 0.5 mL/min), retention time: tS= 21.5 
min,  and  tR=  22.1  min;  [α]D
23  -25.0  (c  1.0,  CHCl3).  All  other  spectroscopic  data  as 
previously  reported  for  1-(2’,2’,2’-trichloromethylcarbonylamino)cyclohepta-2-ene  156 
above. 
 
(2R)-1-(tert-Butyldimethylsilyloxy)-2,3-epoxypropane (185).
119  
 
OTBDMS
O
 
 
A mixture of (S)-glycidol 184 (3.10 g, 0.04 mol), tert-butyldimethylsilyl chloride (9.40 g, 
0.06 mol) and imidazole (4.20 g, 0.06 mol) in THF (70 mL) were stirred overnight at room 
temperature. A white precipitate was removed by filtration and washed with diethyl ether 
(70  mL).  The  combined  filtrate  was  concentrated  and  purified  by  flash  column 
chromatography (elution with petroleum ether : diethyl ether, 10 : 1) to give (2R)-1-(tert-
butyldimethylsilyloxy)-2,3-epoxypropane 185 (7.7 g, 98%) as a clear oil. [α]D
24 +2.7 (c 
1.0, CHCl3), lit.
119 +2.9 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 0.09 (3H, s, SiCH3), 0.10 
(3H, s, SiCH3), 0.92 (9H, s, SiC(CH3)3), 2.66 (1H, dd, J 4.6, 2.4 Hz, 1-HH), 2.79 (1H, dd, 
J 5.2, 4.6 Hz, 1-HH), 3.10-3.14 (1H, m, 2-H), 3.68 (1H, dd, J 11.8, 4.8 Hz, 3-HH), 3.87 
(1H, dd, J 11.8, 3.2 Hz, 3-HH); δC (100 MHz, CDCl3) -5.4 (CH3), -5.3 (CH3), 19.0 (C), 
26.0 (CH3), 45.0 (CH2), 52.5 (CH) and 63.9 (CH2); m/z (CI) 189.1309 (MH
+. C9H21O2Si 
requires 189.1311), 145 (35%), 131 (50), 89 (62), 73 (12). 
 
 
 135 
(2R)-1-(tert-Butyldimethylsilyloxy)hex-5-en-2-ol (186).
120 
  
OTBDMS
OH
 
 
A solution of allyl magnesium bromide (1 M in diethyl ether) (100.0 mL, 100.0 mmol) was 
added drop-wise to a solution of copper(I) bromide dimethylsulfide complex (0.69 g, 3.4 
mmol) in THF (150 mL) at -78 
oC and the white suspension was stirred for 0.5 h. (2R)-1-
(tert-Butyldimethylsilyloxy)-2,3-epoxypropane 185 (12.70 g, 67.0 mmol) in THF (60 mL) 
was then added and the reaction mixture was warmed to 0 
oC and stirred for 2 h. The 
reaction was quenched by the addition of a saturated ammonium chloride solution (100 
mL) and extracted with ethyl acetate (3 x 200 mL). The organic layers were combined, 
dried (MgSO4) and concentrated in vacuo. Purification by flash column chromatography 
(petroleum ether : diethyl ether, 10 : 1) gave (2R)-1-(tert-butyldimethylsilyloxy)hex-5-en-
2-ol 186 (13.9 g, 90%) as a clear oil. Spectroscopic data as reported in literature.
120 [α]D
24 -
6.7 (c 1.2, CHCl3); δH (400 MHz, CDCl3) 0.01 (6H, s, Si(CH3)2), 0.82 (9H, s, SiC(CH3)3), 
1.35-1.55 (2H, m, 3-H2), 2.00-2.22 (2H, m, 4-H2), 2.35 (1H, br d, J 3.3 Hz, OH), 3.33 (1H, 
dd, J 9.9, 7.1 Hz, 1-HH), 3.53-3.62 (2H, m, 1-HH and 2-H), 4.88-4.92 (1H, m, 6-HH), 
4.94-5.00 (1H, m, 6-HH), 5.76 (1H, ddt, J 17.1, 10.3, 6.6 Hz, 5-H); δC (100 MHz, CDCl3) -
5.4 (CH3), -5.3 (CH3), 18.3 (C), 25.9 (CH3), 29.8 (CH2), 32.0 (CH2), 67.2 (CH2), 71.2 
(CH), 114.8 (CH2), 138.4 (CH); m/z (CI) 231.1776 (MH
+. C12H27O2Si requires 231.1780), 
173 (8), 81 (15). 
 
(2R)-1-(tert-Butyldimethylsilyloxy)-2-(methoxymethoxy)hex-5-ene (187). 
 
OTBDMS
OMOM
 
 
The  reaction  was  carried  out  according  to  general  procedure  3  using  (2R)-1-(tert-
butyldimethylsilyloxy)hex-5-en-2-ol  186  (4.00  g,  17.0  mmol).  Flash  column 
chromatography  (petroleum  ether  :  diethyl  ether,  20  :  1)  yielded  (2R)-1-(tert-
butyldimethylsilyloxy)-2-(methoxymethoxy)hex-5-ene 187, as a clear oil (4.7 g, 100%). 
(Found: C, 61.4; H, 11.0. C14H30O3Si requires C, 61.3; H, 11.0%); υmax/cm
-1 (NaCl) 2929 
(CH), 1642 (C=C), 1472 (CH), 1255, 1110 (CO), 1040; [α]D
24 +28.8 (c 1.5, CHCl3); δH 
(400 MHz, CDCl3) 0.01 (6H, s, Si(CH3)2), 0.82 (9H, s, SiC(CH3)3), 1.35-1.54 (2H, m, 3-
H2), 2.00-2.21 (2H, m, 4-H2), 3.34 (3H, s, OCH3), 3.50-3.62 (3H, m, 1-H2 and 2-H), 4.60 
(1H, d, J 6.8 Hz, OCHHO), 4.72 (1H, d, J 6.8 Hz, OCHHO), 4.89-4.94 (1H, m, 6-HH), 136 
4.95-5.01 (1H, m, 6-HH), 5.77 (1H, ddt, J 17.1, 10.3, 6.6 Hz, 5-H); δC (100 MHz, CDCl3) -
5.4 (CH3), -5.4 (CH3), 18.3 (C), 25.9 (CH3), 29.6 (CH2), 31.0 (CH2), 55.5 (CH3), 65.7 
(CH2), 77.7 (CH), 96.4 (CH2), 114.6 (CH2), 138.5 (CH); m/z (CI) 243 (M
+-OCH4, 100%), 
231 (8), 133 (11), 81 (18).  
 
(2R)-2-(Methoxymethoxy)hex-5-en-1-ol (188). 
 
OH
OMOM
 
 
A solution of tetrabutylammonium fluoride (1M in THF) (18.8 mL, 18.8 mmol) was added 
to  a  solution  of  (2R)-1-(tert-butyldimethylsilyloxy)-2-(methoxymethoxy)hex-5-ene  187 
(4.30  g,  15.7  mmol)  in  THF  (100  mL)  at  0 
oC.  The  reaction  was  warmed  to  room 
temperature and stirred  overnight. The reaction mixture was then concentrated and the 
resulting residue was re-suspended in diethyl ether (50 mL). The solution was washed with 
water (50 mL) and the aqueous layer was then extracted with diethyl ether (3 x 50 mL). 
The combined organic extracts were dried (MgSO4), concentrated and then purified by 
flash  column  chromatography  (petroleum  ether  :  diethyl  ether,  5  :  2)  to  give  (2R)-2-
(methoxymethoxy)hex-5-en-1-ol 188, as a clear oil (2.42 g, 98%). (Found: C, 59.9; H, 
10.2. C8H16O3 requires C, 60.0; H, 10.0%); υmax/cm
-1 (NaCl) 3432 (OH), 2947 (CH), 1641 
(C=C), 1450, 1212, 1028; [α]D
24 -66.8 (c 0.6, CHCl3); δH (400 MHz, CDCl3) 1.49-1.70 
(2H, m, 3-H2), 2.07-2.24 (2H, m, 4-H2), 3.14 (1H, br dd, J 8.5, 3.4 Hz, OH) 3.44 (3H, s, 
OCH3), 3.47-3.64 (3H, m, 1-H2 and 2-H), 4.69 (1H, d, J 6.9 Hz, OCHHO), 4.75 (1H, d, J 
6.9 Hz, OCHHO), 4.96-5.07 (2H, m, 6-H2), 5.80 (1H, ddt, J 17.1, 10.3, 6.6 Hz, 5-H); δC 
(100  MHz,  CDCl3)  29.7  (CH2),  30.8  (CH2),  55.7  (CH3),  66.7  (CH2),  81.9  (CH),  97.1 
(CH2), 115.1 (CH2), 138.0 (CH); m/z (CI) 129 (MH
+-OCH4, 100%), 99 (14), 81 (40), 69 
(38).  
 
Ethyl (2E,4R)-4-(methoxymethoxy)octa-2,7-dienoate (189). 
 
OMOM
CO2Et 
 
Reaction  was  carried  out  according  to  general  procedure  1,  using  (2R)-2-
(methoxymethoxy)hex-5-en-1-ol 188 (1.00 g, 6.3 mmol). Flash column chromatography 
(petroleum ether : diethyl ether, 5 : 1) yielded ethyl (2E,4R)-4-(methoxymethoxy)octa-2,7-137 
dienoate  189  (1.35  g,  94%  yield)  as  a  yellow  oil.
  (Found:  C,  63.2;  H,  8.9.  C12H20O4 
requires C, 63.2; H, 8.8%); υmax/cm
-1 (NaCl) 2941 (CH), 1720 (CO), 1658 (C=C), 1446, 
1369, 1269, 1154; [α]D
24 +79.2 (c 1.3, CHCl3); δH (400 MHz, CDCl3) 1.30 (3H, t, J 7.1 Hz, 
OCH2CH3), 1.59-1.80 (2H, m, 5-H2), 2.09-2.21 (2H, m, 6-H2), 3.39 (3H, s, OCH3), 4.18-
4.25 (3H, m, 4-H and OCH2CH3), 4.59 (1H, d, J 6.9 Hz, OCHHO), 4.64 (1H, d, J 6.9 Hz, 
OCHHO), 4.97-5.08 (2H, m, 8-H2), 5.81 (1H, ddt, J 17.1, 10.3, 6.6 Hz, 7-H), 5.99 (1H, dd, 
J 15.7, 1.2 Hz, 2-H), 6.82 (1H, dd, J 15.7, 6.5 Hz, 3-H); δC (100 MHz, CDCl3) 14.2 (CH3), 
29.3 (CH2), 34.0 (CH2), 55.7 (CH3), 60.5 (CH2), 74.6 (CH), 94.7 (CH2), 115.2 (CH2), 
122.1 (CH), 137.7 (CH), 147.6 (CH), 166.2 (C); m/z (CI) 229 (MH
+, 35%), 199 (33), 197 
(37), 167 (100), 81 (16), 69 (24).  
 
(2E,4R)-4-(Methoxymethoxy)octa-2,7-dien-1-ol (190). 
 
OMOM
OH 
 
The  reaction  was  carried  out  according  to  general  procedure  2,  using  ethyl  (2E,4R)-4-
(methoxymethoxy)octa-2,7-dienoate  189  (1.30  g,  5.7  mmol).  Flash  column 
chromatography  (petroleum  ether  :  diethyl  ether,  2  :  3)  yielded,  (2E,4R)-4-
(methoxymethoxy)octa-2,7-dien-1-ol 190 (1.00 g, 98% yield) as a colourless oil. (Found: 
C, 64.5; H, 9.7. C10H18O3 requires C, 64.5; H, 9.7%); υmax/cm
-1 (NaCl) 3408 (OH), 2937 
(CH), 1641 (C=C), 1442, 1373, 1153, 1096, 1036; [α]D
24 +126.8 (c 1.3, CHCl3); δH (400 
MHz, CDCl3) 1.54-1.64 (2H, m, 5-HH and OH), 1.68-1.78 (1H, m, 5-HH), 2.06-2.22 (2H, 
m, 6-H2), 3.38 (3H, s, OCH3), 4.02-4.09 (1H, m, 4-H), 4.17 (2H, m, 1-H2), 4.54 (1H, d, J 
6.9 Hz, OCHHO), 4.70 (1H, d, J 6.9 Hz, OCHHO), 4.95-5.06 (2H, m, 8-H2), 5.58 (1H, 
ddd, J 15.6, 7.8, 1.4 Hz, 3-H) 5.79-5.87 (2H, m 2-H and 7-H); δC (100 MHz, CDCl3) 29.6 
(CH2), 34.7 (CH2), 55.5 (CH3), 62.9 (CH2), 75.7 (CH), 93.7 (CH2), 114.9 (CH2), 131.2 
(CH), 132.3 (CH), 138.2 (CH); m/z (CI) 204 (MNH4
+, 100%), 174 (31), 142 (29), 125 (14), 
58 (16).  
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(1R,2S)-1-(Methoxymethoxy)-2-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-3-
ene  (177a)  and  (1R,2R)-1-(methoxymethoxy)-2-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohexa-3-ene (177b).
 
 
HN
MOMO
O
CCl3
+
1
2
3
4
5
6
HN
MOMO
O
CCl3 
 
The  reaction  was  carried  out  according  general  procedure  6  using  (2E,4R)-4-
(methoxymethoxy)octa-2,7-dien-1-ol  190  (1.10  g,  3.4  mmol). 
Bis(acetonitrile)palladium(II) chloride (0.090 g, 0.3 mmol) was used to catalyze the aza-
Claisen rearrangement, which was stirred at room temperature overnight before addition of 
Grubbs I catalyst. Purification by flash column chromatography (elution with petroleum 
ether  :  diethyl  ether,  7  :  1)  gave  (1R,2S)-1-(methoxymethoxy)-2-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohexa-3-ene  177a  followed  by  (1R,2R)-1-
(methoxymethoxy)-2-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-3-ene  177b,  as  a 
yellow oil (0.46 g, 45% combined yield over 3 steps) and in a 5 : 1 ratio (177a : 177b). 
υmax/cm
-1 (NaCl) 3421 (NH), 2930 (CH), 1709 (CO), 1654 (C=C), 1500, 1148, 1102, 1036. 
Data  for  (1R,2S)-1-(methoxymethoxy)-2-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohexa-3-ene 177a: [α]D
20 +79.1 (c 1.9, CHCl3); δH (400 
MHz, CDCl3) 1.73-1.82 (1H, m, 6-HH), 2.00-2.13 (2H, m, 5-HH and 6-HH), 2.17-2.28 
(1H, m, 5-HH), 3.42 (3H, s, OCH3), 4.05 (1H, td, J 5.6, 1.3 Hz, 1-H), 4.60-4.66 (1H, m, 2-
H), 4.72 (1H, d, J 6.9 Hz, OCHHO), 4.76 (1H, d, J 6.9 Hz, OCHHO), 5.51-5.56 (1H, m, 3-
H), 5.91-5.97 (1H, m, 4-H), 7.31 (1H, br d, J 7.0 Hz, NH); δC (100 MHz, CDCl3) 20.2 
(CH2), 24.2 (CH2), 48.6 (CH), 55.0 (CH3), 70.9 (CH), 91.9 (C), 94.5 (CH2), 123.4 (CH), 
129.9  (CH),  160.7  (C).  Data  for  (1R,2R)-1-(Methoxymethoxy)-2-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohexa-3-ene  177b:  δH  (400  MHz,  CDCl3)  1.75-1.87 
(1H, m, 6-HH), 1.90-1.99 (1H, m, 6-HH), 2.11-2.29 (2H, m, 5-H2), 3.39 (3H, s, OCH3), 
3.71-3.79 (1H, m, 1-H), 4.49-4.56 (1H, m, 2-H), 4.70 (1H, d, J 6.9 Hz, OCHHO), 4.74 
(1H, d, J 6.9 Hz, OCHHO), 5.58-5.62 (1H, m, 3-H), 5.91-5.97 (1H, m, 4-H), 6.78 (1H, br 
d, J 7.1 Hz, NH); δC (100 MHz, CDCl3) 23.3 (CH2), 26.0 (CH2), 52.5 (CH), 55.7 (CH3), 
74.9 (CH), 92.6 (C), 95.3 (CH2), 124.1 (CH), 131.4 (CH), 161.6 (C); m/z (CI) 306.0056 
(MH
+. C10H15NO3
35Cl
37Cl2 requires 306.0062), 268 (100%), 234 (45), 198 (7). 
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(1R,2S)-1-(Methoxymethoxy)-2-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-3-
ene  (177a)  and  (1R,2R)-1-(methoxymethoxy)-2-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohexa-3-ene (177b) using toluene as solvent.
 
 
The  reaction  was  carried  out  according  general  procedure  6  using  (2E,4R)-4-
(methoxymethoxy)-octa-2,7-dien-1-ol  190  (0.10  g,  0.5  mmol). 
Bis(acetonitrile)palladium(II) chloride (0.014 g, 0.05 mmol) was used to catalyze the aza-
Claisen rearrangement, which was stirred in toluene (10 mL), initially at 0 
oC and slowly 
warmed to room temperature over 24 h before addition of Grubbs I catalyst. Purification 
by flash column chromatography (elution with petroleum ether : diethyl ether, 7 : 1) gave 
(1R,2S)-1-(methoxymethoxy)-2-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-3-ene 
177a  followed  by  (1R,2R)-1-(methoxymethoxy)-2-(2’,2’,2’-
trichloromethylcarbonylamino)cyclohexa-3-ene  177b,  as  a  yellow  oil  (0.11  g,  60% 
combined yield over 3 steps) and in a 10 : 1 ratio (177a : 177b) 
 
(3aR,4R,7R,7aS)-3,3,4-Trichloro-octahydro[1,8]oxazole-indol-2-one (195). 
 
N
O
O
1 2
3
3a
4
5
6
7 7a
8
Cl
Cl
Cl
 
 
(1R,2S)-1-(Methoxymethoxy)-2-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-3-ene 
177a (0.085 g, 0.3 mmol) was dissolved in toluene (10 mL) which was then de-gassed for 
1h.  Grubbs  I  catalyst  (0.012  g,  0.014  mmol)  was  added  and  the  reaction  mixture  was 
heated at 155 
oC for 6 h. The reaction mixture was then concentrated under vacuum and 
purified by column chromatography (elution with petroleum ether : diethyl ether, 3 : 2) to 
give  (3aR,4R,7R,7aS)-3,3,4-trichloro-octahydro[1,8]oxazole-indol-2-one  195,  as  a  white 
solid (0.018 g, 24%). υmax/cm
-1 (NaCl) 2920 (CH), 1745 (CO), 1419, 1223; [α]D
25 +39.6 (c 
0.7, CHCl3); δH (400 MHz, CDCl3) 1.28-1.38 (1H, m, 5-HH), 1.65-1.75 (1H, m, 6-HH), 
2.05-2.15 (2H, m, 5-HH and 6-HH), 3.46 (1H, dd, J 7.6, 6.9 Hz, 3a-H), 3.93 (1H, ddd, J 
10.8, 7.6, 3.9 Hz, 4-H), 3.99-4.45 (2H, m, 7-H and 7a-H), 4.78 (1H, d, J 5.3 Hz, 9-HH), 
5.11 (1H, d, J 5.3 Hz, 9-HH); δC (100 MHz, CDCl3) 22.7 (CH2), 29.7 (CH2), 55.2 (CH), 
57.2 (CH), 59.2 (CH), 73.0 (CH), 74.3 (CH2), 87.2 (C), 163.7 (C); m/z (CI) 271.9825 
(MH
+. C9H11NO2
35Cl2
37Cl requires 271.9827), 270 (85%), 236 (87), 200 (100), 166 (64). 
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(3aR,4R,7R,7aS)-3,3,4-Trichloro-7-(methoxymethoxy)octahydroindol-2-one (178). 
 
HN
O
Cl
Cl
Cl
1 2
3
3a
4
5
6
7 7a
MOMO
 
 
(1R,2S)-1-(Methoxymethoxy)-2-(2’,2’,2’-trichloromethylcarbonylamino)cyclohexa-3-ene 
177a (0.45 g, 1.5 mmol) was dissolved in p-xylene (10 mL) which was then de-gassed for 
1h.  Powdered  molecular  sieves  (4Å,  activated)  (0.10  g)  and 
dichlorotris(triphenylphosphine)ruthenium(II) (0.070 g, 0.07 mmol) were then added and 
the reaction mixture was heated at 155 
oC in a sealed tube for 2.0 h. The reaction mixture 
was  then  concentrated  under  vacuum  and  purified  by  column  chromatography  (elution 
with  diethyl  ether  :  petroleum  ether,  4  :  1)  to  give  (3aR,4R,7R,7aS)-3,3,4-trichloro-7-
(methoxymethoxy)octahydroindol-2-one  178,  as  a  brown  oil  (0.34  g,  75%).  υmax/cm
-1 
(NaCl) 3256 (NH), 2953 (CH), 1741 (CO), 1440, 1036; [α]D
25 -60.2 (c 0.5, CHCl3); δH 
(400 MHz, CDCl3) 1.50-1.66 (1H, m, 6-HH), 1.71-1.82 (1H, m, 6-HH), 1.89-1.96 (1H, m, 
5-HH), 2.29-2.36 (1H, m, 5-HH), 3.19 (1H, dd, J 8.6, 5.3 Hz, 3a-H), 3.39 (3H, s, OCH3), 
3.83-3.93 (2H, m, 4-H and 7-H), 4.23-4.27 (1H, m, 7a-H), 4.67 (1H, d, J 6.9 Hz, OCHHO), 
4.72 (1H, d, J 6.9 Hz, OCHHO), 6.20 (1H, br s, NH); δC (100 MHz, CDCl3) 24.5 (CH2), 
32.7 (CH2), 54.0 (CH), 54.7 (CH), 55.0 (CH3), 59.0 (CH), 73.0 (CH), 84.4 (C), 94.4 (CH2), 
167.7 (C); m/z (CI) 302.0115 (MH
+. C10H15NO3
35Cl3 requires 302.0118), 268 (30%), 221 
(18), 165 (50). 
 
(3aR,7R,7aS)-Octahydro[1,8]oxazole-indol-2-one (196). 
 
N
O
O
1 2
3
3a
4
5
6
7 7a
8
 
 
(3aR,4R,7R,7aS)-3,3,4-Trichloro-octahydro[1,8]oxazole-indol-2-one  195,  (0.04  g,  0.3 
mmol was dissolved in THF (10 mL) which was then added to a slurry of activated Raney-
Nickel (1.00 g). The reaction was heated under reflux for 24 h and then cooled, diluted 
with diethyl ether (10 mL) and filtered through a short silica plug. The plug was washed 
with diethyl ether (100 mL), then the washings were dried (MgSO4) and concentrated. 
Purification  by  flash  column  chromatography  (elution  with  diethyl  ether)  gave 141 
(3aR,7R,7aS)-octahydro[1,8]oxazole-indol-2-one  196,  as  a  white  solid  (0.016  g,  61%). 
υmax/cm
-1 (NaCl) 2940 (CH), 1708 (CO), 1390, 1223; [α]D
25 +71.5 (c 1.2, CHCl3); δH (400 
MHz, CDCl3) 1.17-1.28 (2H, m, 5-H2), 1.50-1.60 (3H, m, 4-HH and 6-H2), 1.70-1.79 (1H, 
m, 4-HH), 2.00 (1H, dd, J 16.3, 1.5 Hz, 3-HH), 2.42-2.50 (1H, m, 3a-H), 2.87 (1H, dd, J 
16.3, 7.7 Hz, 3-HH), 3.99-4.09 (2H, m, 7-H and 7a-H), 4.30 (1H, d, J 5.4 Hz, 9-HH), 5.14 
(1H, d, J 5.4 Hz, 9-HH); δC (100 MHz, CDCl3) 17.6 (CH2), 24.9 (CH2), 26.4 (CH2), 32.5 
(CH), 42.4 (CH2), 60.0 (CH), 73.6 (CH), 75.1 (CH2), 177.7 (C); m/z (EI) 167.0947 (M
+. 
C9H13NO2 requires 167.0946), 139 (53%), 111 (35), 96 (100), 68 (38). 
 
(3aR,7R,7aS)-7-(Methoxymethoxy)octahydroindol-2-one (197). 
 
HN
O
1 2
3
3a
4
5
6
7 7a
MOMO
 
 
(3aR,4R,7R,7aS)-3,3,4-Trichloro-7-(methoxymethoxy)octahydroindol-2-one  178  (0.05  g, 
0.2 mmol) was dissolved in THF (10 mL) which was then added to a slurry of activated 
Raney-Nickel (1.00 g). The reaction was heated under reflux for 24 h and then a further 
portion of Raney-Nickel was added (1.00 g). The reaction mixture was heated for a further 
24 h then cooled, diluted with diethyl ether (10 mL) and filtered through a short silica plug. 
The plug was washed with diethyl ether (100 mL), then the washings were dried (MgSO4) 
and concentrated. Purification by column chromatography (elution with ethyl acetate) gave 
(3aR,7R,7aS)-7-(methoxymethoxy)octahydroindol-2-one  197,  as  a  yellow  oil  (0.03  g, 
85%). υmax/cm
-1 (NaCl) 3423 (NH), 2935 (CH), 1686 (CO), 1448 and 1035; [α]D
25 +46.1 
(c 0.8, CHCl3); δH (400 MHz, CDCl3) 1.18-1.29 (2H, m, 5-H2), 1.41-1.52 (1H, m, 6-HH), 
1.59-1.67 (1H, m, 6-HH), 1.69-1.83 (2H, m, 4-H2), 2.00 (1H, d, J 16.0, Hz, 3-HH), 2.32-
2.41 (1H, m, 3a-H), 2.49 (1H, dd, J 16.0, 6.6 Hz, 3-HH), 3.38 (3H, s, OCH3), 3.67 (1H, dt, 
J 11.5, 4.4 Hz, 7-H), 3.95 (1H, t, J 4.4 Hz, 7a-H), 4.65 (1H, d, J 6.9 Hz, OCHHO), 4.71 
(1H, d, J 6.9 Hz, OCHHO), 5.70 (1H, br s, NH); δC (100 MHz, CDCl3) 21.9 (CH2), 25.8 
(CH2), 27.1 (CH2), 35.1 (CH), 39.6 (CH2), 55.6 (CH3), 56.6 (CH), 74.9 (CH), 94.9 (CH2), 
177.9 (C); m/z (CI) 200.1288 (MH
+. C10H18NO3 requires 200.1287), 168 (10%), 73 (10). 
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(3aR,7R,7aS)-7-(Methanesulfonyloxy)octahydroindol-2-one (179). 
 
HN
O
1 2
3
3a
4
5 6
7
7a
MsO
 
 
(3aR,7R,7aS)-7-(Methoxymethoxy)octahydroindol-2-one  197  (0.10  g,  0.5  mmol)  was 
dissolved in methanol (2.0 mL) and 2 M hydrochloric acid (6.0 mL). The solution was 
heated to 40 
oC and stirred vigorously for 14 h. The reaction was cooled and neutralised 
using a 6 M solution of potassium carbonate (3.0 mL). The aqueous solution was then 
extracted with ethyl acetate (6 x 25 mL), the combined organic layer was dried (MgSO4) 
then concentrated in vacuo, to give the hydroxy product 204 as a white solid. This solid 
was  dissolved  in  DCM (5.0  mL)  then  methanesulfonyl  chloride  (0.05  mL,  0.8  mmol), 
triethylamine (0.25 mL, 1.8 mmol) and 4-dimethylaminopyridine (DMAP, catalytic) were 
added. The reaction mixture was stirred at room temperature overnight then acidified to pH 
2 (using 2 M HCl) and extracted with DCM (3 x 20 mL). The resulting organic layer was 
dried (MgSO4) and concentrated to give the crude product, which was purified by flash 
column  chromatography  (eluting  with  ethyl  acetate  :  methanol,  20  :  1)  to  give 
(3aR,7R,7aS)-7-(methanesulfonyloxy)octahydroindol-2-one 179, as a white solid (0.10 g, 
88% yield over 2 steps). υmax/cm
-1 (NaCl) 3397 (NH), 2945 (CH), 1664 (CO), 1424, 1340; 
[α]D
24 +68.0 (c 0.5, CHCl3); δH (400 MHz, CDCl3) 1.30-1.40 (2H, m, 5-H2), 1.62-1.71 
(1H, m, 4-HH), 1.77-1.93 (3H, m, 4-HH and 6-H2), 2.05 (1H, d, J 14.0, Hz, 3-HH), 2.53-
2.42 (2H, m, 3-HH and 3a-H), 3.09 (3H, s, SCH3), 4.04 (1H, t, J 4.6 Hz, 7a-H), 4.84 (1H, 
dt, J 10.4, 4.6 Hz, 7-H), 6.20 (1H, br s, NH); δC (100 MHz, CDCl3) 20.9 (CH2), 26.3 
(CH2), 26.5 (CH2), 35.0 (CH), 38.8 (CH2), 38.9 (CH), 56.0 (CH), 79.4 (CH3), 175.7 (C); 
m/z (CI) 234.0802 (MH
+. C9H16NSO4 requires 234.0800), 198 (3%), 138 (6), 85 (2). 
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(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)-7-(methoxymethoxy)-octahydroindol-2-
one (206). 
 
N
O
O
O
MOMO
1 2
3
4
5 6
7
7a
3a
 
 
(3aR,7R,7aS)-7-(Methoxymethoxy)octahydroindol-2-one  197  (0.05  g,  0.3  mmol)  was 
dissolved in THF (2.0 mL) and cooled to 0 
oC. Sodium hydride (60% in mineral oil) (0.012 
g,  0.3  mmol)  was  added  and  the  solution  was  stirred  for  5  minutes  before  piperonyl 
bromide 205,
98 (0.097 g, 0.5 mmol) in THF (1.0 mL) was slowly added. Sodium iodide 
(0.070 g, 0.5 mmol) was then added and the reaction was heated to 50 
oC for 2 h. The 
reaction mixture was cooled and then a saturated solution of ammonium chloride (2.0 mL) 
was added. The solution was extracted with ethyl acetate (3 x 20 mL), dried (MgSO4) and 
concentrated in vacuo. Purification by flash column chromatography (elution with ethyl 
acetate)  gave  (3aR,7R,7aS)-1-(3,4-methylenedioxybenzyl)-7-(methoxymethoxy)-
octahydroindol-2-one 206, as a colourless oil (0.075 g, 90% yield). υmax/cm
-1 (NaCl) 2937 
(CH), 1668 (CO), 1488, 1252; [α]D
25 -32.1 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 1.23-1.38 
(2H, m, 5-H2), 1.51-1.77 (3H, m, 4-H2 and 6-HH), 1.82-1.90 (1H, m, 6-HH), 2.25 (1H, dd, 
J 14.6, 7.5 Hz, 3-HH), 2.32-2.41 (1H, m, 3a-H), 2.47 (1H, dd, J 14.6, 10.4 Hz, 3-HH), 3.30 
(1H, dd, J 6.5, 3.9 Hz, 7-H), 3.35 (3H, s, OCH3), 3.82 (1H, d, J 14.8 Hz, N-CHH), 3.89-
3.93 (1H, m, 7a-H), 4.48 (1H, d, J 7.0 Hz, OCHHO), 4.62 (1H, d, J 7.0 Hz, OCHHO), 5.00 
(1H, d, J 14.8 Hz, N-CHH), 5.94 (2H, s, OCH2O), 6.71-6.76 (3H, m, Ph); δC (100 MHz, 
CDCl3)  15.7  (CH2),  25.8  (CH2),  26.9  (CH2),  32.6  (CH),  36.5  (CH2),  43.8  (CH2),  55.6 
(CH3), 56.2 (CH), 72.2 (CH), 95.3 (CH2), 101.0 (CH2), 108.1 (CH), 108.5 (CH), 121.3 
(CH), 131.1 (C), 146.9 (C), 147.9 (C), 176.6 (C); m/z (CI) 334.1652 (MH
+. C18H24NO5 
requires 334.1654), 302 (7%), 200 (6), 135 (15), 69 (16). 
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(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)-7-hydroxyoctahydroindol-2-one (207). 
 
N
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O
O
HO
1 2
3
4
5 6
7
7a
3a
 
 
(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)-7-(methoxymethoxy)-octahydroindol-2-one 
206 (0.20 g, 0.6 mmol) was dissolved in methanol (5.0 mL) and 2 M hydrochloric acid 
solution (5.0 mL). The reaction mixture was heated to 35 
oC for 48 h, then cooled and 
neutralised  with  a  6  M  solution  of  potassium  carbonate  (10.0  mL).  The  solution  was 
extracted with ethyl acetate (4 x 50 mL), the organic layer was then dried (MgSO4) and 
concentrated  to  give  (3aR,7R,7aS)-1-(3,4-methylenedioxybenzyl)-7-
hydroxyoctahydroindol-2-one 207 as a white solid (0.173 g, 100%). υmax/cm
-1 (NaCl) 3370 
(OH), 2934 (CH), 1663 (CO), 1489, 1442, 1243; [α]D
25 -22.6 (c 1.4, CHCl3); δH (400 
MHz, CDCl3) 1.25-1.39 (2H, m, 5-H2), 1.51-1.61 (1H, m, 4-HH), 1.67-1.87 (3H, m, 4-HH 
and 6-H2), 1.95 (1H, br s, OH), 2.23 (1H, dd, J 15.0, 7.8 Hz, 3-HH), 2.36-2.45 (1H, m, 3a-
H), 2.51 (1H, dd, J 15.0, 11.3 Hz, 3-HH), 3.28 (1H, dd, J 7.0, 3.8 Hz, 7-H), 3.95-4.00 (1H, 
m, 7a-H), 4.17 (1H, d, J 14.8 Hz, N-CHH), 4.71 (1H, d, J 14.8 Hz, N-CHH), 5.95 (2H, s, 
OCH2O),  6.75-6.82  (3H,  m,  Ph);  δC  (100  MHz,  CDCl3)  14.6  (CH2),  25.8  (CH2),  29.4 
(CH2), 32.4 (CH), 36.4 (CH2), 44.9 (CH2), 60.1 (CH), 65.8 (CH), 101.1 (CH2), 108.4 (CH), 
108.5 (CH), 121.4 (CH), 131.3 (C), 147.1 (C), 148.1 (C), 176.8 (C); m/z (CI) 290.1391 
(MH
+. C16H20NO4 requires 290.1392), 289 (12%), 85 (52), 51 (55), 49 (75). 
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(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)-7-(methanesulfonyloxy)octahydroindol-
2-one (209). 
 
N
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7a
3a
 
 
(3aR,7R,7aS)-1-(3,4-Methylenedioxybenzyl)-7-hydroxyoctahydroindol-2-one 207 (0.10 g, 
0.4  mmol)  was  dissolved  in  DCM  (3.0  mL).  Methanesulfonyl  chloride  (0.04  mL,  0.5 
mmol),  triethylamine  (0.17  mL,  1.2  mmol)  and  4-dimethylaminopyridine  (DMAP, 
catalytic) were added and the solution was heated to 35 
oC for 48 h. The reaction mixture 
was then acidified to pH 2 (using 2 M HCl) and extracted with DCM (3 x 10 mL). The 
resulting organic layer was dried (MgSO4) and concentrated to give the crude product, 
which  was  purified  by  flash  column  chromatography  (eluting  with  ethyl  acetate  : 
petroleum  ether,  3  :  2)  to  give  (3aR,7R,7aS)-1-(3,4-methylenedioxybenzyl)-7-
(methanesulfonyloxy)octahydroindol-2-one 209, as a white solid (0.09 g, 73%). υmax/cm
-1 
(NaCl) 2940 (CH), 1687 (CO), 1490, 1443, 1334; [α]D
25 -19.3 (c 1.4, CHCl3); δH (400 
MHz, CDCl3) 1.42-1.52 (2H, m, 5-H2), 1.59-1.66 (2H, m, 4-H2), 1.70-1.79 (2H, m, 6-H2), 
2.11-2.20 (1H, m, 3-HH), 2.32-2.37 (1H, m, 3a-H), 2.43-2.51 (1H, m, 3-HH), 3.01 (3H, s, 
SCH3), 3.36 (1H, dd, J 6.9, 3.9 Hz, 7-H), 3.84 (1H, d, J 14.9 Hz, N-CHH), 5.06 (1H, d, J 
14.9 Hz, N-CHH), 5.14-5.18 (1H, m, 7a-H), 5.95 (2H, s, OCH2O), 6.72-6.76 (3H, m, Ph); 
δC (100 MHz, CDCl3) 14.9 (CH2), 25.1 (CH2), 28.3 (CH2), 32.0 (CH), 35.8 (CH2) 39.2 
(CH), 43.9 (CH2), 57.0 (CH), 75.6 (CH3), 101.1 (CH2), 108.3 (CH), 108.4 (CH), 121.5 
(CH), 130.1 (C), 147.2 (C), 148.1 (C), 175.7 (C); m/z (CI) 368.1173 (MH
+. C17H22NSO6 
requires 368.1168), 335 (12%), 290 (30), 272 (36), 150 (84), 136 (100). 146 
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